archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO BLEB ASSEMBLY,6.6003e-08,1.7343,1.5719,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,6.7728e-06,1.7175,1.4925,1,1
1,GO MEMBRANE RAFT ASSEMBLY,6.0198e-07,1.4257,1.6445,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.0184e-05,1.3467,1.1695,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,5.4272e-08,1.303,1.2366,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,1.3441e-06,1.2854,1.1482,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,7.6379e-08,1.2584,1.1116,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,2.8891e-07,1.2317,1.0967,1,1
1,GO RESPONSE TO INTERFERON ALPHA,1.4963e-07,1.2191,1.2698,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,3.9418e-06,1.1702,1.2062,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,3.479e-08,1.1619,1.0771,1,1
1,GO REGULATION OF PLASMINOGEN ACTIVATION,2.3418e-05,1.1467,0.95586,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,1.2366e-07,1.1353,1.0767,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,4.2424e-08,1.134,1.0678,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.3605e-07,1.0998,1.0618,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.5149e-05,1.0667,0.85449,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4268e-07,1.054,0.9941,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.7801e-06,1.0428,0.90089,1,1
1,GO NEUTROPHIL HOMEOSTASIS,2.5122e-07,1.0348,1.0035,1,1
1,GO HYALURONAN CATABOLIC PROCESS,3.479e-08,1.0272,1.1009,1,1
1,GO RESPONSE TO INTERFERON BETA,1.1776e-06,1.0058,1.033,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,1.1788e-07,0.99651,0.90864,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,3.6228e-06,0.9933,0.89653,1,1
1,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,8.4205e-05,0.98701,0.74943,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.6623e-06,0.98231,0.88503,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.3975e-07,0.9695,0.97875,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,4.0375e-08,0.9585,0.95684,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,9.0221e-07,0.95684,0.92944,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,7.3528e-06,0.94575,0.92346,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,3.6563e-08,0.93272,0.9348,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.3605e-07,0.93216,0.80337,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,2.3654e-06,0.92892,0.858,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,2.0829e-07,0.92401,0.91301,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,3.8423e-08,0.92007,0.96341,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,1.9873e-07,0.91736,0.91716,1,1
1,GO TROPHOBLAST CELL MIGRATION,1.906e-06,0.91154,0.8571,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,2.3975e-07,0.90628,0.83367,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,7.5427e-07,0.90321,0.81819,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,4.1802e-07,0.90128,0.97494,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,4.8612e-06,0.89158,1.0618,1,1
1,GO HEMIDESMOSOME ASSEMBLY,3.3287e-06,0.88821,1.2073,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,3.1491e-08,0.87035,0.95802,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00026903,0.8676,0.78172,1,1
1,GO PLASMINOGEN ACTIVATION,1.8521e-05,0.86665,0.68547,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,2.3975e-07,0.8622,0.83093,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,6.5896e-07,0.85984,0.78978,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9957e-08,0.85508,0.87959,1,1
1,GO MEMBRANE RAFT ORGANIZATION,5.0194e-07,0.85217,0.99459,1,1
1,GO BONE TRABECULA FORMATION,8.1192e-05,0.84706,0.79743,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.628e-07,0.84679,0.85944,1,1
1,GO SKIN MORPHOGENESIS,3.7791e-06,0.84373,0.84871,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,2.0784e-06,0.8346,0.7533,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.5691e-07,0.83422,0.80833,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.5774e-06,0.83326,0.72078,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.1802e-07,0.83235,0.73023,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.9873e-07,0.83091,0.84161,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,9.7275e-08,0.82991,0.72955,1,1
1,GO CD40 SIGNALING PATHWAY,1.071e-07,0.82693,0.78661,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,5.986e-08,0.82175,0.82217,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.93e-08,0.81999,0.78734,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,7.889e-07,0.81364,0.87486,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,2.8496e-08,0.81041,0.84108,1,1
1,GO GAP JUNCTION ASSEMBLY,2.5122e-07,0.80677,0.73331,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,3.1888e-05,0.80489,0.75416,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,2.0033e-05,0.80448,0.81205,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,5.4977e-07,0.80446,0.67085,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,5.4977e-07,0.80137,0.70197,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.2111e-07,0.80017,0.70266,1,1
1,GO EPIBOLY,6.2859e-08,0.79749,0.83601,1,1
1,GO ZYMOGEN INHIBITION,1.2971e-07,0.79652,0.85368,1,1
1,GO T CELL EXTRAVASATION,1.5331e-06,0.79627,0.75655,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.5427e-07,0.7921,0.70611,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.7955e-07,0.79033,0.72759,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,3.3132e-05,0.78963,0.7247,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.1831e-07,0.78271,0.77168,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,3.6228e-06,0.7774,0.67642,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,3.6228e-06,0.77559,0.76888,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,8.0176e-08,0.77482,0.74853,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,2.7343e-05,0.77217,0.70913,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.0571e-06,0.77167,0.6634,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,2.8077e-06,0.77004,0.6934,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,1.4268e-07,0.76737,0.75365,1,1
1,GO ENDODERM FORMATION,4.0375e-08,0.76452,0.8457,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,2.6902e-06,0.76067,0.76505,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.5774e-06,0.75977,0.67578,1,1
1,GO HIPPO SIGNALING,1.6729e-06,0.75833,0.62735,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,6.5149e-05,0.75597,0.61071,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,4.1112e-06,0.75393,0.62146,1,1
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.5774e-06,0.75166,0.69475,1,1
1,GO CYTIDINE TO URIDINE EDITING,8.4205e-05,0.74461,0.71199,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.8131e-07,0.74302,0.70166,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.6015e-06,0.74179,0.66911,1,1
1,GO LATERAL MESODERM DEVELOPMENT,5.9841e-06,0.73191,0.62572,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.6003e-08,0.72952,0.69631,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,6.2859e-08,0.72741,0.71031,1,1
1,GO CELLULAR RESPONSE TO X RAY,0.00013433,0.72155,0.53144,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00034072,0.72057,0.58704,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.2862e-06,0.72044,0.69502,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,5.6999e-08,0.71959,0.70702,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00018427,0.71858,0.78407,1,1
1,GO APOPTOTIC CELL CLEARANCE,4.0375e-08,0.71696,0.81572,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,6.2985e-07,0.71329,0.6428,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,2.9301e-06,0.71297,0.66657,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,6.2859e-08,0.71003,0.73612,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,3.8583e-05,0.70654,0.57953,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,7.889e-07,0.70503,0.70231,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,2.5308e-05,0.70463,0.6123,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,3.7791e-06,0.69998,0.61504,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,3.6228e-06,0.69745,0.62964,1,1
1,GO LEUKOCYTE AGGREGATION,0.00020448,0.69722,0.58568,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.2366e-07,0.69716,0.67967,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.1831e-07,0.69521,0.6397,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,1.0184e-05,0.69515,0.62839,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.8131e-07,0.69471,0.70272,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,1.0207e-07,0.69393,0.88488,1,1
1,GO REGULATION OF FIBRINOLYSIS,6.7728e-06,0.69285,0.67011,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,2.9532e-05,0.692,0.50299,1,1
1,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,2.8891e-07,0.69195,0.65683,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,2.1702e-06,0.69164,0.53907,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.1776e-06,0.69014,0.60535,1,1
1,GO NOTOCHORD DEVELOPMENT,2.8891e-07,0.68927,0.74138,1,1
1,GO REGULATION OF PINOCYTOSIS,1.8251e-06,0.68909,0.70459,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.007729,0.68733,0.4513,1,1
1,GO FIBRINOLYSIS,3.4772e-07,0.68504,0.86242,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,6.6003e-08,0.68278,0.66508,1,1
1,GO VASCULOGENESIS,2.2167e-08,0.68204,0.6732,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,9.0221e-07,0.68135,0.75409,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,2.2879e-07,0.68064,0.75264,1,1
1,GO ENTRY INTO HOST,1.2971e-07,0.67845,0.6264,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,4.1802e-07,0.67786,0.77426,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,9.0221e-07,0.67604,0.61611,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,2.1663e-05,0.67531,0.57336,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.3132e-05,0.6748,0.59212,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,4.3218e-05,0.67352,0.62093,1,1
1,GO BIOLOGICAL PHASE,0.00024286,0.67212,0.61049,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,3.6228e-06,0.67087,0.64908,1,1
1,GO GLOMERULAR MESANGIAL CELL PROLIFERATION,1.9904e-06,0.67077,0.77993,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,1.1788e-07,0.67023,0.68361,1,1
1,GO SALIVARY GLAND DEVELOPMENT,3.3202e-07,0.66806,0.67263,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,1.1267e-06,0.66682,0.72114,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,2.3975e-07,0.66655,0.65647,1,1
1,GO DNA DEAMINATION,3.0576e-06,0.66525,0.64833,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.8891e-07,0.6649,0.76616,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.0194e-07,0.66483,0.70536,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00028792,0.664,0.49663,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,2.5774e-06,0.66131,0.59379,1,1
1,GO RESPONSE TO INTERLEUKIN 18,0.0097392,0.66078,0.54077,1,1
1,GO MUCUS SECRETION,0.0010528,0.65965,0.51844,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,5.2837e-06,0.65809,0.5825,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.508e-06,0.65686,0.55897,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,1.4674e-06,0.65289,0.666,1,1
1,GO ZYMOGEN ACTIVATION,9.0179e-06,0.6524,0.56803,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,9.0179e-06,0.65086,0.6772,1,1
1,GO RESPONSE TO TYPE I INTERFERON,1.1964e-05,0.65077,0.70956,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,9.8628e-07,0.65073,0.80224,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,4.0073e-05,0.65072,0.61108,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,6.2859e-08,0.65032,0.67194,1,1
1,GO TYPE 2 IMMUNE RESPONSE,2.9301e-06,0.64825,0.61795,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00054072,0.64802,0.55281,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,8.3127e-06,0.63626,0.71091,1,1
1,GO ENDODERM DEVELOPMENT,4.6826e-08,0.63415,0.7021,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.3202e-07,0.63111,0.6132,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,2.0784e-06,0.63023,0.61086,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,1.1267e-06,0.62999,0.6615,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,1.3605e-07,0.62907,0.60414,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,5.7413e-06,0.62864,0.54327,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,7.9801e-06,0.6284,0.5946,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00040247,0.62824,0.58964,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,3.6414e-07,0.62692,0.55482,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,6.8936e-07,0.62613,0.57245,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.1776e-06,0.62269,0.57482,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,1.2962e-05,0.62263,0.52059,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,5.2533e-07,0.62018,0.58431,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,2.6902e-06,0.6144,0.53115,1,1
1,GO VAGINA DEVELOPMENT,3.6414e-07,0.61256,0.6536,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,2.4692e-06,0.61151,0.54494,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,5.7413e-06,0.6115,0.61409,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,3.6228e-06,0.61138,0.48197,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,5.986e-08,0.61085,0.62214,1,1
1,GO TOLERANCE INDUCTION,5.0226e-05,0.61007,0.57023,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,7.3528e-06,0.60987,0.5323,1,1
1,GO CELLULAR RESPONSE TO IRON ION,3.0264e-07,0.60935,0.60705,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013917,0.60855,0.54073,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.0207e-07,0.60837,0.61171,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.9873e-07,0.60627,0.54857,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.0184e-05,0.60619,0.4669,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.7806e-05,0.60417,0.5503,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,1.4268e-07,0.60263,0.62953,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,8.8325e-08,0.60211,0.67548,1,1
1,GO COLLAGEN METABOLIC PROCESS,8.4155e-08,0.60033,0.63959,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,1.5691e-07,0.59871,0.52163,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,4.2876e-06,0.59831,0.56226,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.1702e-06,0.59621,0.49788,1,1
1,GO LIVER REGENERATION,2.7104e-08,0.59611,0.61888,1,1
1,GO CELLULAR RESPONSE TO DSRNA,5.6999e-08,0.59578,0.61221,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,1.906e-06,0.59474,0.64553,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.5331e-06,0.59292,0.64011,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,2.0833e-05,0.59277,0.51846,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,8.6584e-06,0.59212,0.54979,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.4772e-07,0.59159,0.68276,1,1
1,GO RESPONSE TO HYPEROXIA,2.1702e-06,0.59114,0.57452,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,4.1112e-06,0.58951,0.60806,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,1.9904e-06,0.58863,0.57135,1,1
1,GO ELASTIC FIBER ASSEMBLY,4.0073e-05,0.58863,0.79007,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,1.2308e-06,0.58592,0.4638,1,1
1,GO BONE TRABECULA MORPHOGENESIS,0.00072223,0.58369,0.49627,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,7.3528e-06,0.58286,0.49704,1,1
1,GO MACROPHAGE PROLIFERATION,4.3218e-05,0.57999,0.55742,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,6.93e-08,0.57919,0.64132,1,1
1,GO PIGMENT GRANULE MATURATION,6.0504e-05,0.57854,0.45917,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,6.0198e-07,0.57823,0.53013,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,1.8521e-05,0.57671,0.70441,1,1
1,GO RESPONSE TO PROGESTERONE,0.00067758,0.57627,0.35914,1,1
1,GO AORTIC VALVE DEVELOPMENT,1.4044e-06,0.57598,0.57209,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,2.5308e-05,0.57594,0.47418,1,1
1,GO AMYLOID BETA CLEARANCE,1.4963e-07,0.57467,0.5274,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.0829e-07,0.57329,0.66275,1,1
1,GO HEME METABOLIC PROCESS,2.9301e-06,0.57183,0.50114,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,6.4994e-06,0.57001,0.50208,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.071e-07,0.56886,0.57341,1,1
1,GO INTERLEUKIN 1 PRODUCTION,3.4728e-06,0.56824,0.50603,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,1.5816e-05,0.56806,0.74913,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,6.2859e-08,0.56781,0.59198,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.1493e-05,0.56698,0.64883,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.8958e-07,0.56691,0.53681,1,1
1,GO T CELL MEDIATED IMMUNITY,1.2308e-06,0.56609,0.50891,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.6307e-05,0.56598,0.45653,1,1
1,GO VIRAL GENOME REPLICATION,4.1802e-07,0.56574,0.50879,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,6.2367e-06,0.56519,0.48356,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.8612e-06,0.56309,0.73153,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,1.7474e-06,0.56301,0.55564,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,6.0198e-07,0.5628,0.60966,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,7.889e-07,0.56132,0.51634,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,2.4346e-05,0.5601,0.50503,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,4.6623e-06,0.55985,0.59852,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,1.6015e-06,0.55959,0.51314,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.00023468,0.55925,0.49242,1,1
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0090226,0.5589,0.46188,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,4.0375e-08,0.55852,0.55759,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,3.9418e-06,0.5582,0.56087,1,1
1,GO DETECTION OF BIOTIC STIMULUS,1.0311e-06,0.55707,0.54028,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0018173,0.55514,0.38871,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,3.6414e-07,0.55416,0.52035,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,5.2837e-06,0.5539,0.53653,1,1
1,GO REGULATION OF TRANSPOSITION,9.3916e-06,0.5537,0.53527,1,1
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00026903,0.5528,0.57998,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.9926e-07,0.55218,0.50646,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00049035,0.55096,0.47401,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,3.6228e-06,0.55091,0.59367,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,4.4712e-06,0.5507,0.67119,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,2.2658e-06,0.5505,0.51302,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.0779e-06,0.55005,0.5331,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,2.0033e-05,0.5498,0.72527,1,1
1,GO CYTOLYSIS,9.4334e-07,0.54962,0.51424,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,1.8521e-05,0.54701,0.53148,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.2971e-07,0.54697,0.54059,1,1
1,GO RESPONSE TO X RAY,9.2696e-08,0.54625,0.59561,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,6.5896e-07,0.54452,0.56859,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,0.0017641,0.54418,0.44431,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00029782,0.54357,0.54548,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.00090094,0.54243,0.43222,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.4039e-05,0.54205,0.40514,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.4728e-06,0.54154,0.5181,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,1.8251e-06,0.54077,0.46865,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,2.7343e-05,0.53792,0.51744,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,0.00018427,0.53754,0.55693,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,8.7323e-05,0.53752,0.546,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.5816e-05,0.53723,0.55095,1,1
1,GO COLLAGEN CATABOLIC PROCESS,5.2533e-07,0.53677,0.59798,1,1
1,GO MESODERMAL CELL DIFFERENTIATION,6.8936e-07,0.53434,0.47598,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.2879e-07,0.5333,0.59531,1,1
1,GO PULMONARY VALVE DEVELOPMENT,1.9263e-05,0.53324,0.55383,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.00012964,0.53213,0.48093,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,2.5774e-06,0.53181,0.457,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3218e-05,0.53178,0.45989,1,1
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0087944,0.53123,0.33574,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,6.5149e-05,0.53122,0.3745,1,1
1,GO HYALURONAN METABOLIC PROCESS,4.4572e-08,0.53042,0.5495,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.0054795,0.5304,0.34067,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,4.7955e-07,0.52885,0.51054,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2454e-05,0.52781,0.44473,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.3605e-07,0.52641,0.60221,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,6.2985e-07,0.52555,0.63601,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.4692e-06,0.52482,0.52906,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0037331,0.52333,0.3723,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,2.5774e-06,0.52328,0.47355,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.8496e-08,0.52304,0.52672,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.5691e-07,0.52267,0.52094,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.104e-05,0.52091,0.54716,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,1.1237e-07,0.52077,0.58726,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,2.4692e-06,0.52066,0.53071,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,3.8423e-08,0.51963,0.51888,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.00017186,0.51944,0.56515,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.1702e-06,0.51921,0.45827,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,9.8628e-07,0.51821,0.49684,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.0829e-07,0.51815,0.51921,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,5.8301e-05,0.51805,0.4527,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.7118e-05,0.51731,0.61061,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.6228e-06,0.51651,0.5248,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,4.5813e-07,0.51605,0.43619,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,8.628e-07,0.51547,0.57989,1,1
1,GO INTERLEUKIN 13 PRODUCTION,0.00022676,0.51521,0.4854,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.8521e-05,0.51455,0.54143,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,3.17e-07,0.51437,0.52492,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,2.4692e-06,0.51408,0.51478,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00016595,0.5127,0.48649,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.7806e-05,0.51208,0.57237,1,1
1,GO CERAMIDE CATABOLIC PROCESS,4.3218e-05,0.51182,0.40081,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.2366e-07,0.51101,0.56856,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,2.5122e-07,0.50975,0.76364,1,1
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0025083,0.50851,0.3925,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.1831e-07,0.5081,0.54952,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,3.31e-08,0.50793,0.52547,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,4.4712e-06,0.50716,0.47216,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,5.4977e-07,0.50644,0.44126,1,1
1,GO RESPONSE TO ANGIOTENSIN,5.2533e-07,0.50515,0.48438,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,8.628e-07,0.50496,0.48497,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,9.3916e-06,0.5048,0.48162,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,6.7596e-05,0.50438,0.48746,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.00026003,0.50425,0.50136,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,8.4155e-08,0.50284,0.55052,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.2962e-05,0.50273,0.42488,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.104e-05,0.50264,0.40258,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.6902e-06,0.50254,0.52648,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,6.5896e-07,0.50181,0.45692,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,6.5149e-05,0.50176,0.42037,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,6.7728e-06,0.50115,0.56573,1,1
1,GO BLOOD VESSEL REMODELING,6.7728e-06,0.50076,0.46706,1,1
1,GO DEFENSE RESPONSE TO VIRUS,2.6902e-06,0.50064,0.45922,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.04854,0.50006,0.2542,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,9.7346e-05,0.4997,0.494,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,4.1802e-07,0.49959,0.53472,1,1
1,GO MAMMARY GLAND MORPHOGENESIS,2.5774e-06,0.49926,0.48431,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.508e-06,0.49898,0.44844,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.9263e-05,0.49861,0.56295,1,1
1,GO FIBROBLAST MIGRATION,3.0264e-07,0.49855,0.46646,1,1
1,GO PEPTIDE CROSS LINKING,3.4421e-05,0.49844,0.53775,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,4.2876e-06,0.49831,0.44894,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,4.3763e-07,0.49818,0.46539,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,3.7791e-06,0.4981,0.46189,1,1
1,GO LYMPHANGIOGENESIS,2.8891e-07,0.49659,0.51491,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.00067758,0.49644,0.40788,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,3.5759e-05,0.49636,0.52043,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0011549,0.49568,0.36272,1,1
1,GO STORE OPERATED CALCIUM ENTRY,1.8521e-05,0.49539,0.39451,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.4044e-06,0.49427,0.48241,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.6015e-06,0.49401,0.47542,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,1.4609e-05,0.49289,0.3845,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.00014418,0.49267,0.47491,1,1
1,GO GLAND MORPHOGENESIS,2.5774e-06,0.49221,0.48561,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,2.5774e-06,0.49171,0.63856,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,4.7955e-07,0.49122,0.58375,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,9.8628e-07,0.49025,0.57129,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,4.1802e-07,0.48984,0.45321,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,5.7413e-06,0.48951,0.52327,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,9.4334e-07,0.48892,0.60988,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,8.628e-07,0.48846,0.45909,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,8.6584e-06,0.48821,0.422,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00353,0.48779,0.39157,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.5331e-06,0.48769,0.51933,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.2524e-05,0.48733,0.42807,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,2.8891e-07,0.48693,0.50085,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.1112e-06,0.48682,0.52208,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.00027832,0.48633,0.49921,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,3.7791e-06,0.48598,0.4942,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.48596,0.37563,1,1
1,GO PINOCYTOSIS,2.0829e-07,0.48579,0.62778,1,1
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.009256,0.48552,0.33314,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,2.6322e-07,0.48502,0.48339,1,1
1,GO ENAMEL MINERALIZATION,0.00020448,0.48459,0.45583,1,1
1,GO PROTEIN OXIDATION,0.00037661,0.48447,0.46922,1,1
1,GO CYTOKINE METABOLIC PROCESS,5.753e-07,0.48375,0.45955,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,3.1904e-06,0.48323,0.49039,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.0226e-05,0.48284,0.33506,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,1.6455e-05,0.48197,0.52127,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,1.2962e-05,0.48084,0.44092,1,1
1,GO PROGESTERONE METABOLIC PROCESS,0.0049174,0.48008,0.28273,1,1
1,GO BASEMENT MEMBRANE ASSEMBLY,3.3132e-05,0.47998,0.62723,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00021909,0.47855,0.52904,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.00087311,0.47826,0.53206,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.17e-07,0.47805,0.51146,1,1
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0066042,0.47781,0.31326,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.1788e-07,0.47778,0.4548,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,8.4155e-08,0.4766,0.4265,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.0829e-07,0.4763,0.54747,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,7.0571e-06,0.4763,0.47269,1,1
1,GO NIK NF KAPPAB SIGNALING,1.3605e-07,0.4751,0.43736,1,1
1,GO ANIMAL ORGAN REGENERATION,4.6826e-08,0.47503,0.53449,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.0504e-05,0.47431,0.36411,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,2.5308e-05,0.47414,0.42279,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.1237e-07,0.47342,0.44377,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00024286,0.47236,0.37171,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.004408,0.47222,0.36615,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.5813e-07,0.47221,0.49628,1,1
1,GO VIRAL LIFE CYCLE,1.1788e-07,0.47198,0.45327,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,2.6902e-06,0.47196,0.43203,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,1.6452e-07,0.47182,0.44481,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,6.0198e-07,0.47149,0.42825,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.3287e-06,0.4713,0.49577,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.010245,0.47047,0.38009,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00023468,0.47033,0.51582,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,0.00019079,0.4702,0.54251,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,0.00027832,0.46992,0.43739,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013457,0.46929,0.37979,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00047456,0.46889,0.33519,1,1
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.001191,0.46835,0.44214,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,8.3127e-06,0.46829,0.44803,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,8.2505e-07,0.46826,0.4042,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,7.5427e-07,0.4665,0.43753,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,3.5759e-05,0.46611,0.36049,1,1
1,GO FIBROBLAST ACTIVATION,0.00016023,0.46606,0.40229,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,9.7801e-06,0.46581,0.51899,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.7118e-05,0.4654,0.39039,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.00052342,0.46532,0.55295,1,1
1,GO MUSCLE CELL FATE COMMITMENT,1.6455e-05,0.4651,0.47466,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.00013433,0.46484,0.37743,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00023468,0.46455,0.38358,1,1
1,GO INTERLEUKIN 8 PRODUCTION,2.5774e-06,0.46405,0.42237,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.4044e-06,0.46341,0.45971,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.2862e-06,0.4632,0.42199,1,1
1,GO OSTEOBLAST DEVELOPMENT,0.00021909,0.46245,0.40981,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.1904e-06,0.46236,0.44001,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,9.8628e-07,0.46192,0.41053,1,1
1,GO BONE GROWTH,2.6902e-06,0.4616,0.5436,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00017796,0.46009,0.42936,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,6.2985e-07,0.45935,0.47452,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,3.6414e-07,0.45809,0.43418,1,1
1,GO INTERACTION WITH HOST,2.5122e-07,0.45792,0.46015,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.2505e-07,0.45791,0.41868,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,6.0198e-07,0.45779,0.40277,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,5.0226e-05,0.4577,0.45794,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.0001547,0.45763,0.4231,1,1
1,GO T CELL APOPTOTIC PROCESS,6.0198e-07,0.45744,0.39471,1,1
1,GO CHONDROCYTE DEVELOPMENT,1.5201e-05,0.45718,0.44742,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.9904e-06,0.457,0.52252,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,5.2533e-07,0.45695,0.45328,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,4.4712e-06,0.45662,0.41491,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.00021167,0.45661,0.41133,1,1
1,GO REPLICATIVE SENESCENCE,0.00031859,0.4566,0.45358,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.001986,0.45626,0.59156,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,4.6623e-06,0.45603,0.55163,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,2.6902e-06,0.4558,0.4604,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.7791e-06,0.45526,0.44421,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.4674e-06,0.45481,0.40066,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.8891e-07,0.45439,0.3966,1,1
1,GO PROTEASOME ASSEMBLY,0.0001547,0.45437,0.31569,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.0829e-07,0.45311,0.40931,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,5.4121e-05,0.45213,0.3986,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0007696,0.45158,0.38395,1,1
1,GO MRNA TRANSCRIPTION,5.508e-06,0.45148,0.39486,1,1
1,GO SPROUTING ANGIOGENESIS,6.8936e-07,0.45123,0.40348,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,8.2505e-07,0.44963,0.41691,1,1
1,GO PLATELET DEGRANULATION,1.5331e-06,0.4495,0.48527,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,3.7791e-06,0.44868,0.43264,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.1802e-07,0.44812,0.44657,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,1.6015e-06,0.44741,0.52474,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,4.1112e-06,0.44725,0.46669,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.6015e-06,0.44685,0.48634,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,3.0576e-06,0.44665,0.39809,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.00025131,0.44657,0.47461,1,1
1,GO HAIR FOLLICLE MATURATION,0.0011199,0.44653,0.34128,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0066042,0.44388,0.30513,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.9904e-06,0.44374,0.51661,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.00020448,0.44332,0.39296,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,3.6228e-06,0.44252,0.45115,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,1.9873e-07,0.4425,0.4329,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.0311e-06,0.44232,0.50666,1,1
1,GO EMBRYO IMPLANTATION,6.8936e-07,0.44132,0.5159,1,1
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00081984,0.44109,0.40131,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.2658e-06,0.44086,0.44166,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,4.3763e-07,0.4407,0.42983,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,0.00013433,0.44055,0.40527,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,1.8521e-05,0.44037,0.3208,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00098941,0.44034,0.3639,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.00010092,0.43999,0.43733,1,1
1,GO REGULATION OF KIDNEY DEVELOPMENT,4.4712e-06,0.4395,0.39005,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,9.0221e-07,0.43934,0.4582,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,8.3127e-06,0.43924,0.46754,1,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.013139,0.43896,0.29277,1,1
1,GO GALACTOSE METABOLIC PROCESS,0.00025131,0.43881,0.34801,1,1
1,GO INTERFERON BETA PRODUCTION,1.6455e-05,0.43801,0.33831,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.0184e-05,0.43683,0.35953,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,3.0576e-06,0.43679,0.48713,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.7145e-05,0.43643,0.40879,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.0015189,0.43639,0.39947,1,1
1,GO CELL SUBSTRATE ADHESION,1.9873e-07,0.43531,0.45599,1,1
1,GO INTERLEUKIN 2 PRODUCTION,4.3763e-07,0.43407,0.46074,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0024367,0.43363,0.52164,1,1
1,GO REGULATION OF PHAGOCYTOSIS,1.0207e-07,0.43217,0.44679,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,6.2985e-07,0.43214,0.43694,1,1
1,GO I KAPPAB PHOSPHORYLATION,4.1112e-06,0.43193,0.35058,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9263e-05,0.43171,0.3889,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.5331e-06,0.43127,0.47048,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0027346,0.43098,0.29851,1,1
1,GO VIRAL TRANSLATION,9.0551e-05,0.42984,0.3619,1,1
1,GO PLATELET AGGREGATION,4.1802e-07,0.4298,0.40465,1,1
1,GO RECEPTOR CATABOLIC PROCESS,5.4977e-07,0.42956,0.44795,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00021167,0.42954,0.37958,1,1
1,GO MATURATION OF LSU RRNA,0.0007696,0.42949,0.34848,1,1
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.007729,0.42942,0.27081,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.00087311,0.42801,0.38768,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,7.547e-05,0.42777,0.39324,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,1.4609e-05,0.42759,0.3969,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.0017641,0.42732,0.41538,1,1
1,GO MULTI ORGANISM LOCALIZATION,4.4572e-08,0.42725,0.42712,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,1.071e-07,0.42609,0.46346,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.4712e-06,0.426,0.42732,1,1
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,1.0779e-06,0.42583,0.43438,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.0018173,0.42582,0.31186,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,5.2139e-05,0.42516,0.42117,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.3132e-05,0.42502,0.37483,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,1.8084e-07,0.42501,0.38354,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00010845,0.42454,0.35763,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,6.5149e-05,0.42401,0.38069,1,1
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.00013433,0.42369,0.34666,1,1
1,GO RETINAL METABOLIC PROCESS,0.0066042,0.42325,0.32833,1,1
1,GO WOUND HEALING,1.1776e-06,0.42324,0.37195,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,7.5427e-07,0.42324,0.39522,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.00037661,0.42323,0.35917,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.8418e-05,0.42282,0.33596,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.00011241,0.42276,0.38373,1,1
1,GO MESODERM MORPHOGENESIS,1.071e-07,0.42227,0.40766,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,4.6623e-06,0.42173,0.39972,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0001165,0.42162,0.35646,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00072223,0.42144,0.35224,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,4.6623e-06,0.4214,0.48748,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,7.2754e-05,0.42104,0.35757,1,1
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0050528,0.42075,0.3258,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,2.0833e-05,0.42058,0.39265,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,1.5201e-05,0.42048,0.39161,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,9.0221e-07,0.42008,0.43909,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0040578,0.41967,0.42946,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,1.906e-06,0.41965,0.36589,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0011199,0.41884,0.38484,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,3.4728e-06,0.4188,0.39651,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0013457,0.41816,0.38064,1,1
1,GO TOOTH MINERALIZATION,0.00041602,0.41799,0.33647,1,1
1,GO VASCULAR TRANSPORT,0.0039469,0.41798,0.50539,1,1
1,GO IMMATURE T CELL PROLIFERATION,4.8612e-06,0.41788,0.48511,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,3.7791e-06,0.41743,0.36452,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,1.906e-06,0.41709,0.42651,1,1
1,GO TYPE I INTERFERON PRODUCTION,5.508e-06,0.41708,0.34885,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00020448,0.41703,0.38071,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,0.0011199,0.41683,0.34279,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.1964e-05,0.41629,0.42836,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,0.0053338,0.41592,0.29835,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.7728e-06,0.41589,0.3773,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0779e-06,0.41555,0.39265,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.8521e-05,0.41549,0.35256,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,9.7346e-05,0.41503,0.42545,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,1.6015e-06,0.41471,0.37307,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,2.2524e-05,0.41442,0.39241,1,1
1,GO COPPER ION HOMEOSTASIS,1.0779e-06,0.41386,0.52073,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.6414e-07,0.41376,0.40272,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00036427,0.41375,0.2743,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,1.7474e-06,0.41343,0.41422,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,1.2454e-05,0.4132,0.35995,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.011047,0.41319,0.27324,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,8.0176e-08,0.41314,0.41463,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.1831e-07,0.41237,0.45249,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.0011549,0.41227,0.3257,1,1
1,GO RESPONSE TO VIRUS,1.4674e-06,0.41178,0.39445,1,1
1,GO LENS FIBER CELL DEVELOPMENT,6.7596e-05,0.41124,0.46705,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,4.4878e-05,0.41118,0.47354,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,3.0689e-05,0.41059,0.43964,1,1
1,GO RESPONSE TO SALT STRESS,6.0198e-07,0.41028,0.40254,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1.1493e-05,0.41027,0.46688,1,1
1,GO VASCULATURE DEVELOPMENT,7.2111e-07,0.40884,0.34911,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00047456,0.40821,0.3797,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,1.7118e-05,0.40742,0.44996,1,1
1,GO INTERACTION WITH SYMBIONT,6.7728e-06,0.40735,0.34656,1,1
1,GO CYTOPLASMIC TRANSLATION,0.0038387,0.40715,0.25174,1,1
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,5.2139e-05,0.40714,0.39519,1,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.014486,0.40645,0.3442,1,1
1,GO FIBROBLAST PROLIFERATION,9.0179e-06,0.40637,0.38948,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.3132e-05,0.40614,0.36261,1,1
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.00084609,0.4059,0.4487,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,9.7801e-06,0.40534,0.40955,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,5.9841e-06,0.40512,0.38149,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.00010845,0.40504,0.57559,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.00026003,0.40488,0.35675,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0036303,0.40464,0.30599,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,2.3418e-05,0.40416,0.38557,1,1
1,GO NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0038387,0.40393,0.39895,1,1
1,GO REGULATION OF MRNA BINDING,8.1192e-05,0.40386,0.34548,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00011241,0.40385,0.42767,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.2308e-06,0.40384,0.35121,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,7.3528e-06,0.40331,0.51003,1,1
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0046564,0.40315,0.27631,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.8251e-06,0.40259,0.37231,1,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.015574,0.40251,0.2451,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.026586,0.40219,0.24996,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.0221e-07,0.40216,0.4072,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,6.4994e-06,0.40163,0.34761,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0054795,0.4016,0.27817,1,1
1,GO FOREGUT MORPHOGENESIS,2.0033e-05,0.40157,0.44918,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,8.4205e-05,0.40103,0.32543,1,1
1,GO RIBOSOME ASSEMBLY,0.0057817,0.40089,0.26437,1,1
1,GO REGULATION OF STEROL TRANSPORT,1.2862e-06,0.40018,0.36399,1,1
1,GO HYPOTONIC RESPONSE,7.8282e-05,0.40014,0.35458,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,6.7596e-05,0.39992,0.47335,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00090094,0.39951,0.46257,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.010506,0.39943,0.26807,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,4.3763e-07,0.39927,0.38953,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,5.2533e-07,0.39902,0.41428,1,1
1,GO SERTOLI CELL DEVELOPMENT,0.00020448,0.399,0.38376,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,2.5308e-05,0.39866,0.37266,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00092958,0.39854,0.36735,1,1
1,GO MUSCLE CELL MIGRATION,0.0023671,0.39763,0.30063,1,1
1,GO AMYLOID FIBRIL FORMATION,0.0017123,0.39736,0.3416,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,7.5427e-07,0.39712,0.37734,1,1
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.00032948,0.39708,0.33462,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,4.8379e-05,0.39707,0.29401,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,1.1493e-05,0.39689,0.42623,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.4728e-06,0.39685,0.352,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,7.2111e-07,0.39651,0.44345,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.7118e-05,0.39648,0.38561,1,1
1,GO TONGUE MORPHOGENESIS,0.015203,0.39634,0.3059,1,1
1,GO PRIMARY MIRNA PROCESSING,3.0689e-05,0.39624,0.39882,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,3.7791e-06,0.39609,0.37752,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,1.6015e-06,0.39547,0.49931,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,6.8936e-07,0.39547,0.40153,1,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0022332,0.39467,0.31758,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,8.6584e-06,0.39465,0.39479,1,1
1,GO RESPONSE TO PROTOZOAN,8.1192e-05,0.39417,0.36425,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.0013457,0.39414,0.31458,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,5.4121e-05,0.39396,0.37899,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,2.3418e-05,0.39379,0.30352,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00041602,0.39326,0.33791,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.0020453,0.3931,0.35781,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00021909,0.39304,0.39507,1,1
1,GO LIPID IMPORT INTO CELL,0.0018173,0.39287,0.27224,1,1
1,GO RIG I SIGNALING PATHWAY,2.3418e-05,0.39285,0.3791,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,4.5813e-07,0.39279,0.35425,1,1
1,GO B CELL MEDIATED IMMUNITY,1.9904e-06,0.39219,0.37751,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.9926e-07,0.39214,0.45133,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.00024286,0.39213,0.34521,1,1
1,GO MYOBLAST DIFFERENTIATION,9.4334e-07,0.39197,0.39885,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00027832,0.3915,0.39781,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.8628e-07,0.39099,0.4036,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.7413e-06,0.39084,0.41559,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,0.00011241,0.39024,0.41393,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,2.2524e-05,0.39002,0.36388,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.00019753,0.38987,0.35211,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,2.5774e-06,0.38968,0.38766,1,1
1,GO GLIAL CELL ACTIVATION,1.7118e-05,0.38964,0.39319,1,1
1,GO URETER DEVELOPMENT,0.00054072,0.38905,0.33442,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,9.0551e-05,0.38866,0.35991,1,1
1,GO MONONUCLEAR CELL MIGRATION,0.00013917,0.38858,0.32803,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2962e-05,0.38827,0.31667,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.6228e-06,0.38782,0.3493,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,5.6174e-05,0.38778,0.32123,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.389e-05,0.38766,0.36986,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.8521e-05,0.3867,0.33765,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,5.6999e-08,0.38616,0.39687,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.00049035,0.3861,0.32688,1,1
1,GO RESPONSE TO ESTROGEN,3.9926e-07,0.38605,0.40164,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,9.0179e-06,0.3859,0.44325,1,1
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0037331,0.38555,0.2811,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.0779e-06,0.38548,0.37835,1,1
1,GO REGULATION OF GASTRULATION,3.6414e-07,0.38483,0.40149,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00074557,0.38479,0.38527,1,1
1,GO INNATE IMMUNE RESPONSE,4.1112e-06,0.38451,0.30934,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,9.0179e-06,0.3845,0.32381,1,1
1,GO GASTRULATION,1.1237e-07,0.38327,0.40411,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,3.1904e-06,0.38297,0.36979,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0014738,0.38251,0.39801,1,1
1,GO TRACHEA MORPHOGENESIS,9.0551e-05,0.38239,0.35716,1,1
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,3.0689e-05,0.38235,0.42733,1,1
1,GO PHAGOCYTOSIS RECOGNITION,0.00011241,0.38198,0.52758,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.0571e-06,0.38186,0.35608,1,1
1,GO REGULATION OF WOUND HEALING,4.4878e-05,0.38177,0.34053,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.001986,0.38149,0.41958,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.0010859,0.38122,0.40095,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.3916e-06,0.3812,0.39537,1,1
1,GO T CELL CYTOKINE PRODUCTION,2.8077e-06,0.38114,0.43522,1,1
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.0024367,0.38098,0.39959,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,4.1617e-05,0.38085,0.3765,1,1
1,GO TISSUE MIGRATION,3.3287e-06,0.38082,0.35054,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.0011549,0.3808,0.41522,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.0018173,0.38076,0.25034,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00036427,0.38064,0.37398,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.4609e-05,0.38043,0.32926,1,1
1,GO EOSINOPHIL CHEMOTAXIS,0.0081404,0.38018,0.42647,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.6729e-06,0.38015,0.44974,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,6.8936e-07,0.37995,0.38305,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.00036427,0.37978,0.35991,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,2.4692e-06,0.37969,0.32933,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.0689e-05,0.37929,0.29005,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,1.1493e-05,0.37912,0.33768,1,1
1,GO REGULATION OF PROTEIN MATURATION,6.2985e-07,0.37879,0.39146,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00011241,0.3787,0.30715,1,1
1,GO MEMBRANE INVAGINATION,9.2696e-08,0.37863,0.403,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,2.6902e-06,0.3785,0.46188,1,1
1,GO NEGATIVE REGULATION OF CELL SIZE,3.4728e-06,0.37795,0.33702,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,2.2658e-06,0.37787,0.352,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,3.4728e-06,0.3776,0.33054,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.7474e-06,0.37758,0.4559,1,1
1,GO MUSCLE FILAMENT SLIDING,4.8612e-06,0.37727,0.37377,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,8.628e-07,0.37707,0.34741,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.906e-06,0.37701,0.37121,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.0689e-05,0.37689,0.40447,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0024367,0.37671,0.43471,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,9.389e-05,0.3767,0.30204,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,4.4878e-05,0.37659,0.45841,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0073363,0.37638,0.45374,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,2.8077e-06,0.37625,0.34587,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,8.6584e-06,0.37618,0.41075,1,1
1,GO REGULATION OF COAGULATION,9.0179e-06,0.37611,0.44957,1,1
1,GO TELOMERASE RNA LOCALIZATION,0.0023671,0.37609,0.27547,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.9301e-06,0.37587,0.35364,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,7.889e-07,0.37582,0.52043,1,1
1,GO MACROPHAGE DIFFERENTIATION,1.9904e-06,0.37572,0.4104,1,1
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,4.0073e-05,0.3757,0.46166,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.00014935,0.37536,0.37616,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.349e-05,0.37529,0.39226,1,1
1,GO PROSTANOID METABOLIC PROCESS,4.0073e-05,0.37505,0.38893,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00024286,0.37486,0.31665,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00010462,0.37483,0.30609,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.00052342,0.37462,0.34912,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,6.7728e-06,0.37454,0.31764,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,8.4205e-05,0.3744,0.2952,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00016595,0.37435,0.36314,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,4.8612e-06,0.37434,0.31491,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,0.014841,0.37432,0.25471,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00026003,0.37418,0.34759,1,1
1,GO RESPONSE TO CYTOKINE,2.0784e-06,0.37381,0.32963,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.5149e-05,0.37364,0.3838,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.00036427,0.37334,0.39065,1,1
1,GO NEURAL CREST CELL MIGRATION,0.0027346,0.37327,0.27237,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.00032948,0.37317,0.395,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.00047456,0.37296,0.42477,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,2.0833e-05,0.37273,0.34296,1,1
1,GO MUSCLE CELL PROLIFERATION,3.6414e-07,0.3725,0.36641,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.0504e-05,0.37118,0.45607,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,9.389e-05,0.37105,0.55115,1,1
1,GO TRABECULA FORMATION,0.00028792,0.37094,0.46282,1,1
1,GO MITRAL VALVE DEVELOPMENT,0.0045306,0.37088,0.39814,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,3.3287e-06,0.37079,0.34862,1,1
1,GO MEMBRANE DISASSEMBLY,0.00023468,0.37042,0.30362,1,1
1,GO INTERLEUKIN 17 PRODUCTION,4.1112e-06,0.37025,0.45409,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012074,0.37024,0.32931,1,1
1,GO REGULATION OF LIPASE ACTIVITY,7.9801e-06,0.37003,0.29286,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,3.9926e-07,0.36953,0.43785,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,3.9418e-06,0.36948,0.45357,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,3.7791e-06,0.36934,0.33727,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,3.1904e-06,0.36904,0.37832,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,2.9532e-05,0.36893,0.32007,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.5331e-06,0.3687,0.32292,1,1
1,GO CHEMOKINE PRODUCTION,0.00065623,0.36857,0.29519,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0011199,0.36841,0.28985,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.00098941,0.36824,0.30027,1,1
1,GO FOCAL ADHESION ASSEMBLY,4.4712e-06,0.36793,0.42102,1,1
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0083534,0.36762,0.26336,1,1
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.00022676,0.36739,0.38245,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0019282,0.36695,0.28926,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0015653,0.36667,0.43112,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.001191,0.36639,0.28318,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,2.7343e-05,0.36627,0.31701,1,1
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.1888e-05,0.36599,0.33382,1,1
1,GO ENDOTHELIAL CELL MIGRATION,1.1267e-06,0.36594,0.3859,1,1
1,GO TISSUE REGENERATION,9.3916e-06,0.36568,0.35208,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,2.8077e-06,0.36495,0.30619,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.0604e-05,0.36482,0.35258,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.349e-05,0.36466,0.34563,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.00036427,0.36451,0.31076,1,1
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,9.0551e-05,0.36434,0.38034,1,1
1,GO RESPONSE TO WOUNDING,8.628e-07,0.36419,0.32686,1,1
1,GO PROTEIN LOCALIZATION TO EARLY ENDOSOME,0.0090226,0.36361,0.372,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00013433,0.36279,0.27472,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,6.8936e-07,0.36256,0.37586,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,7.9801e-06,0.36256,0.32879,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,0.0010206,0.36236,0.38619,1,1
1,GO LYMPH VESSEL DEVELOPMENT,0.00012964,0.3623,0.39243,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,3.1904e-06,0.36204,0.38419,1,1
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0017641,0.36198,0.24991,1,1
1,GO TRANSLATIONAL INITIATION,0.0020453,0.36161,0.25471,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.00010092,0.36156,0.43266,1,1
1,GO RESPONSE TO CORTICOSTEROID,7.8282e-05,0.36104,0.27107,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,1.9873e-07,0.36102,0.42186,1,1
1,GO NECROTIC CELL DEATH,3.9418e-06,0.36079,0.44839,1,1
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0021689,0.36077,0.29845,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.2111e-07,0.36068,0.38096,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,4.8612e-06,0.36047,0.30469,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.037747,0.3604,0.20121,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00063551,0.36026,0.33659,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.042857,0.36024,0.22215,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,1.1237e-07,0.36015,0.36814,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.1776e-06,0.36,0.34022,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00017796,0.35981,0.32363,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00011241,0.35978,0.2636,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,2.7343e-05,0.3595,0.34584,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,8.3127e-06,0.35923,0.29497,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,3.9418e-06,0.35894,0.29484,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.4878e-05,0.35889,0.47115,1,1
1,GO MATURATION OF 5 8S RRNA,0.00087311,0.35875,0.25878,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,1.3441e-06,0.35873,0.37801,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.00010092,0.35868,0.29377,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,3.8583e-05,0.35853,0.35104,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0037331,0.35843,0.3563,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,9.389e-05,0.35839,0.39692,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00027832,0.3579,0.44236,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00045924,0.35754,0.32637,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.4674e-06,0.35751,0.35183,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,5.0226e-05,0.35696,0.34294,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,5.7413e-06,0.3568,0.33278,1,1
1,GO SERTOLI CELL DIFFERENTIATION,0.00031859,0.35657,0.33457,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0022332,0.35637,0.26093,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,0.0041716,0.3562,0.30452,1,1
1,GO CELL MATRIX ADHESION,2.2658e-06,0.3556,0.379,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00098941,0.35529,0.31496,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,2.6322e-07,0.35527,0.39224,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.0097392,0.35493,0.28,1,1
1,GO PHAGOCYTOSIS,2.0829e-07,0.35493,0.36181,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.9263e-05,0.3549,0.28063,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,0.00065623,0.35474,0.34273,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00047456,0.35459,0.35503,1,1
1,GO EPOXYGENASE P450 PATHWAY,0.0022992,0.3545,0.2813,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,2.0033e-05,0.35434,0.39127,1,1
1,GO CARTILAGE DEVELOPMENT,1.9904e-06,0.35431,0.33071,1,1
1,GO GENITALIA MORPHOGENESIS,0.0034322,0.35428,0.31737,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.0184e-05,0.35398,0.34128,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,6.4994e-06,0.35377,0.39507,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,8.2505e-07,0.35363,0.36015,1,1
1,GO MONOCYTE CHEMOTAXIS,0.00022676,0.35351,0.34407,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,2.6902e-06,0.35336,0.37689,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,2.3975e-07,0.35322,0.35999,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,1.5331e-06,0.35283,0.345,1,1
1,GO GLOMERULUS DEVELOPMENT,2.3418e-05,0.3525,0.42191,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,6.5149e-05,0.35224,0.415,1,1
1,GO RESPONSE TO MANGANESE ION,7.9801e-06,0.3521,0.33444,1,1
1,GO PIGMENT ACCUMULATION,0.00014935,0.35138,0.32446,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00038934,0.35124,0.33656,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0014299,0.35095,0.43473,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0013054,0.35083,0.23613,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,5.4977e-07,0.35079,0.37868,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0018173,0.35078,0.23958,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.0833e-05,0.35072,0.3405,1,1
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00017796,0.35045,0.32752,1,1
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.7596e-05,0.35041,0.3767,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,2.6902e-06,0.35015,0.34187,1,1
1,GO ERAD PATHWAY,2.4692e-06,0.34991,0.28158,1,1
1,GO REGULATION OF HEART MORPHOGENESIS,0.00028792,0.34977,0.35018,1,1
1,GO CYTOKINE PRODUCTION,4.6623e-06,0.34917,0.29108,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,1.5201e-05,0.34883,0.38944,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.00010462,0.34882,0.32748,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.0198e-07,0.34856,0.34666,1,1
1,GO NATURAL KILLER CELL ACTIVATION,5.753e-07,0.34786,0.36064,1,1
1,GO RESPONSE TO INTERLEUKIN 1,7.5427e-07,0.34732,0.376,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.3418e-05,0.34683,0.37324,1,1
1,GO MACROPHAGE CHEMOTAXIS,1.349e-05,0.34669,0.3955,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,2.1663e-05,0.3465,0.32305,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00074557,0.346,0.32945,1,1
1,GO REGENERATION,8.8325e-08,0.34574,0.33928,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.6452e-07,0.34519,0.36713,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0006154,0.34513,0.34775,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,3.0576e-06,0.34355,0.40075,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0032441,0.34269,0.32852,1,1
1,GO INNER CELL MASS CELL PROLIFERATION,0.00034072,0.34226,0.36278,1,1
1,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0046564,0.3422,0.46414,1,1
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0033369,0.34201,0.27185,1,1
1,GO REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0017123,0.34158,0.34809,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00010845,0.34126,0.32928,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,4.8379e-05,0.34108,0.35298,1,1
1,GO PROTEIN HYDROXYLATION,0.0053338,0.34105,0.37091,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.00017186,0.34094,0.34868,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.4346e-05,0.3408,0.42054,1,1
1,GO SYNCYTIUM FORMATION,3.9418e-06,0.34049,0.38342,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.0020453,0.33988,0.37652,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.5308e-05,0.3398,0.37306,1,1
1,GO IMMUNE EFFECTOR PROCESS,2.8077e-06,0.33966,0.30914,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,4.0073e-05,0.33935,0.32425,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00042998,0.33924,0.38506,1,1
1,GO COPPER ION TRANSPORT,3.5759e-05,0.33905,0.32821,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00035231,0.33902,0.40342,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.00021167,0.33897,0.29624,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.001662,0.33885,0.28574,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,0.00032948,0.33869,0.30682,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,3.4421e-05,0.33863,0.29276,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.00063551,0.33851,0.44076,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,1.1964e-05,0.33849,0.31723,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,1.349e-05,0.33832,0.40647,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00012512,0.33824,0.39364,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.8521e-05,0.33819,0.44161,1,1
1,GO DECIDUALIZATION,0.0014738,0.33798,0.41172,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,1.1267e-06,0.33794,0.31501,1,1
1,GO L GLUTAMATE IMPORT,0.0029794,0.33789,0.29356,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,2.0833e-05,0.33746,0.27529,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.4609e-05,0.33712,0.44371,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.1964e-05,0.33709,0.33301,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.8612e-06,0.33702,0.29362,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00013917,0.33692,0.27191,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00024286,0.33684,0.33617,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.00095906,0.33684,0.28661,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.014486,0.33682,0.23139,1,1
1,GO VIRAL GENE EXPRESSION,0.00072223,0.33661,0.28667,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.00013433,0.33646,0.32761,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,8.2505e-07,0.33634,0.4712,1,1
1,GO INTERFERON ALPHA PRODUCTION,0.00049035,0.33612,0.27053,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.009256,0.33589,0.21885,1,1
1,GO REGULATION OF VASOCONSTRICTION,1.349e-05,0.33568,0.29196,1,1
1,GO ALPHA BETA T CELL ACTIVATION,7.2754e-05,0.33552,0.26196,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,2.6307e-05,0.33541,0.34709,1,1
1,GO MACROPHAGE APOPTOTIC PROCESS,0.00029782,0.3351,0.40305,1,1
1,GO ASTROCYTE ACTIVATION,3.8583e-05,0.33503,0.39026,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00012074,0.33502,0.27398,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,2.9532e-05,0.33452,0.28999,1,1
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00012512,0.33435,0.3286,1,1
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,4.1617e-05,0.33413,0.39829,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,1.9263e-05,0.3341,0.29127,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,7.9801e-06,0.3341,0.4016,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.7791e-06,0.33405,0.32283,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0014299,0.334,0.29127,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,0.00059588,0.33395,0.21818,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00011241,0.33394,0.28226,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.0022332,0.33382,0.28864,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,3.3132e-05,0.33369,0.30687,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,5.2139e-05,0.33289,0.33044,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.00020448,0.33285,0.3104,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00025131,0.3328,0.3013,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,3.0689e-05,0.33262,0.25538,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.0050528,0.33222,0.23197,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.7118e-05,0.33172,0.28015,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,7.0571e-06,0.33143,0.3349,1,1
1,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0010206,0.33142,0.2261,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00035231,0.33104,0.28717,1,1
1,GO PROTEIN TARGETING TO VACUOLE,7.0571e-06,0.331,0.29846,1,1
1,GO COAGULATION,1.2308e-06,0.3299,0.32456,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,9.389e-05,0.32967,0.2626,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.0604e-05,0.32958,0.33361,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,2.5308e-05,0.32953,0.30815,1,1
1,GO RENAL FILTRATION,0.0031536,0.32943,0.40513,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0010528,0.32867,0.25644,1,1
1,GO MACROPHAGE MIGRATION,8.2505e-07,0.3277,0.40125,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.2139e-05,0.32681,0.23769,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00023468,0.32681,0.3389,1,1
1,GO PEPTIDE CATABOLIC PROCESS,1.7806e-05,0.32645,0.28671,1,1
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.00010845,0.3263,0.29327,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,0.00012074,0.3263,0.39282,1,1
1,GO T CELL MIGRATION,7.547e-05,0.32607,0.29129,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.011047,0.32561,0.22065,1,1
1,GO COMPLEMENT ACTIVATION,1.906e-06,0.32499,0.36441,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00010845,0.32472,0.32344,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,2.9532e-05,0.32465,0.28234,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.018398,0.32455,0.23779,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0013054,0.32455,0.29427,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,8.628e-07,0.32442,0.30064,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.2876e-06,0.32437,0.31976,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6902e-06,0.32427,0.32955,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,9.7346e-05,0.32408,0.2416,1,1
1,GO REGULATION OF HEART GROWTH,5.0226e-05,0.32407,0.2688,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.4674e-06,0.32407,0.28294,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00017796,0.32349,0.278,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,3.7145e-05,0.32286,0.29069,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.00074557,0.32241,0.2835,1,1
1,GO MATURATION OF SSU RRNA,0.0022332,0.3222,0.27357,1,1
1,GO MYOBLAST FUSION,2.3418e-05,0.32214,0.39351,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.349e-05,0.32196,0.35474,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.010506,0.32163,0.23613,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.0025817,0.32154,0.43119,1,1
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.016734,0.3215,0.24439,1,1
1,GO IRON ION HOMEOSTASIS,2.2658e-06,0.32142,0.28898,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,3.9418e-06,0.32058,0.33859,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,3.0576e-06,0.32029,0.27459,1,1
1,GO CYTOKINETIC PROCESS,5.508e-06,0.32024,0.31259,1,1
1,GO HEART VALVE DEVELOPMENT,9.389e-05,0.31997,0.3319,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,0.00029782,0.31967,0.23638,1,1
1,GO DETECTION OF OTHER ORGANISM,0.00065623,0.31948,0.36001,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.7791e-06,0.31913,0.27158,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,2.8418e-05,0.31876,0.35792,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.1802e-07,0.31874,0.35393,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,5.6174e-05,0.31863,0.31828,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0041716,0.31844,0.28637,1,1
1,GO HISTONE PHOSPHORYLATION,5.4977e-07,0.31819,0.3116,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.00027832,0.31814,0.33987,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,6.7596e-05,0.31796,0.26168,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,9.0221e-07,0.31778,0.34,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.043763,0.31777,0.23419,1,1
1,GO VIRAL RELEASE FROM HOST CELL,5.8301e-05,0.31754,0.28511,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.7474e-06,0.31665,0.32429,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,5.2533e-07,0.31659,0.36658,1,1
1,GO PLACENTA DEVELOPMENT,5.4121e-05,0.3162,0.25672,1,1
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.00059588,0.31617,0.29989,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.013465,0.31581,0.35825,1,1
1,GO ASTROCYTE DEVELOPMENT,7.0571e-06,0.31525,0.38399,1,1
1,GO SNRNA PROCESSING,0.0097392,0.31481,0.52713,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,4.4712e-06,0.31465,0.38092,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,9.7275e-08,0.3146,0.3235,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.4205e-05,0.31443,0.30914,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,1.9263e-05,0.31429,0.35875,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,3.3287e-06,0.31422,0.36766,1,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0053338,0.31416,0.25523,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.2308e-06,0.31412,0.30972,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.00072223,0.31368,0.24997,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00017186,0.31363,0.28398,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00026003,0.31284,0.31098,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.00014935,0.31264,0.37985,1,1
1,GO LIPOPROTEIN LOCALIZATION,0.00052342,0.31231,0.37455,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,5.9841e-06,0.31189,0.39558,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00018427,0.31172,0.27773,1,1
1,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.0017641,0.31166,0.28493,1,1
1,GO KERATINOCYTE MIGRATION,5.0226e-05,0.31165,0.35068,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,1.0184e-05,0.31156,0.3933,1,1
1,GO RESPONSE TO DSRNA,9.4334e-07,0.3112,0.37716,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00035231,0.31038,0.237,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.0025083,0.31015,0.3914,1,1
1,GO OSTEOBLAST DIFFERENTIATION,1.1776e-06,0.31013,0.34644,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,0.00012512,0.30971,0.35508,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00025131,0.30968,0.28873,1,1
1,GO INFLAMMATORY RESPONSE,2.4346e-05,0.30945,0.27295,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.00019079,0.30892,0.29745,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.9801e-06,0.30878,0.28609,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,2.2524e-05,0.30867,0.32946,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,6.0198e-07,0.30854,0.32208,1,1
1,GO GONADOTROPIN SECRETION,0.0075304,0.30838,0.26332,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,2.1663e-05,0.30795,0.26109,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.0056288,0.30795,0.18944,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0029794,0.30761,0.29297,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0087944,0.30758,0.25358,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,1.0184e-05,0.30748,0.2646,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.014486,0.30719,0.22533,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.3654e-06,0.30716,0.24813,1,1
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00090094,0.30653,0.26688,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00055855,0.30639,0.27155,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,1.4044e-06,0.30637,0.28001,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,2.4346e-05,0.306,0.31755,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.037747,0.30564,0.19631,1,1
1,GO RESPONSE TO DEXAMETHASONE,0.0021689,0.30549,0.26154,1,1
1,GO RESPONSE TO BACTERIUM,7.6603e-06,0.30545,0.28759,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00016023,0.30545,0.25042,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0087944,0.30531,0.20141,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00016023,0.30525,0.24427,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,3.9418e-06,0.30521,0.30993,1,1
1,GO COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY,1.0184e-05,0.30497,0.37266,1,1
1,GO POSITIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.007729,0.30491,0.46781,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0007696,0.30485,0.28094,1,1
1,GO CELLULAR RESPONSE TO LIPID,2.8418e-05,0.30479,0.2253,1,1
1,GO CARDIOBLAST DIFFERENTIATION,0.00037661,0.30475,0.37849,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00032948,0.30395,0.25145,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,9.8628e-07,0.30374,0.25452,1,1
1,GO CELLULAR DEFENSE RESPONSE,0.00069957,0.30365,0.32081,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0036303,0.30363,0.30972,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,9.4334e-07,0.30344,0.24001,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION,0.00022676,0.30326,0.39371,1,1
1,GO REGULATION OF PROTEOLYSIS,5.508e-06,0.30322,0.22965,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00049035,0.3032,0.24369,1,1
1,GO P38MAPK CASCADE,1.5201e-05,0.30289,0.34972,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,2.8418e-05,0.30279,0.31195,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.001191,0.30263,0.30719,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,7.0571e-06,0.30247,0.30245,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,1.5816e-05,0.3022,0.28441,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,1.2308e-06,0.30217,0.30671,1,1
1,GO PIGMENT METABOLIC PROCESS,4.3218e-05,0.30198,0.25393,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00074557,0.30164,0.25514,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00012074,0.30158,0.25271,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.0013457,0.30127,0.27446,1,1
1,GO SELECTIVE AUTOPHAGY,5.753e-07,0.30121,0.3089,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,6.2786e-05,0.30117,0.29113,1,1
1,GO DEFENSE RESPONSE,1.349e-05,0.30106,0.25163,1,1
1,GO PLASMA MEMBRANE TUBULATION,3.7791e-06,0.30096,0.35779,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,0.00030804,0.30084,0.24687,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.7343e-05,0.30073,0.27206,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.4346e-05,0.30023,0.27078,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00019753,0.30006,0.20824,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0066042,0.29989,0.22229,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.019739,0.29975,0.24435,1,1
1,GO STEROL TRANSPORT,3.0689e-05,0.29969,0.25333,1,1
1,GO REGULATION OF CELL KILLING,0.0010528,0.29963,0.23092,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.9801e-06,0.29958,0.32212,1,1
1,GO SPERM EGG RECOGNITION,9.3916e-06,0.29954,0.25818,1,1
1,GO POSITIVE CHEMOTAXIS,0.00095906,0.29949,0.26817,1,1
1,GO LYMPHOCYTE MIGRATION,3.8583e-05,0.29943,0.24832,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,3.7145e-05,0.29938,0.25945,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,2.6902e-06,0.29918,0.34229,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.547e-05,0.29918,0.30544,1,1
1,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.0029794,0.29904,0.2922,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.29899,0.2447,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.0779e-06,0.29872,0.30356,1,1
1,GO CELLULAR RESPONSE TO VIRUS,0.00014935,0.29843,0.28248,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0028957,0.29829,0.22658,1,1
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0015653,0.29826,0.24634,1,1
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0014738,0.29813,0.25251,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00031859,0.29811,0.2815,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00040247,0.29798,0.18805,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,6.7728e-06,0.29783,0.29037,1,1
1,GO FACE DEVELOPMENT,2.6307e-05,0.29741,0.31456,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.1617e-05,0.29726,0.29359,1,1
1,GO PROTEIN KINASE B SIGNALING,2.1702e-06,0.29715,0.24977,1,1
1,GO PROSTATE GLAND DEVELOPMENT,0.00012512,0.2967,0.42467,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.00016023,0.29661,0.28061,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00065623,0.29639,0.23494,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.8958e-07,0.296,0.30091,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.8612e-06,0.29565,0.27754,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,1.7118e-05,0.29552,0.34122,1,1
1,GO TRANSPOSITION,0.0011199,0.29552,0.308,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.7343e-05,0.29543,0.27344,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.016339,0.29542,0.21956,1,1
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.013798,0.29532,0.25167,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.0056288,0.29514,0.28992,1,1
1,GO RESPONSE TO RETINOIC ACID,2.4346e-05,0.29505,0.28537,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.00041602,0.29502,0.23501,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,5.508e-06,0.29489,0.24916,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,4.6597e-05,0.29489,0.23925,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.6015e-06,0.2947,0.32274,1,1
1,GO TONGUE DEVELOPMENT,0.00049035,0.29437,0.38238,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,1.7118e-05,0.29422,0.26807,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.3418e-05,0.29416,0.30101,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0028141,0.29414,0.23673,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,6.2367e-06,0.29409,0.27408,1,1
1,GO REGULATION OF CELL AGING,3.3202e-07,0.29407,0.32737,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00069957,0.29391,0.34183,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00010462,0.2933,0.22974,1,1
1,GO TISSUE REMODELING,5.2139e-05,0.29321,0.30245,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0001165,0.29295,0.34213,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,3.8583e-05,0.29281,0.29546,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,7.013e-05,0.2926,0.26729,1,1
1,GO REGULATION OF PROTEIN IMPORT,2.0033e-05,0.29254,0.35247,1,1
1,GO AUTOPHAGY OF NUCLEUS,0.00023468,0.2924,0.26219,1,1
1,GO SNRNA METABOLIC PROCESS,0.0039469,0.29222,0.42039,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,8.4205e-05,0.29221,0.22145,1,1
1,GO MESODERM DEVELOPMENT,1.9904e-06,0.2921,0.25643,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,9.0179e-06,0.29206,0.29506,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0034322,0.29199,0.2298,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,7.547e-05,0.29191,0.27067,1,1
1,GO HEAD MORPHOGENESIS,0.00040247,0.29125,0.29389,1,1
1,GO LEFT RIGHT AXIS SPECIFICATION,0.031059,0.29121,0.27762,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,7.013e-05,0.29119,0.35853,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.020205,0.29112,0.31204,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00030804,0.29107,0.28551,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,4.4878e-05,0.29105,0.25317,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.0264e-07,0.29091,0.27793,1,1
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.00035231,0.29074,0.35121,1,1
1,GO ERK1 AND ERK2 CASCADE,1.7474e-06,0.29047,0.29294,1,1
1,GO LUNG MORPHOGENESIS,0.00045924,0.29041,0.3213,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.0021689,0.28987,0.20949,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,9.0221e-07,0.28982,0.26321,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0056288,0.28967,0.27929,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.2837e-06,0.28939,0.39802,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,7.8282e-05,0.28896,0.22599,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.1493e-05,0.28882,0.28509,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00084609,0.28837,0.2709,1,1
1,GO MEMBRANE BIOGENESIS,0.0007696,0.28817,0.27722,1,1
1,GO RESPONSE TO ISCHEMIA,0.00010845,0.28779,0.2242,1,1
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.8418e-05,0.28766,0.2753,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,5.2837e-06,0.28761,0.24732,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,8.1192e-05,0.28737,0.26079,1,1
1,GO NCRNA PROCESSING,0.00092958,0.28724,0.22441,1,1
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,1.1964e-05,0.28707,0.25636,1,1
1,GO SYMBIOTIC PROCESS,1.725e-07,0.28705,0.28632,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,5.0683e-06,0.28697,0.27367,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,7.3528e-06,0.28683,0.28002,1,1
1,GO ACUTE PHASE RESPONSE,0.0022992,0.28671,0.28937,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,6.5149e-05,0.28646,0.33813,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.7596e-05,0.28627,0.29479,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00050664,0.28621,0.26432,1,1
1,GO MESENCHYME DEVELOPMENT,1.4039e-05,0.28619,0.26374,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,8.4205e-05,0.286,0.25262,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,0.0012662,0.28595,0.28201,1,1
1,GO NEGATIVE T CELL SELECTION,0.020205,0.28593,0.22308,1,1
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.014841,0.28592,0.22024,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00036427,0.28574,0.24244,1,1
1,GO CELL CELL RECOGNITION,1.5331e-06,0.28569,0.28384,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,3.1904e-06,0.28563,0.25775,1,1
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.01282,0.28563,0.33969,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,8.1192e-05,0.28543,0.28989,1,1
1,GO BONE MORPHOGENESIS,4.3218e-05,0.2853,0.30189,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0087944,0.2853,0.21399,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,1.5201e-05,0.28522,0.24266,1,1
1,GO REGULATION OF RNA BINDING,3.7145e-05,0.28465,0.27706,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,0.0016129,0.2842,0.29948,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,2.8077e-06,0.28401,0.26727,1,1
1,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.349e-05,0.28384,0.34916,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.010773,0.28353,0.19133,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.001191,0.28291,0.28974,1,1
1,GO NEURAL TUBE PATTERNING,0.0010528,0.2828,0.24915,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0021062,0.28263,0.23174,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.0017123,0.28253,0.36733,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,3.8583e-05,0.28247,0.29432,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,1.8251e-06,0.28244,0.26855,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.349e-05,0.28227,0.30248,1,1
1,GO RNA 5 END PROCESSING,0.0017123,0.28201,0.2332,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,3.3132e-05,0.28184,0.26743,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,7.3528e-06,0.28165,0.28787,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,7.6379e-08,0.28164,0.30476,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00012964,0.2811,0.28806,1,1
1,GO GLIAL CELL APOPTOTIC PROCESS,0.0027346,0.28107,0.3847,1,1
1,GO HISTONE H4 DEACETYLATION,0.0040578,0.28093,0.24318,1,1
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.041967,0.28057,0.18237,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.6307e-05,0.28057,0.2347,1,1
1,GO RESPONSE TO OSMOTIC STRESS,8.1192e-05,0.28015,0.23064,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0007696,0.28015,0.24053,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.00098941,0.28014,0.32851,1,1
1,GO REGULATION OF GENE SILENCING,4.4712e-06,0.28012,0.24807,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.00030804,0.27988,0.22759,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.0007696,0.27984,0.31549,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.2454e-05,0.27951,0.22921,1,1
1,GO CHOLESTEROL EFFLUX,9.3916e-06,0.27905,0.28948,1,1
1,GO NUCLEOSIDE SALVAGE,0.0022332,0.27852,0.40672,1,1
1,GO REGULATION OF IMMUNE RESPONSE,5.7413e-06,0.2785,0.239,1,1
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.00063551,0.27839,0.28922,1,1
1,GO REGULATION OF CELL ADHESION,0.00026903,0.27835,0.22756,1,1
1,GO INTERLEUKIN 4 PRODUCTION,0.00087311,0.27826,0.21436,1,1
1,GO T CELL ACTIVATION,2.2524e-05,0.27804,0.23954,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.2139e-05,0.27785,0.37918,1,1
1,GO REGULATION OF ORGAN GROWTH,6.2985e-07,0.27763,0.32142,1,1
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00032948,0.27759,0.27924,1,1
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0029794,0.27741,0.25099,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,6.2786e-05,0.27737,0.2769,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,0.00019753,0.27727,0.25717,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.00072223,0.2772,0.31755,1,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0025817,0.27715,0.19593,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.6228e-06,0.27713,0.30057,1,1
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.7806e-05,0.27695,0.29164,1,1
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.02843,0.27687,0.21809,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.012203,0.27668,0.23012,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,2.5774e-06,0.2766,0.2638,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.007729,0.27655,0.23353,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,7.013e-05,0.27649,0.24546,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,1.8521e-05,0.27556,0.2886,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00021909,0.27554,0.34821,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.0689e-05,0.27534,0.27319,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00047456,0.27529,0.19362,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00025131,0.27523,0.29913,1,1
1,GO REGULATION OF BODY FLUID LEVELS,2.5308e-05,0.27514,0.22474,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,1.6455e-05,0.27512,0.25086,1,1
1,GO TUBE MORPHOGENESIS,9.7801e-06,0.27479,0.2544,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.9532e-05,0.27461,0.24732,1,1
1,GO LIVER MORPHOGENESIS,0.023205,0.27455,0.2311,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.009256,0.27447,0.20721,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,3.4772e-07,0.2744,0.30435,1,1
1,GO RRNA METABOLIC PROCESS,0.00353,0.27425,0.21031,1,1
1,GO RESPONSE TO IONIZING RADIATION,2.9301e-06,0.27378,0.28192,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.00063551,0.27372,0.26187,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,8.3127e-06,0.27361,0.22491,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0021062,0.27345,0.20671,1,1
1,GO CELL ACTIVATION,4.6623e-06,0.27318,0.25693,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,2.9301e-06,0.27312,0.32754,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.00084609,0.27301,0.25913,1,1
1,GO TRNA 5 LEADER REMOVAL,0.00090094,0.27293,0.28974,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.6597e-05,0.27282,0.24583,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.00028792,0.27261,0.29248,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0038387,0.27249,0.29515,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.00017796,0.2718,0.24941,1,1
1,GO RESPONSE TO LIPID,0.00018427,0.27176,0.18965,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.001662,0.27174,0.27231,1,1
1,GO INTRACELLULAR MRNA LOCALIZATION,4.0073e-05,0.27126,0.36614,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,0.00017796,0.26994,0.28292,1,1
1,GO ASTROCYTE DIFFERENTIATION,0.00049035,0.26975,0.22679,1,1
1,GO PROTEIN PROCESSING,0.00014935,0.26974,0.21505,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.013798,0.26939,0.24033,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,1.4044e-06,0.26926,0.25887,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,1.5201e-05,0.26917,0.29849,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.00010462,0.26826,0.26725,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0045306,0.26816,0.27201,1,1
1,GO NCRNA 3 END PROCESSING,0.037747,0.26797,0.33153,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,5.8301e-05,0.26759,0.25599,1,1
1,GO SEQUESTERING OF METAL ION,0.0013054,0.26745,0.24837,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.8936e-07,0.26716,0.28074,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0026572,0.26664,0.21769,1,1
1,GO RIBOSOME BIOGENESIS,0.0030654,0.26621,0.22142,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,1.0184e-05,0.2662,0.29098,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00038934,0.2662,0.24671,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00034072,0.266,0.29467,1,1
1,GO LEUKOCYTE PROLIFERATION,0.0006154,0.26595,0.20516,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,4.0073e-05,0.26587,0.28666,1,1
1,GO NEUROINFLAMMATORY RESPONSE,0.0018173,0.26586,0.26856,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,5.508e-06,0.26562,0.26523,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,1.2962e-05,0.26549,0.31653,1,1
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.00074557,0.26538,0.31646,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0017641,0.2653,0.35413,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,3.0264e-07,0.26522,0.27493,1,1
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.00047456,0.26488,0.27644,1,1
1,GO RESPONSE TO OXYGEN LEVELS,0.0001165,0.2647,0.21131,1,1
1,GO CELL AGING,2.3654e-06,0.26455,0.22842,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,2.0033e-05,0.26455,0.25459,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5201e-05,0.26452,0.27789,1,1
1,GO VIRION ASSEMBLY,5.4121e-05,0.26433,0.21284,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0053338,0.26425,0.2133,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,2.6902e-06,0.2642,0.25981,1,1
1,GO TOXIN TRANSPORT,0.0047853,0.26416,0.1711,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00049035,0.26416,0.28751,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.6414e-07,0.26409,0.2685,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0038387,0.26397,0.21058,1,1
1,GO ATP BIOSYNTHETIC PROCESS,0.001986,0.26389,0.22311,1,1
1,GO REGULATION OF DEFENSE RESPONSE,5.0226e-05,0.26384,0.21564,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.014138,0.26359,0.22035,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,7.0571e-06,0.26344,0.26235,1,1
1,GO FATTY ACID BETA OXIDATION,0.00024286,0.26323,0.24954,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,7.0571e-06,0.26321,0.4022,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0094949,0.26317,0.25066,1,1
1,GO RNA CATABOLIC PROCESS,2.5308e-05,0.26285,0.22936,1,1
1,GO STEROL IMPORT,0.00024286,0.2628,0.43124,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.1493e-05,0.2625,0.21846,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,6.2367e-06,0.26241,0.27092,1,1
1,GO CHONDROCYTE PROLIFERATION,0.0030654,0.26231,0.40567,1,1
1,GO RESPONSE TO TESTOSTERONE,1.7118e-05,0.26231,0.29085,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,4.8379e-05,0.2622,0.24682,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.9904e-06,0.26203,0.29542,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0007696,0.26187,0.22394,1,1
1,GO NCRNA METABOLIC PROCESS,0.0016129,0.26176,0.19724,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,5.9841e-06,0.26167,0.31574,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.0571e-06,0.26154,0.28412,1,1
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0025083,0.26149,0.176,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00079435,0.26143,0.22394,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.9532e-05,0.26104,0.24561,1,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.021165,0.26096,0.14348,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.00038934,0.2609,0.23428,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,2.7343e-05,0.26079,0.26599,1,1
1,GO AUTOPHAGOSOME MATURATION,5.0226e-05,0.26078,0.2656,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,8.3127e-06,0.26068,0.22793,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,1.7474e-06,0.26056,0.33633,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0060989,0.26052,0.2081,1,1
1,GO PROTEIN FOLDING,1.1493e-05,0.26016,0.23639,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0079323,0.26005,0.20106,1,1
1,GO RESPONSE TO STEROID HORMONE,0.00014935,0.2599,0.20652,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.012508,0.25965,0.25455,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,6.7596e-05,0.25962,0.20915,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00035231,0.25951,0.23274,1,1
1,GO BILE ACID AND BILE SALT TRANSPORT,0.027803,0.25951,0.14299,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00040247,0.2593,0.26827,1,1
1,GO T CELL PROLIFERATION,0.00022676,0.25878,0.23091,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.0027346,0.25871,0.26344,1,1
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.00013917,0.25858,0.25475,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.7413e-06,0.25816,0.25044,1,1
1,GO RNA DESTABILIZATION,6.0504e-05,0.25812,0.24289,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.0184e-05,0.25786,0.22981,1,1
1,GO RESPONSE TO VITAMIN A,0.013798,0.25784,0.19944,1,1
1,GO GRANULOCYTE MIGRATION,7.2754e-05,0.2577,0.30037,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.016734,0.25757,0.18931,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.0036303,0.25748,0.24853,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.0021689,0.25724,0.19788,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,2.8077e-06,0.2572,0.25398,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,0.0006154,0.25703,0.22286,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.2454e-05,0.25672,0.2399,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,6.7596e-05,0.25664,0.2376,1,1
1,GO INTERFERON GAMMA PRODUCTION,2.5308e-05,0.25635,0.27613,1,1
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0010859,0.25617,0.3058,1,1
1,GO EPITHELIAL CELL PROLIFERATION,0.00014418,0.25604,0.23688,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00035231,0.25563,0.30073,1,1
1,GO STRESS FIBER ASSEMBLY,0.00057693,0.25553,0.25206,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0039469,0.25536,0.31129,1,1
1,GO REGULATION OF CELL ACTIVATION,2.7343e-05,0.25535,0.2236,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.0779e-06,0.25531,0.25053,1,1
1,GO XENOBIOTIC TRANSPORT,0.00059588,0.25525,0.25623,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0025083,0.25501,0.25301,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.0028141,0.25458,0.22944,1,1
1,GO CELL KILLING,0.001662,0.25397,0.17353,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,2.7343e-05,0.25371,0.23267,1,1
1,GO OSSIFICATION,3.1888e-05,0.25339,0.26082,1,1
1,GO PLATELET ACTIVATION,3.0689e-05,0.25307,0.26159,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,1.2308e-06,0.25298,0.24103,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0064317,0.25294,0.18307,1,1
1,GO TRNA 5 END PROCESSING,0.001228,0.2529,0.25823,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.00353,0.25284,0.32707,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0099891,0.25259,0.24656,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.026586,0.25252,0.21411,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,2.8418e-05,0.25242,0.21153,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,9.3916e-06,0.25146,0.24092,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.001191,0.25123,0.20111,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.00026903,0.25104,0.24131,1,1
1,GO OSTEOCLAST DIFFERENTIATION,2.5774e-06,0.25017,0.24036,1,1
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,5.2139e-05,0.2499,0.29454,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.001662,0.24977,0.22365,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,5.2139e-05,0.24948,0.2172,1,1
1,GO AGING,7.3528e-06,0.24932,0.21327,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.0014738,0.2492,0.23545,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,2.3418e-05,0.24918,0.28947,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00010092,0.24857,0.23989,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00014935,0.24852,0.21906,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.0011199,0.24792,0.45549,1,1
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.00023468,0.24784,0.22545,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0066042,0.24779,0.22758,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.00019079,0.24752,0.21234,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00042998,0.24725,0.1871,1,1
1,GO GTP METABOLIC PROCESS,0.0007696,0.24681,0.27435,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00074557,0.24641,0.25274,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.24613,0.21503,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.0034322,0.2461,0.15977,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,7.6603e-06,0.24603,0.2376,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00012512,0.24598,0.37393,1,1
1,GO LYMPHOCYTE ACTIVATION,1.349e-05,0.24588,0.21943,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00055855,0.24579,0.19057,1,1
1,GO CELLULAR EXTRAVASATION,6.5149e-05,0.24568,0.23578,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,0.022165,0.24541,0.31963,1,1
1,GO REGULATION OF HEMOPOIESIS,2.1702e-06,0.24503,0.23207,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,1.6455e-05,0.24501,0.20317,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,3.4772e-07,0.24482,0.29585,1,1
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.019283,0.24469,0.17669,1,1
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00040247,0.2446,0.19598,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,8.7323e-05,0.24449,0.20754,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0027346,0.24447,0.18841,1,1
1,GO MESENCHYME MORPHOGENESIS,0.0013457,0.24437,0.32692,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.4346e-05,0.24432,0.24152,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0024367,0.2442,0.35152,1,1
1,GO POSITIVE REGULATION OF CELL DIVISION,0.014841,0.24378,0.1646,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0050528,0.24285,0.15003,1,1
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0025817,0.24281,0.24794,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,2.2524e-05,0.24276,0.2195,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,3.5759e-05,0.24259,0.21046,1,1
1,GO LEUKOCYTE HOMEOSTASIS,5.2139e-05,0.24253,0.22623,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00019079,0.24249,0.1944,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00063551,0.24248,0.30221,1,1
1,GO REGULATION OF BONE DEVELOPMENT,0.00057693,0.24247,0.2638,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.00019753,0.24213,0.22117,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.1493e-05,0.24206,0.24299,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,0.00038934,0.24204,0.24829,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00063551,0.24196,0.20605,1,1
1,GO RRNA MODIFICATION,0.033894,0.24195,0.14078,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,6.2786e-05,0.24183,0.1962,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00047456,0.24174,0.19689,1,1
1,GO REGULATION OF MITOPHAGY,0.02068,0.24166,0.18959,1,1
1,GO NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0094949,0.24148,0.15898,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.018398,0.2414,0.23105,1,1
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00054072,0.24124,0.24728,1,1
1,GO DNA DEALKYLATION,0.00031859,0.24115,0.23838,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,0.00042998,0.24084,0.21126,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,6.7728e-06,0.24064,0.22536,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.3418e-05,0.24064,0.2894,1,1
1,GO MYELOID CELL HOMEOSTASIS,1.1776e-06,0.24028,0.24844,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.0001165,0.24023,0.23271,1,1
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.047551,0.24021,0.16558,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.00052342,0.24018,0.24617,1,1
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.037747,0.24007,0.16786,1,1
1,GO SCHWANN CELL DIFFERENTIATION,4.6597e-05,0.23988,0.22781,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,7.9801e-06,0.23988,0.21947,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.1964e-05,0.23978,0.21157,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0097392,0.23957,0.19724,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0011199,0.23952,0.2642,1,1
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.050569,0.23911,0.26181,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0037331,0.23905,0.18447,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.7145e-05,0.2387,0.20718,1,1
1,GO REGULATION OF T CELL ACTIVATION,0.00010462,0.23854,0.21534,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0017641,0.23848,0.37138,1,1
1,GO REGULATION OF LIPID STORAGE,0.00038934,0.23789,0.25262,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.0066042,0.23784,0.22188,1,1
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0010206,0.23758,0.22742,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0045306,0.23749,0.22004,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.015203,0.23743,0.23183,1,1
1,GO ANIMAL ORGAN FORMATION,0.00092958,0.23742,0.21888,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,3.5759e-05,0.23722,0.32645,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,6.7728e-06,0.23716,0.23697,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00029782,0.23711,0.22017,1,1
1,GO MYOBLAST MIGRATION,0.018398,0.23699,0.31206,1,1
1,GO CAMP METABOLIC PROCESS,0.019283,0.23681,0.22775,1,1
1,GO PEPTIDE METABOLIC PROCESS,4.3218e-05,0.23607,0.18785,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0016129,0.23592,0.17757,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00063551,0.23584,0.18515,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.00079435,0.23575,0.24804,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,5.6174e-05,0.23556,0.18661,1,1
1,GO DNA LIGATION,0.0025817,0.23519,0.24586,1,1
1,GO CELL JUNCTION DISASSEMBLY,0.0022332,0.23519,0.24383,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0021062,0.23516,0.21408,1,1
1,GO RESPONSE TO KETONE,0.0017641,0.23516,0.17251,1,1
1,GO HYPEROSMOTIC RESPONSE,0.0011549,0.23488,0.24068,1,1
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0081404,0.23485,0.26885,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.6307e-05,0.23448,0.25159,1,1
1,GO AMINE CATABOLIC PROCESS,0.00036427,0.23447,0.33797,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.010773,0.23405,0.18128,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.026586,0.23397,0.34995,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00017796,0.23381,0.23851,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,0.001228,0.2338,0.24457,1,1
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0018173,0.23368,0.18256,1,1
1,GO TRANSEPITHELIAL TRANSPORT,0.00059588,0.23338,0.23338,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00095906,0.23327,0.30952,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,3.3132e-05,0.23317,0.21258,1,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,1.5201e-05,0.23313,0.24377,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0017641,0.23302,0.17162,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.00024286,0.23301,0.23874,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.014138,0.23292,0.17571,1,1
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00027832,0.23282,0.24183,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00095906,0.23266,0.27315,1,1
1,GO DE NOVO PROTEIN FOLDING,0.0010206,0.23247,0.19432,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,2.6902e-06,0.23247,0.21594,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,0.00092958,0.23107,0.18635,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.0013457,0.23106,0.19703,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0010206,0.23055,0.19768,1,1
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00026903,0.23044,0.20747,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.011047,0.23037,0.18399,1,1
1,GO CELLULAR RESPONSE TO ATP,0.00040247,0.23013,0.21027,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,9.3916e-06,0.22991,0.22166,1,1
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,9.0551e-05,0.22964,0.21971,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,8.4205e-05,0.2294,0.21843,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,0.00095906,0.22915,0.16192,1,1
1,GO AORTA DEVELOPMENT,0.0037331,0.22894,0.289,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.00081984,0.22889,0.25826,1,1
1,GO PODOSOME ASSEMBLY,0.00057693,0.22863,0.33463,1,1
1,GO RUFFLE ORGANIZATION,0.00087311,0.2284,0.17816,1,1
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.02843,0.22833,0.32026,1,1
1,GO SCHWANN CELL DEVELOPMENT,0.00036427,0.22832,0.19556,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.045624,0.22792,0.27889,1,1
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00041602,0.2277,0.25343,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.0040578,0.22764,0.30222,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,0.0022332,0.22757,0.2163,1,1
1,GO TRABECULA MORPHOGENESIS,0.00021909,0.22732,0.29553,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,6.4994e-06,0.22727,0.2205,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,4.0073e-05,0.2271,0.20606,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.036948,0.227,0.17164,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.00353,0.22693,0.18698,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.5201e-05,0.22691,0.23069,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.1493e-05,0.22686,0.19666,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00010092,0.22675,0.23507,1,1
1,GO MITOPHAGY,0.00084609,0.22669,0.22456,1,1
1,GO NATURAL KILLER CELL PROLIFERATION,0.0046564,0.22648,0.3409,1,1
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0034322,0.22627,0.19207,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.014138,0.22607,0.18795,1,1
1,GO RNA 3 END PROCESSING,0.0041716,0.22577,0.15988,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,5.0226e-05,0.22557,0.18405,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,0.00010092,0.2255,0.22797,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.00063551,0.22541,0.21854,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,1.4674e-06,0.2252,0.19638,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,1.0604e-05,0.22465,0.20522,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00072223,0.22425,0.25052,1,1
1,GO CERAMIDE TRANSPORT,0.024846,0.2242,0.19217,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.7118e-05,0.22415,0.22546,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,0.00098941,0.22394,0.18673,1,1
1,GO T CELL CHEMOTAXIS,0.00010462,0.22383,0.23388,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00011241,0.22367,0.24044,1,1
1,GO PERICARDIUM DEVELOPMENT,0.0013457,0.2236,0.27533,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0054795,0.2233,0.22409,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00041602,0.22327,0.18313,1,1
1,GO PLATELET MORPHOGENESIS,0.00021909,0.22279,0.23836,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00013917,0.22208,0.33298,1,1
1,GO HINDLIMB MORPHOGENESIS,0.022165,0.22184,0.21695,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0027346,0.22171,0.27655,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0097392,0.2217,0.16746,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,1.9263e-05,0.22163,0.19805,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00014935,0.22142,0.19023,1,1
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,1.3441e-06,0.22127,0.21831,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00019753,0.22122,0.21531,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,5.4977e-07,0.22092,0.21669,1,1
1,GO INTEGRIN ACTIVATION,0.0083534,0.22079,0.19127,1,1
1,GO REGULATION OF URINE VOLUME,5.0226e-05,0.22054,0.26068,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,9.7346e-05,0.22045,0.21007,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.00050664,0.22032,0.18222,1,1
1,GO MITOCHONDRIAL DNA REPLICATION,0.0033369,0.22028,0.16456,1,1
1,GO ARTERY DEVELOPMENT,0.00050664,0.22026,0.29762,1,1
1,GO REPLACEMENT OSSIFICATION,0.0020453,0.22015,0.28872,1,1
1,GO RESPONSE TO GONADOTROPIN,0.0037331,0.22012,0.2879,1,1
1,GO BODY FLUID SECRETION,0.00028792,0.21983,0.21212,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,3.7791e-06,0.2198,0.19227,1,1
1,GO NUCLEUS LOCALIZATION,0.036948,0.2198,0.13068,1,1
1,GO DNA DEMETHYLATION,0.018836,0.21962,0.16172,1,1
1,GO TISSUE MORPHOGENESIS,2.4346e-05,0.21928,0.20722,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.011612,0.21913,0.21016,1,1
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0060989,0.21909,0.18902,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,3.7791e-06,0.21896,0.21774,1,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.0062634,0.21884,0.15974,1,1
1,GO REGULATION OF LIPID LOCALIZATION,0.00016023,0.21857,0.18037,1,1
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.00042998,0.21848,0.21485,1,1
1,GO ERBB SIGNALING PATHWAY,4.1617e-05,0.2183,0.26456,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,3.1888e-05,0.21817,0.20435,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,0.011326,0.21801,0.15244,1,1
1,GO LEUKOCYTE MIGRATION,0.0006154,0.2179,0.21709,1,1
1,GO ORGAN GROWTH,6.5149e-05,0.21763,0.22492,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,2.0033e-05,0.21732,0.19953,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0001165,0.21723,0.26046,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0011549,0.21707,0.23815,1,1
1,GO NUCLEAR PORE ORGANIZATION,0.00353,0.217,0.21525,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.00092958,0.21687,0.22439,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0010859,0.21664,0.1902,1,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00010845,0.21654,0.19719,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.00021909,0.21647,0.18237,1,1
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.022165,0.21635,0.16469,1,1
1,GO MORPHOGENESIS OF AN EPITHELIUM,2.6307e-05,0.21603,0.21053,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0026572,0.21592,0.22657,1,1
1,GO PORE COMPLEX ASSEMBLY,0.0051916,0.21566,0.17825,1,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.017969,0.21565,0.14411,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,1.6455e-05,0.21533,0.21881,1,1
1,GO HISTONE H2B UBIQUITINATION,0.0090226,0.21531,0.16598,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00092958,0.21528,0.23599,1,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0032441,0.21523,0.20813,1,1
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.00098941,0.21505,0.2105,1,1
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,5.508e-06,0.21471,0.19643,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.00017186,0.21461,0.2,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.00012964,0.21444,0.23233,1,1
1,GO MYELOID CELL DIFFERENTIATION,2.0784e-06,0.21439,0.20302,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.001228,0.21394,0.22782,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.0034322,0.21379,0.21315,1,1
1,GO RESPONSE TO INTERLEUKIN 6,0.024846,0.21361,0.13498,1,1
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.02843,0.21359,0.16895,1,1
1,GO BONE DEVELOPMENT,3.7145e-05,0.21353,0.23885,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.2454e-05,0.21344,0.23168,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.00095906,0.21322,0.19912,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0012662,0.21267,0.25191,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00057693,0.21254,0.19072,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.014486,0.21245,0.16274,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.0047853,0.21199,0.1913,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.010506,0.21193,0.15997,1,1
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.045624,0.21181,0.1589,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.001662,0.21175,0.16741,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.012508,0.21153,0.24884,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.012508,0.21144,0.194,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,1.6455e-05,0.21132,0.21882,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.4421e-05,0.21107,0.26008,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0046564,0.21102,0.2402,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.4039e-05,0.21087,0.2532,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.013e-05,0.21083,0.18289,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00047456,0.21067,0.22491,1,1
1,GO PROTEIN MATURATION,8.4205e-05,0.21039,0.16192,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,1.7806e-05,0.21036,0.329,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,8.7323e-05,0.20992,0.17104,1,1
1,GO RESPONSE TO GROWTH FACTOR,5.0226e-05,0.20968,0.19533,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.00040247,0.20962,0.18479,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.00024286,0.20959,0.19992,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00095906,0.20956,0.21161,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,0.00024286,0.20952,0.15719,1,1
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0099891,0.20888,0.14046,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,0.00017186,0.20836,0.21807,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.1888e-05,0.20805,0.19707,1,1
1,GO TRNA PROCESSING,0.0067808,0.20777,0.13598,1,1
1,GO PROTEIN TARGETING TO MEMBRANE,0.026586,0.20773,0.14718,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0025083,0.20768,0.21272,1,1
1,GO BODY MORPHOGENESIS,0.001662,0.20753,0.22407,1,1
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,8.6584e-06,0.20749,0.22708,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.3916e-06,0.20742,0.25222,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.0040578,0.20729,0.1671,1,1
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.02166,0.20718,0.18584,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.00026903,0.2069,0.17697,1,1
1,GO RNA MODIFICATION,0.0018173,0.20637,0.15337,1,1
1,GO RESPONSE TO GAMMA RADIATION,5.6174e-05,0.20609,0.24201,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,0.0011549,0.20609,0.20884,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.01282,0.20604,0.1701,1,1
1,GO PROTEIN ADP RIBOSYLATION,0.015953,0.20567,0.15661,1,1
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0032441,0.20564,0.1736,1,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.0015189,0.20557,0.21672,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00019079,0.2054,0.22981,1,1
1,GO RETINOL METABOLIC PROCESS,0.00353,0.20526,0.19936,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00034072,0.2047,0.17987,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,5.9841e-06,0.20377,0.21227,1,1
1,GO VESICLE TARGETING,0.0001547,0.20346,0.21382,1,1
1,GO MIDBODY ABSCISSION,0.0083534,0.2034,0.21112,1,1
1,GO LYSOSOMAL TRANSPORT,4.4878e-05,0.20327,0.20075,1,1
1,GO RESPONSE TO CHEMOKINE,0.0050528,0.20321,0.20375,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0013872,0.20321,0.18837,1,1
1,GO KERATINOCYTE PROLIFERATION,0.0059384,0.2029,0.34115,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00017186,0.20248,0.20724,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.00040247,0.20236,0.22188,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00028792,0.20205,0.17457,1,1
1,GO ENDOCRINE PROCESS,0.007729,0.20176,0.15373,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.00013917,0.20137,0.20016,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.045624,0.20113,0.29468,1,1
1,GO ENDOTHELIUM DEVELOPMENT,0.037747,0.20091,0.11793,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,2.5774e-06,0.20085,0.18431,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.001662,0.2008,0.14688,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.010773,0.2008,0.21987,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.00014935,0.20058,0.16765,1,1
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,3.1904e-06,0.20027,0.17697,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.016339,0.20027,0.18404,1,1
1,GO POSITIVE REGULATION OF TISSUE REMODELING,0.001872,0.20026,0.22889,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,9.4334e-07,0.20009,0.19844,1,1
1,GO MITOTIC CYTOKINESIS,0.00069957,0.20002,0.20258,1,1
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0064317,0.19996,0.23022,1,1
1,GO REGULATION OF RESPONSE TO STRESS,1.1964e-05,0.19937,0.17613,1,1
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.041093,0.19912,0.14359,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,1.5816e-05,0.19912,0.22289,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,8.1192e-05,0.19886,0.2456,1,1
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,1.0311e-06,0.19884,0.16315,1,1
1,GO NUCLEAR EXPORT,2.5308e-05,0.19868,0.19347,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,4.4878e-05,0.19858,0.17251,1,1
1,GO TUBE DEVELOPMENT,7.8282e-05,0.19846,0.20806,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0022332,0.19815,0.2047,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,0.0073363,0.19784,0.21057,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.0006154,0.19721,0.16489,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,5.8301e-05,0.19716,0.19887,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00054072,0.19711,0.194,1,1
1,GO NEURAL TUBE FORMATION,0.0023671,0.19646,0.19233,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,8.3127e-06,0.1964,0.16905,1,1
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.024288,0.19601,0.12751,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.0025083,0.19597,0.23389,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,6.5149e-05,0.1959,0.16823,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.6174e-05,0.19559,0.22112,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.029719,0.19503,0.20172,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00079435,0.19496,0.20266,1,1
1,GO RESPONSE TO HEAT,0.00012074,0.19478,0.18746,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.00047456,0.19454,0.19264,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0018173,0.1944,0.16646,1,1
1,GO TRANSLATIONAL ELONGATION,0.015203,0.19408,0.14996,1,1
1,GO RESPONSE TO NUTRIENT,0.014138,0.19386,0.15299,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,6.2786e-05,0.19382,0.15347,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.00017796,0.19375,0.15333,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,4.8612e-06,0.19337,0.20732,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,1.5201e-05,0.19335,0.20464,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0040578,0.19278,0.14238,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,2.3418e-05,0.19276,0.21152,1,1
1,GO RESPONSE TO VITAMIN,0.024846,0.19267,0.1825,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.0011549,0.19253,0.16496,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.015953,0.19244,0.18272,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.01282,0.19226,0.16369,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,5.9841e-06,0.19226,0.17863,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0083534,0.19192,0.19214,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00021167,0.19187,0.15871,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,1.1493e-05,0.19162,0.20156,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00013917,0.1916,0.2177,1,1
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.00021167,0.19129,0.15671,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,2.7343e-05,0.19122,0.1669,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.019283,0.19121,0.16235,1,1
1,GO LEUKOCYTE DIFFERENTIATION,9.0551e-05,0.19109,0.1813,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,3.5759e-05,0.19094,0.21965,1,1
1,GO AMIDE BIOSYNTHETIC PROCESS,0.00044439,0.19072,0.1511,1,1
1,GO MACROPHAGE ACTIVATION,0.0081404,0.19062,0.19315,1,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00049035,0.19045,0.17765,1,1
1,GO PROTEIN TARGETING,0.00050664,0.19024,0.15924,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0018173,0.19021,0.16014,1,1
1,GO TRNA METABOLIC PROCESS,0.010245,0.19021,0.12994,1,1
1,GO SULFUR COMPOUND METABOLIC PROCESS,5.4121e-05,0.19004,0.18438,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.00028792,0.18966,0.18234,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,0.00035231,0.18945,0.16608,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,0.00021909,0.18941,0.20093,1,1
1,GO B CELL ACTIVATION,0.00037661,0.1892,0.16528,1,1
1,GO RESPONSE TO REDOX STATE,0.031748,0.18902,0.20299,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.034637,0.18894,0.14985,1,1
1,GO PROTEIN STABILIZATION,2.7343e-05,0.18881,0.16525,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.011904,0.18876,0.28445,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.00072223,0.18864,0.14948,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,3.0576e-06,0.18851,0.19072,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,7.3528e-06,0.18843,0.21129,1,1
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.00098941,0.18842,0.19488,1,1
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00074557,0.18803,0.19968,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,2.4346e-05,0.1879,0.18993,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00072223,0.18753,0.19213,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.023205,0.1873,0.13418,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,2.7578e-07,0.18718,0.18091,1,1
1,GO HISTONE DEACETYLATION,0.00095906,0.18712,0.12562,1,1
1,GO REGULATION OF B CELL ACTIVATION,0.004408,0.18691,0.15414,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00059588,0.18689,0.14472,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.00027832,0.18675,0.16754,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0059384,0.18631,0.14362,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.035393,0.18628,0.13029,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,2.2524e-05,0.18623,0.1853,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00353,0.18621,0.22376,1,1
1,GO ORGANELLE INHERITANCE,0.0017641,0.18615,0.17057,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.0060989,0.18604,0.13279,1,1
1,GO AUTOPHAGOSOME ORGANIZATION,2.5308e-05,0.18603,0.21616,1,1
1,GO VACUOLAR TRANSPORT,0.00012964,0.18549,0.16567,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.015953,0.18538,0.21247,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,8.628e-07,0.18517,0.16005,1,1
1,GO REGULATION OF CELL DEATH,3.5759e-05,0.18511,0.15288,1,1
1,GO SULFUR COMPOUND TRANSPORT,5.2139e-05,0.18493,0.18917,1,1
1,GO ISOPRENOID METABOLIC PROCESS,0.023205,0.1848,0.13751,1,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.043763,0.18475,0.11829,1,1
1,GO REGULATION OF MAPK CASCADE,3.3132e-05,0.18471,0.1945,1,1
1,GO BIOLOGICAL ADHESION,0.0034322,0.18456,0.15351,1,1
1,GO CELLULAR RESPONSE TO UV,0.0011199,0.18438,0.1657,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.00038934,0.1842,0.29234,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.027803,0.18383,0.13958,1,1
1,GO ALDITOL METABOLIC PROCESS,0.0030654,0.18344,0.18958,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.0056288,0.18333,0.13852,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.031748,0.18316,0.14097,1,1
1,GO RESPONSE TO ANTIBIOTIC,0.0013872,0.18295,0.19787,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00037661,0.18284,0.17932,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00353,0.18244,0.2343,1,1
1,GO STEM CELL DIFFERENTIATION,2.5308e-05,0.18242,0.1987,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00011241,0.18222,0.20839,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00017796,0.18185,0.15968,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,1.5816e-05,0.18183,0.19674,1,1
1,GO FLUID TRANSPORT,0.0022332,0.18171,0.16459,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.00065623,0.18152,0.15582,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0018173,0.18143,0.14338,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00023468,0.18119,0.19272,1,1
1,GO RESPONSE TO PH,0.012203,0.18082,0.18732,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,0.0083534,0.18059,0.17638,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.00074557,0.18021,0.16625,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,2.0833e-05,0.18017,0.17014,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,1.0604e-05,0.18001,0.21723,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.02843,0.17981,0.1286,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.0829e-07,0.17974,0.1839,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,0.00025131,0.17924,0.17355,1,1
1,GO CHYLOMICRON ASSEMBLY,0.045624,0.17901,0.17032,1,1
1,GO REGULATION OF DNA RECOMBINATION,0.00041602,0.17888,0.18932,1,1
1,GO RESPONSE TO INTERLEUKIN 4,0.0021062,0.17885,0.16106,1,1
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.17882,0.1529,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,0.0013054,0.17844,0.38062,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00055855,0.17842,0.18685,1,1
1,GO RESPONSE TO IRON ION,0.015953,0.17827,0.15201,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,3.8131e-07,0.17826,0.17354,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,2.2524e-05,0.17776,0.17529,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,4.8379e-05,0.17771,0.18424,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.0034322,0.17763,0.14925,1,1
1,GO RNA METHYLATION,0.0099891,0.17758,0.13227,1,1
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.0087944,0.17663,0.11127,1,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.0040578,0.17648,0.18397,1,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00074557,0.1764,0.13572,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0007696,0.1761,0.18759,1,1
1,GO GOLGI VESICLE BUDDING,0.0007696,0.17591,0.17865,1,1
1,GO SPINDLE LOCALIZATION,1.4039e-05,0.17579,0.19369,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00019753,0.17572,0.17867,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00014935,0.17566,0.20047,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,4.5813e-07,0.17557,0.17853,1,1
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0001547,0.17497,0.14499,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0016129,0.17494,0.1581,1,1
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0059384,0.17469,0.1663,1,1
1,GO GOLGI VESICLE TRANSPORT,1.0184e-05,0.1745,0.17167,1,1
1,GO ETHANOL METABOLIC PROCESS,0.027188,0.1745,0.23419,1,1
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.0041716,0.17356,0.15316,1,1
1,GO POSITIVE REGULATION OF BINDING,5.0226e-05,0.17322,0.17158,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,9.0221e-07,0.17273,0.17037,1,1
1,GO RESPONSE TO DRUG,0.004408,0.17253,0.12951,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.013798,0.1722,0.14419,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.014841,0.17217,0.14325,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,0.0023671,0.17191,0.20136,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.00037661,0.17181,0.18513,1,1
1,GO REGULATION OF PROTEIN BINDING,8.1192e-05,0.17131,0.17233,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0087944,0.17126,0.12225,1,1
1,GO TRANSLESION SYNTHESIS,0.00023468,0.17119,0.17542,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00017186,0.17099,0.15287,1,1
1,GO MULTIVESICULAR BODY ORGANIZATION,0.0067808,0.17095,0.13401,1,1
1,GO COENZYME A METABOLIC PROCESS,0.013465,0.17074,0.1539,1,1
1,GO PROTEOLYSIS,6.4994e-06,0.17062,0.15634,1,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.042857,0.17057,0.13156,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0056288,0.17018,0.12955,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.1663e-05,0.1701,0.23316,1,1
1,GO REGULATION OF NUCLEAR DIVISION,3.4421e-05,0.17003,0.14737,1,1
1,GO BLASTOCYST GROWTH,0.0038387,0.16955,0.23514,1,1
1,GO REGULATION OF CATABOLIC PROCESS,3.6414e-07,0.1695,0.16737,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.011904,0.16933,0.17671,1,1
1,GO REGULATION OF CELL SHAPE,0.0028141,0.16902,0.19612,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0013457,0.16866,0.23545,1,1
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0069616,0.16858,0.1909,1,1
1,GO POSITIVE REGULATION OF OSSIFICATION,0.0047853,0.16845,0.24976,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0050528,0.16841,0.14131,1,1
1,GO REGULATION OF PHOSPHORYLATION,0.00012074,0.16825,0.14063,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.025994,0.16813,0.14915,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00052342,0.16789,0.15466,1,1
1,GO DIOL BIOSYNTHETIC PROCESS,0.016339,0.16757,0.12481,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,3.6228e-06,0.16748,0.15638,1,1
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.00054072,0.16683,0.18002,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.7343e-05,0.16647,0.18761,1,1
1,GO RESPONSE TO BMP,0.016734,0.16642,0.15399,1,1
1,GO PROTEIN DENEDDYLATION,0.027188,0.16628,0.13814,1,1
1,GO OXALATE TRANSPORT,0.025414,0.16623,0.11557,1,1
1,GO MAINTENANCE OF LOCATION,1.1493e-05,0.16586,0.18244,1,1
1,GO ENDOSOME ORGANIZATION,0.00020448,0.16568,0.1703,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0023671,0.16567,0.18498,1,1
1,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0085714,0.16532,0.17843,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0099891,0.16522,0.1168,1,1
1,GO PROTEIN KINASE A SIGNALING,0.00021167,0.16514,0.20877,1,1
1,GO EXOCYTOSIS,0.00034072,0.16504,0.15811,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0013054,0.16447,0.16902,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.2308e-06,0.16447,0.17552,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.00021167,0.16445,0.17969,1,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.0050528,0.16434,0.14369,1,1
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00353,0.16433,0.20661,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,9.389e-05,0.16413,0.14486,1,1
1,GO LYMPHOCYTE COSTIMULATION,0.0038387,0.16395,0.15174,1,1
1,GO VACUOLE ORGANIZATION,7.013e-05,0.16375,0.15601,1,1
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.033166,0.16366,0.11584,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,0.00023468,0.16357,0.16469,1,1
1,GO RECEPTOR RECYCLING,0.0067808,0.16318,0.13033,1,1
1,GO CELL MOTILITY,0.0024367,0.16294,0.13552,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.0571e-06,0.16292,0.185,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,2.5774e-06,0.16278,0.15116,1,1
1,GO HEART MORPHOGENESIS,0.0032441,0.16235,0.16378,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0016129,0.16207,0.15705,1,1
1,GO HEART GROWTH,0.00072223,0.16206,0.18942,1,1
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.023741,0.16186,0.12917,1,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.031748,0.16186,0.15484,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,4.0073e-05,0.16183,0.15971,1,1
1,GO REGULATION OF BINDING,7.547e-05,0.16172,0.15523,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.001228,0.16152,0.13259,1,1
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0057817,0.16141,0.17546,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,1.5816e-05,0.1613,0.17334,1,1
1,GO OUTFLOW TRACT MORPHOGENESIS,0.0015653,0.16115,0.28193,1,1
1,GO PROTEIN POLYUBIQUITINATION,2.5308e-05,0.161,0.15442,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,0.012203,0.161,0.15341,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,7.013e-05,0.16094,0.19125,1,1
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0027346,0.16083,0.16006,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.019739,0.16049,0.119,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.04854,0.15959,0.10804,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.00057693,0.15953,0.12321,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0016129,0.15952,0.12769,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0097392,0.15933,0.19074,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0027346,0.15919,0.13898,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00017796,0.15918,0.1489,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.011904,0.15898,0.18476,1,1
1,GO COPII COATED VESICLE BUDDING,0.0025083,0.15894,0.17179,1,1
1,GO REGULATION OF CELL DIVISION,0.0056288,0.15879,0.11199,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,1.5201e-05,0.15872,0.14075,1,1
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0032441,0.1587,0.21026,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00041602,0.15824,0.15095,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,9.0551e-05,0.15816,0.16923,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.0022992,0.15794,0.17702,1,1
1,GO POSTREPLICATION REPAIR,0.00034072,0.15789,0.14722,1,1
1,GO RESPONSE TO UV,8.1192e-05,0.15756,0.17548,1,1
1,GO APOPTOTIC PROCESS,2.7343e-05,0.15756,0.14671,1,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.041967,0.1575,0.077913,1,1
1,GO CELL CELL SIGNALING BY WNT,0.001191,0.15697,0.14046,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,5.2139e-05,0.15674,0.1568,1,1
1,GO AMYLOID BETA FORMATION,0.0062634,0.15602,0.19673,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.0029794,0.15593,0.14231,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00028792,0.15527,0.12236,1,1
1,GO RESPONSE TO ESTRADIOL,0.010773,0.15524,0.1363,1,1
1,GO ENDOCYTOSIS,0.00013917,0.15523,0.15058,1,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.0036303,0.1551,0.15368,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.0779e-06,0.15492,0.15396,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00010092,0.1549,0.16117,1,1
1,GO REGULATION OF DNA BINDING,0.0097392,0.15473,0.097507,1,1
1,GO PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER,0.026586,0.15459,0.16504,1,1
1,GO IMPORT INTO NUCLEUS,0.00036427,0.15452,0.13546,1,1
1,GO RRNA 3 END PROCESSING,0.0060989,0.15438,0.16781,1,1
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.016734,0.15429,0.15409,1,1
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.022165,0.1538,0.18064,1,1
1,GO LACTATION,0.0031536,0.15374,0.18547,1,1
1,GO PROTEIN IMPORT,0.00012964,0.15338,0.15374,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,9.0221e-07,0.15325,0.1664,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.5201e-05,0.15305,0.18198,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0013054,0.15297,0.17275,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,2.0833e-05,0.15264,0.14537,1,1
1,GO LAMELLIPODIUM ASSEMBLY,0.0023671,0.15144,0.1861,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00045924,0.15137,0.13101,1,1
1,GO REGULATION OF ENDOCYTOSIS,0.00090094,0.151,0.13703,1,1
1,GO TELOMERE ORGANIZATION,0.0069616,0.15099,0.10642,1,1
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.00081984,0.15055,0.1209,1,1
1,GO REGULATION OF ERAD PATHWAY,0.00018427,0.1504,0.15445,1,1
1,GO RESPONSE TO LEPTIN,0.018836,0.15038,0.18827,1,1
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.011326,0.15027,0.13163,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,0.0010528,0.15017,0.12424,1,1
1,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.019283,0.15009,0.23443,1,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.031748,0.14992,0.1053,1,1
1,GO VACUOLAR ACIDIFICATION,0.004408,0.14956,0.1614,1,1
1,GO POSITIVE REGULATION OF CELL AGING,0.02268,0.1495,0.23266,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00014418,0.14949,0.19165,1,1
1,GO HEART DEVELOPMENT,0.00020448,0.14936,0.168,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,0.0033369,0.14929,0.19603,1,1
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0021062,0.14917,0.19057,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.0042883,0.14916,0.1032,1,1
1,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.043763,0.14909,0.13694,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,5.2139e-05,0.14904,0.13955,1,1
1,GO GOLGI ORGANIZATION,0.00063551,0.14886,0.13554,1,1
1,GO RESPONSE TO HORMONE,0.00055855,0.14867,0.13408,1,1
1,GO MITOTIC RECOMBINATION,0.0066042,0.14863,0.18162,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.02843,0.14829,0.14219,1,1
1,GO AMINE METABOLIC PROCESS,0.0087944,0.14824,0.11005,1,1
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.041093,0.1479,0.09023,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.030383,0.14786,0.14912,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00090094,0.14784,0.15708,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.03939,0.14778,0.13703,1,1
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.019739,0.14769,0.13609,1,1
1,GO DNA BIOSYNTHETIC PROCESS,3.1904e-06,0.14764,0.16028,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0026572,0.1476,0.11116,1,1
1,GO ACTIVATED T CELL PROLIFERATION,0.041967,0.1474,0.12097,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0066042,0.14723,0.10817,1,1
1,GO TUBE FORMATION,0.007729,0.147,0.14401,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0042883,0.14694,0.15141,1,1
1,GO POSITIVE REGULATION OF DNA BINDING,0.024846,0.14691,0.11908,1,1
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0029794,0.14677,0.17976,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00016023,0.14583,0.13418,1,1
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.024288,0.14562,0.21845,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0013054,0.14543,0.1147,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00032948,0.14511,0.15902,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,4.6597e-05,0.14491,0.14576,1,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.0037331,0.14478,0.1724,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.03245,0.1446,0.11737,1,1
1,GO NUCLEAR TRANSPORT,0.00010092,0.14458,0.14275,1,1
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0042883,0.14453,0.17044,1,1
1,GO CELLULAR RESPONSE TO RADIATION,0.00054072,0.14447,0.14379,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.012203,0.1443,0.11933,1,1
1,GO CHROMOSOME LOCALIZATION,0.03939,0.14391,0.11261,1,1
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.017137,0.14321,0.15145,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,0.020205,0.14311,0.20968,1,1
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00027832,0.14295,0.12927,1,1
1,GO IRON ION TRANSPORT,0.0023671,0.14287,0.10906,1,1
1,GO RNA LOCALIZATION,0.001872,0.14285,0.16066,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0014299,0.14264,0.18929,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00025131,0.1425,0.13131,1,1
1,GO EPITHELIAL TUBE FORMATION,0.024846,0.14213,0.13186,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0017123,0.14191,0.13199,1,1
1,GO RNA CAPPING,0.0023671,0.14165,0.13775,1,1
1,GO GENITALIA DEVELOPMENT,0.0057817,0.14131,0.12687,1,1
1,GO RNA PROCESSING,0.0027346,0.14111,0.12934,1,1
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.036164,0.14051,0.11863,1,1
1,GO PROTEIN NEDDYLATION,0.012508,0.14027,0.1542,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0069616,0.13997,0.12082,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00018427,0.1399,0.1229,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.00014418,0.13932,0.11875,1,1
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.0604e-05,0.13892,0.15364,1,1
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.017969,0.13863,0.14255,1,1
1,GO MEMBRANE ORGANIZATION,0.00023468,0.13828,0.12248,1,1
1,GO NUCLEUS ORGANIZATION,0.0011549,0.13804,0.12414,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0064317,0.13779,0.13378,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0099891,0.13775,0.11224,1,1
1,GO HISTONE MRNA METABOLIC PROCESS,0.036948,0.13739,0.10176,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.040234,0.13735,0.25002,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.00055855,0.1373,0.1107,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00095906,0.13716,0.16117,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0057817,0.13715,0.18347,1,1
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,6.7596e-05,0.13711,0.14463,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.00026903,0.13645,0.16544,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.00012074,0.13616,0.12555,1,1
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.0083534,0.13575,0.13002,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.00032948,0.13571,0.13196,1,1
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.013465,0.13564,0.14866,1,1
1,GO SULFATE TRANSPORT,0.00092958,0.13554,0.13088,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.5816e-05,0.13536,0.15978,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00353,0.13528,0.10535,1,1
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0071468,0.13524,0.096165,1,1
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.0085714,0.1349,0.089288,1,1
1,GO TRNA TRANSPORT,0.030383,0.1346,0.13066,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0010206,0.13443,0.13967,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.0007696,0.13418,0.11168,1,1
1,GO OVULATION CYCLE,0.011904,0.13382,0.15912,1,1
1,GO CENTRIOLE ASSEMBLY,0.025994,0.13348,0.1047,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,4.0073e-05,0.13298,0.14187,1,1
1,GO VIRAL BUDDING,0.0033369,0.13218,0.14296,1,1
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00072223,0.13156,0.12257,1,1
1,GO CELLULAR SENESCENCE,0.00067758,0.13145,0.13857,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0007696,0.13127,0.1438,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.00353,0.13114,0.12747,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00098941,0.13107,0.17359,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0046564,0.13103,0.17029,1,1
1,GO REGULATION OF SPINDLE ORGANIZATION,0.0047853,0.13089,0.13782,1,1
1,GO REGULATION OF CENTROSOME DUPLICATION,0.0085714,0.13082,0.14202,1,1
1,GO TRANSITION METAL ION TRANSPORT,0.00044439,0.13007,0.098626,1,1
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0094949,0.12991,0.11452,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.02268,0.12982,0.1914,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.027803,0.12978,0.12303,1,1
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.015574,0.1294,0.11746,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.014138,0.12938,0.18185,1,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0024367,0.12923,0.1253,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.00084609,0.12904,0.14528,1,1
1,GO RNA DECAPPING,0.0015189,0.12903,0.15982,1,1
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.001228,0.12889,0.15398,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,4.1617e-05,0.12868,0.12291,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.0017123,0.12837,0.11399,1,1
1,GO REGULATION OF TRANSFERASE ACTIVITY,5.2139e-05,0.12829,0.12651,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00065623,0.12766,0.14242,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.018836,0.12755,0.10371,1,1
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.031059,0.12753,0.1042,1,1
1,GO CELL DIVISION,0.00084609,0.12747,0.11226,1,1
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.00049035,0.12725,0.14586,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,4.3218e-05,0.12657,0.14719,1,1
1,GO REGULATION OF CHROMOSOME SEPARATION,0.0069616,0.12624,0.16288,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.0099891,0.12619,0.16324,1,1
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.044685,0.12612,0.093749,1,1
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.033894,0.1261,0.16331,1,1
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.0021062,0.12609,0.19048,1,1
1,GO PROTEIN LOCALIZATION TO ORGANELLE,4.6623e-06,0.12604,0.1227,1,1
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00055855,0.12601,0.12081,1,1
1,GO GENE SILENCING,0.00042998,0.12577,0.12393,1,1
1,GO MRNA METABOLIC PROCESS,0.0010528,0.12576,0.12761,1,1
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.01282,0.12574,0.086297,1,1
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.0013457,0.12564,0.12859,1,1
1,GO ACTIVATION OF MAPK ACTIVITY,0.0062634,0.1253,0.12018,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.013798,0.12507,0.096128,1,1
1,GO CENTRIOLE CENTRIOLE COHESION,0.014138,0.12489,0.17441,1,1
1,GO LAMELLIPODIUM ORGANIZATION,0.0013054,0.12479,0.19478,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0007696,0.12468,0.12675,1,1
1,GO REGULATION OF DNA REPLICATION,0.001228,0.12451,0.11734,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,9.7801e-06,0.12394,0.13502,1,1
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0097392,0.12369,0.10328,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00038934,0.12336,0.1308,1,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.0064317,0.12267,0.10145,1,1
1,GO SPHINGOID METABOLIC PROCESS,0.043763,0.12236,0.093046,1,1
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.016339,0.12222,0.094333,1,1
1,GO PROTEIN MONOUBIQUITINATION,0.04854,0.12216,0.070175,1,1
1,GO NEGATIVE REGULATION OF BINDING,0.0032441,0.12205,0.11926,1,1
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0067808,0.12184,0.13182,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.031748,0.12171,0.10133,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.012508,0.12133,0.094024,1,1
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011549,0.12107,0.092733,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.0057817,0.12057,0.18434,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0041716,0.12051,0.11011,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.033166,0.12043,0.085112,1,1
1,GO GLIAL CELL DEVELOPMENT,0.04854,0.12016,0.093945,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0054795,0.11976,0.10522,1,1
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.016339,0.11971,0.10037,1,1
1,GO RESPONSE TO ATP,0.012508,0.11969,0.12207,1,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.00090094,0.11943,0.12539,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.013798,0.11917,0.091522,1,1
1,GO CYTOKINESIS,0.0050528,0.11861,0.11466,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02268,0.11856,0.12588,1,1
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.013465,0.11787,0.10263,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,8.4205e-05,0.11775,0.13683,1,1
1,GO AUTOPHAGY OF MITOCHONDRION,0.00022676,0.11735,0.15139,1,1
1,GO REGULATION OF AUTOPHAGY,2.5308e-05,0.11693,0.14265,1,1
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00029782,0.11693,0.12109,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00087311,0.1163,0.12478,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.0021689,0.11599,0.11481,1,1
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.027803,0.11537,0.16407,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.025414,0.11512,0.083658,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.0047853,0.11436,0.092595,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.014138,0.11379,0.097381,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.00057693,0.11379,0.21799,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.020205,0.11318,0.086495,1,1
1,GO ORGANELLE FISSION,0.0042883,0.11284,0.091281,1,1
1,GO SPINDLE ORGANIZATION,0.007729,0.11271,0.11308,1,1
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.042857,0.11269,0.098506,1,1
1,GO MITOTIC CELL CYCLE,0.00052342,0.11238,0.11191,1,1
1,GO CHROMOSOME SEPARATION,0.029719,0.11213,0.12249,1,1
1,GO MACROAUTOPHAGY,4.0073e-05,0.11204,0.13413,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.0075304,0.11201,0.10728,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0010206,0.11173,0.16551,1,1
1,GO RNA SURVEILLANCE,0.014841,0.11171,0.12981,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00353,0.11169,0.095981,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00098941,0.11143,0.10896,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.018398,0.1111,0.10618,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0085714,0.11068,0.092663,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0025817,0.11048,0.10661,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.00055855,0.11031,0.10277,1,1
1,GO METAPHASE PLATE CONGRESSION,0.029719,0.11002,0.10755,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.023741,0.10999,0.088435,1,1
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.015574,0.10969,0.13064,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.014486,0.10967,0.098047,1,1
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.0017123,0.10927,0.17844,1,1
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,1.104e-05,0.10925,0.12753,1,1
1,GO ORGANELLE DISASSEMBLY,0.00035231,0.10897,0.12278,1,1
1,GO NUCLEOTIDE EXCISION REPAIR,0.0032441,0.10897,0.11245,1,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.0045306,0.10874,0.099869,1,1
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.00044439,0.10845,0.10323,1,1
1,GO CYTOSKELETON ORGANIZATION,0.027803,0.10832,0.074483,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015574,0.10787,0.10036,1,1
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,7.2754e-05,0.10751,0.1077,1,1
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.045624,0.1074,0.13435,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.023205,0.10723,0.11072,1,1
1,GO FEMALE GAMETE GENERATION,0.0097392,0.10704,0.08897,1,1
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.0057817,0.10593,0.1123,1,1
1,GO CHROMOSOME CONDENSATION,0.015574,0.10575,0.11723,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0032441,0.10522,0.1077,1,1
1,GO VESICLE ORGANIZATION,0.0037331,0.10505,0.10573,1,1
1,GO MRNA TRANSPORT,0.0030654,0.10496,0.14544,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.023741,0.10453,0.10406,1,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.004408,0.10287,0.10872,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.02068,0.10254,0.090692,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.0056288,0.10219,0.12694,1,1
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0017123,0.10165,0.091217,1,1
1,GO PROTEIN TETRAMERIZATION,0.0041716,0.10143,0.1089,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.017137,0.10141,0.081961,1,1
1,GO NON RECOMBINATIONAL REPAIR,0.0032441,0.10133,0.12661,1,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.036948,0.10117,0.073047,1,1
1,GO MACROMOLECULE DEACYLATION,0.011326,0.10102,0.078174,1,1
1,GO PEPTIDYL SERINE MODIFICATION,0.013798,0.1007,0.073877,1,1
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.027188,0.10063,0.092069,1,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.045624,0.10055,0.11926,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.014138,0.09988,0.077779,1,1
1,GO T CELL LINEAGE COMMITMENT,0.013139,0.099631,0.12533,1,1
1,GO REGULATION OF DNA REPAIR,0.045624,0.099424,0.077528,1,1
1,GO CELL CYCLE PROCESS,0.0013054,0.098459,0.090709,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00084609,0.098249,0.10298,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.034637,0.096286,0.072244,1,1
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.009256,0.096042,0.096087,1,1
1,GO REGULATION OF CELL CYCLE,0.00063551,0.095836,0.085117,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.00069957,0.095805,0.076261,1,1
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.033894,0.095575,0.08424,1,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.026586,0.095376,0.14988,1,1
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.045624,0.094725,0.072851,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.00028792,0.094263,0.092299,1,1
1,GO G2 DNA DAMAGE CHECKPOINT,0.024288,0.093569,0.10896,1,1
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00017796,0.093442,0.13328,1,1
1,GO MULTI ORGANISM PROCESS,0.0014738,0.093044,0.076346,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0090226,0.092537,0.1759,1,1
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.0014299,0.092091,0.13472,1,1
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.033894,0.091918,0.082976,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.015203,0.091715,0.092639,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.007729,0.090295,0.089772,1,1
1,GO REGULATION OF ATPASE ACTIVITY,0.02068,0.090262,0.085625,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.013139,0.090208,0.07618,1,1
1,GO MITOTIC NUCLEAR DIVISION,0.0040578,0.089101,0.10645,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.02166,0.088204,0.12901,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00023468,0.087704,0.094303,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.013465,0.087492,0.10514,1,1
1,GO CELL CYCLE,0.001872,0.087191,0.077657,1,1
1,GO REGULATION OF CENTROSOME CYCLE,0.021165,0.087053,0.10245,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.013139,0.086983,0.097658,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.0025817,0.086683,0.13136,1,1
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.00011241,0.086551,0.093299,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.0040578,0.085483,0.097915,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.026586,0.084692,0.082944,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.014138,0.083768,0.071041,1,1
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.0054795,0.083163,0.064743,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00026903,0.083088,0.093166,1,1
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00098941,0.081653,0.094987,1,1
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.044685,0.081561,0.053407,1,1
1,GO REGULATION OF DNA METABOLIC PROCESS,0.00079435,0.081321,0.10093,1,1
1,GO REPRODUCTION,0.016734,0.08109,0.063835,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.02268,0.081036,0.070192,1,1
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.019283,0.076661,0.091759,1,1
1,GO SPINDLE ASSEMBLY,0.041093,0.075853,0.077714,1,1
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.0081404,0.075433,0.057875,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.0039469,0.075382,0.13545,1,1
1,GO DNA METABOLIC PROCESS,0.0028957,0.07527,0.084378,1,1
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.00044439,0.075076,0.076749,1,1
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0081404,0.074231,0.068812,1,1
1,GO DNA CATABOLIC PROCESS,0.012508,0.071217,0.068963,1,1
1,GO EMBRYO DEVELOPMENT,0.015574,0.070658,0.089968,1,1
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.014486,0.070269,0.065543,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.017549,0.0678,0.051994,1,1
1,GO INTRACELLULAR TRANSPORT,0.00079435,0.065394,0.074318,1,1
1,GO SNRNA TRANSCRIPTION,0.020205,0.065074,0.086002,1,1
1,GO RESPONSE TO RADIATION,0.014841,0.065004,0.064216,1,1
1,GO REGULATION OF MACROAUTOPHAGY,0.0031536,0.060104,0.12261,1,1
1,GO CELL CYCLE CHECKPOINT,0.027188,0.059245,0.072525,1,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.031748,0.058932,0.047742,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.03939,0.055151,0.056102,1,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.042857,0.049955,0.067311,1,1
1,GO DNA REPAIR,0.047551,0.049107,0.065785,1,1
1,GO ORGANELLE ASSEMBLY,0.021165,0.039794,0.060407,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.3975e-07,1.2188,0.98077,1,1
2,GO ETHANOL OXIDATION,6.8936e-07,1.0574,0.91957,1,1
2,GO NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS,0.00025131,0.96721,0.71972,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00353,0.96422,0.68716,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0028957,0.8366,0.52159,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.6414e-07,0.82551,0.76751,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.00049035,0.82084,0.6559,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,3.7791e-06,0.80051,0.61412,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.00024286,0.79234,0.65233,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.4963e-07,0.77703,0.7163,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00012074,0.75668,0.61402,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.0001547,0.7414,0.61311,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00067758,0.73434,0.48717,1,1
2,GO RESPONSE TO INTERLEUKIN 18,8.4205e-05,0.71907,0.69033,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,9.7801e-06,0.70935,0.70201,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,0.00021909,0.69788,0.51912,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,4.2876e-06,0.68144,0.51662,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,3.8131e-07,0.68021,0.52836,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,3.3202e-07,0.67989,0.64115,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,2.0833e-05,0.67581,0.59002,1,1
2,GO BIOLOGICAL PHASE,5.8301e-05,0.67252,0.64455,1,1
2,GO MUCUS SECRETION,0.00041602,0.66447,0.62258,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,0.00014418,0.66081,0.48671,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00012512,0.65356,0.55602,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0032441,0.64671,0.46843,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00079435,0.63924,0.56895,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0067808,0.63783,0.41816,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,8.1192e-05,0.62672,0.54969,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.00026903,0.62238,0.47929,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,7.9801e-06,0.61743,0.54446,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00079435,0.6163,0.43915,1,1
2,GO MYOBLAST MIGRATION,0.012203,0.61214,0.48969,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.9904e-06,0.61141,0.58141,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0006154,0.60615,0.39289,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,2.8077e-06,0.59842,0.53565,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,7.013e-05,0.59822,0.57271,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,3.4421e-05,0.59241,0.56255,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.001662,0.5892,0.41026,1,1
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.0037331,0.58809,0.38473,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0014738,0.58398,0.48389,1,1
2,GO PROSTATE GLAND GROWTH,2.6902e-06,0.58277,0.66094,1,1
2,GO PROSTANOID METABOLIC PROCESS,1.2454e-05,0.57692,0.50387,1,1
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.0036303,0.57617,0.5243,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.5746,0.41042,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8612e-06,0.5727,0.41492,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,8.3127e-06,0.57002,0.51339,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00054072,0.56861,0.49296,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.0226e-05,0.56849,0.50487,1,1
2,GO HAIR FOLLICLE MATURATION,5.0226e-05,0.56535,0.46299,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.8379e-05,0.56446,0.5591,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,7.547e-05,0.56443,0.52748,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,6.0504e-05,0.5639,0.50941,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00029782,0.55977,0.55728,1,1
2,GO ETHER METABOLIC PROCESS,2.2658e-06,0.55969,0.52151,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00041602,0.55842,0.38525,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.00057693,0.54504,0.45648,1,1
2,GO LYSINE METABOLIC PROCESS,0.00027832,0.54427,0.50937,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,1.5331e-06,0.53953,0.52941,1,1
2,GO OTIC VESICLE DEVELOPMENT,0.00035231,0.53863,0.44538,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.2533e-07,0.5381,0.50383,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS,1.1493e-05,0.53748,0.58244,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00035231,0.53501,0.54111,1,1
2,GO PSEUDOPODIUM ORGANIZATION,0.0085714,0.53404,0.37151,1,1
2,GO RETINAL METABOLIC PROCESS,0.011612,0.52399,0.33519,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.5201e-05,0.52013,0.45297,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,8.1192e-05,0.50824,0.40378,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00040247,0.50678,0.4586,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.0023671,0.50474,0.3476,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.00045924,0.50334,0.43411,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.0184e-05,0.50221,0.42961,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00012964,0.50121,0.46953,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.8418e-05,0.50099,0.40463,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,0.00013433,0.49905,0.45815,1,1
2,GO HEPATOCYTE DIFFERENTIATION,0.0034322,0.49763,0.40906,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014299,0.49496,0.35548,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.0073363,0.49416,0.4227,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00037661,0.49345,0.43814,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0010206,0.48643,0.35473,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00034072,0.48059,0.47727,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4692e-06,0.47901,0.43059,1,1
2,GO ACTIN FILAMENT SEVERING,0.03939,0.47803,0.31778,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,0.00011241,0.47764,0.43602,1,1
2,GO OXYGEN TRANSPORT,0.0097392,0.47714,0.44234,1,1
2,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,6.7728e-06,0.47699,0.47013,1,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.2139e-05,0.4752,0.43857,1,1
2,GO ETHANOL METABOLIC PROCESS,3.9418e-06,0.47423,0.53454,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0094949,0.47382,0.31455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7806e-05,0.47187,0.42891,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.043763,0.47024,0.31162,1,1
2,GO MUSCLE ATROPHY,0.0056288,0.46832,0.35363,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074557,0.46758,0.36777,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,2.8077e-06,0.46665,0.46345,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.017969,0.46374,0.33599,1,1
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0039469,0.46115,0.3362,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.00010092,0.45356,0.32321,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,5.0683e-06,0.45162,0.44542,1,1
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0025083,0.45013,0.35679,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.2139e-05,0.44985,0.38143,1,1
2,GO NEPHRON TUBULE FORMATION,0.0051916,0.44818,0.29165,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,1.8521e-05,0.44531,0.36481,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,5.2139e-05,0.44416,0.39268,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,3.4421e-05,0.44402,0.44861,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00038934,0.4434,0.31054,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00079435,0.44175,0.41148,1,1
2,GO OTIC VESICLE MORPHOGENESIS,0.00065623,0.43886,0.40518,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.0012662,0.43534,0.28381,1,1
2,GO PSEUDOURIDINE SYNTHESIS,0.00065623,0.43487,0.32608,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0037331,0.43454,0.36136,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.021165,0.4339,0.38552,1,1
2,GO DENDRITIC CELL MIGRATION,0.00023468,0.43328,0.35887,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0013054,0.43308,0.34556,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.0014738,0.43185,0.41882,1,1
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.43045,0.34009,1,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.0099891,0.41912,0.31179,1,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.03245,0.41769,0.28844,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00081984,0.41675,0.40011,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,8.7323e-05,0.41199,0.35263,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,7.6603e-06,0.41126,0.34496,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00095906,0.40983,0.34481,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.00067758,0.40915,0.3631,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.013798,0.40864,0.36164,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0013872,0.40716,0.36921,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.036948,0.40538,0.21569,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00059588,0.40313,0.31314,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00024286,0.40309,0.35282,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.0021689,0.40206,0.36819,1,1
2,GO PIGMENT GRANULE MATURATION,0.0064317,0.40113,0.28935,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,5.8301e-05,0.39563,0.37481,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0007696,0.39535,0.36431,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00084609,0.39496,0.37627,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.4609e-05,0.39275,0.36363,1,1
2,GO NEURAL CREST FORMATION,0.001986,0.39274,0.31258,1,1
2,GO TOLERANCE INDUCTION,0.0081404,0.39066,0.29059,1,1
2,GO PORE COMPLEX ASSEMBLY,1.5331e-06,0.39017,0.3861,1,1
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00012512,0.39002,0.30019,1,1
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0036303,0.38886,0.24956,1,1
2,GO NEUTROPHIL HOMEOSTASIS,0.0056288,0.38851,0.34701,1,1
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021062,0.38673,0.39568,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00024286,0.38641,0.33182,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.0071468,0.3838,0.34373,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.6228e-06,0.38376,0.3767,1,1
2,GO GAS TRANSPORT,0.0027346,0.38344,0.3948,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00047456,0.38307,0.29409,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00034072,0.38284,0.29717,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0085714,0.38202,0.30739,1,1
2,GO RRNA PSEUDOURIDINE SYNTHESIS,0.010506,0.38191,0.27894,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00013917,0.37995,0.34824,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,5.2139e-05,0.3795,0.44891,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0060989,0.37871,0.24295,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.0059384,0.37771,0.34512,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0022992,0.3771,0.31748,1,1
2,GO LIMB BUD FORMATION,0.004408,0.37637,0.45708,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,3.6228e-06,0.37556,0.3522,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,7.9801e-06,0.37499,0.34095,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00081984,0.37398,0.26276,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.00020448,0.3725,0.44521,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00019753,0.37234,0.31057,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,1.6015e-06,0.37228,0.38208,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00059588,0.37187,0.25297,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.001986,0.37038,0.27804,1,1
2,GO VESICLE CARGO LOADING,7.6603e-06,0.36955,0.32422,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00079435,0.36948,0.30425,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00017186,0.36863,0.3066,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,8.1192e-05,0.36734,0.34248,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00095906,0.36619,0.34868,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,3.4421e-05,0.36571,0.30276,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.00050664,0.36557,0.26279,1,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.042857,0.36536,0.1533,1,1
2,GO POSITIVE REGULATION OF CELL MATURATION,0.015574,0.36517,0.32126,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0015189,0.36464,0.39153,1,1
2,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0025083,0.3632,0.3316,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0007696,0.36136,0.28495,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.00013433,0.36053,0.30139,1,1
2,GO PENTOSE METABOLIC PROCESS,9.389e-05,0.36036,0.36299,1,1
2,GO REGULATION OF RIBOSOME BIOGENESIS,2.5308e-05,0.35899,0.36324,1,1
2,GO ERYTHROCYTE MATURATION,0.0032441,0.35683,0.33047,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00055855,0.3557,0.30435,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,5.4121e-05,0.35549,0.35851,1,1
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011199,0.35417,0.25943,1,1
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.044685,0.35396,0.22261,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.0040578,0.35337,0.21368,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,4.4878e-05,0.35275,0.36296,1,1
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.015203,0.35094,0.22572,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00079435,0.35091,0.3868,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0013872,0.35069,0.28011,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.0006154,0.35048,0.29794,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00037661,0.34998,0.27938,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,3.7791e-06,0.3499,0.32381,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,6.5149e-05,0.34977,0.29849,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,4.8379e-05,0.34956,0.49294,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0011199,0.34881,0.38049,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00029782,0.34843,0.37059,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.0001165,0.34839,0.33558,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,8.7323e-05,0.34835,0.24901,1,1
2,GO PROTEIN DEMANNOSYLATION,0.0015653,0.34824,0.25943,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.00017796,0.34744,0.30255,1,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.016734,0.34708,0.26331,1,1
2,GO T CELL MEDIATED IMMUNITY,0.00047456,0.34696,0.27333,1,1
2,GO GLYCINE METABOLIC PROCESS,0.0010859,0.34597,0.28162,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.017969,0.34567,0.21733,1,1
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0028957,0.34167,0.22797,1,1
2,GO PRE MIRNA PROCESSING,0.0024367,0.34144,0.21951,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.015953,0.34087,0.33089,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.0001165,0.33992,0.29113,1,1
2,GO REGULATION OF DNA METHYLATION,0.00049035,0.3388,0.242,1,1
2,GO NEUROBLAST DIVISION,0.00072223,0.33846,0.37127,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057693,0.33599,0.28252,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0024367,0.33597,0.23208,1,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.038561,0.3359,0.18055,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.0019282,0.33542,0.26919,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00017186,0.3353,0.50849,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.021165,0.33524,0.21581,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.027803,0.3351,0.19838,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.00011241,0.33447,0.3165,1,1
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0033369,0.3344,0.33026,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0083534,0.33389,0.21814,1,1
2,GO RNA DECAPPING,1.1493e-05,0.33388,0.25129,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00035231,0.3336,0.25115,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.6455e-05,0.33295,0.37286,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00353,0.33197,0.20721,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.001662,0.33102,0.3149,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00074557,0.33092,0.25496,1,1
2,GO TONGUE MORPHOGENESIS,0.019283,0.33071,0.29047,1,1
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.001228,0.33066,0.33854,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,2.5308e-05,0.33032,0.35008,1,1
2,GO RETINOL METABOLIC PROCESS,8.1192e-05,0.33001,0.34236,1,1
2,GO FIBROBLAST ACTIVATION,0.00032948,0.32998,0.33966,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0018173,0.32972,0.32863,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.001662,0.32941,0.2276,1,1
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.00031859,0.32938,0.3004,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0087944,0.32827,0.20394,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00084609,0.32825,0.27999,1,1
2,GO MICROVILLUS ASSEMBLY,0.010506,0.32748,0.307,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0062634,0.3265,0.22607,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0067808,0.32616,0.21725,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.017969,0.32523,0.24907,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00063551,0.32312,0.24574,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.0057817,0.32299,0.26181,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,9.7801e-06,0.32178,0.32829,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.0011199,0.32154,0.29743,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0010528,0.32145,0.2392,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.0036303,0.32106,0.27455,1,1
2,GO FOREGUT MORPHOGENESIS,0.001228,0.32032,0.36484,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0073363,0.3201,0.28901,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0066042,0.3199,0.31447,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00013917,0.31908,0.42465,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00022676,0.31757,0.28225,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,2.4692e-06,0.31751,0.26071,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,4.3218e-05,0.31731,0.30741,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0059384,0.31716,0.23558,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.024288,0.31666,0.21477,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0012662,0.31647,0.25098,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,6.2985e-07,0.31647,0.29308,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.0053338,0.31633,0.24956,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0013054,0.31594,0.27754,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00011241,0.31574,0.2736,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00013917,0.31551,0.29973,1,1
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.0034322,0.31543,0.26202,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00021909,0.31514,0.27835,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.012203,0.31502,0.22058,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.6902e-06,0.31497,0.33393,1,1
2,GO PHAGOCYTOSIS RECOGNITION,0.0075304,0.31489,0.24774,1,1
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0081404,0.31474,0.29061,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.00050664,0.3143,0.2573,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.011326,0.31389,0.23893,1,1
2,GO RESPONSE TO ANGIOTENSIN,0.00017186,0.3137,0.29961,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.00027832,0.31301,0.28947,1,1
2,GO CARNITINE SHUTTLE,4.4878e-05,0.31298,0.32458,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0069616,0.31284,0.29225,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO TUMOR CELL,0.0022992,0.31212,0.25508,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.31211,0.22347,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001228,0.31164,0.26226,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,3.6228e-06,0.3115,0.30406,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0604e-05,0.31107,0.26557,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0040578,0.31092,0.30449,1,1
2,GO HISTONE SERINE PHOSPHORYLATION,0.00087311,0.31004,0.25051,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00050664,0.30986,0.21472,1,1
2,GO REGULATION OF LIPASE ACTIVITY,1.6455e-05,0.3096,0.24778,1,1
2,GO AMP METABOLIC PROCESS,0.0083534,0.30824,0.24605,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.015953,0.30823,0.22793,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013872,0.30794,0.20978,1,1
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0025817,0.30789,0.24625,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.0014738,0.30768,0.32743,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00017186,0.3076,0.27318,1,1
2,GO OVULATION,7.547e-05,0.30732,0.34627,1,1
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.00055855,0.30703,0.26567,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.0028957,0.30673,0.22582,1,1
2,GO DNA LIGATION,0.0013872,0.30662,0.22916,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00059588,0.30575,0.26266,1,1
2,GO MONONUCLEAR CELL MIGRATION,5.4121e-05,0.3057,0.27806,1,1
2,GO INTERLEUKIN 2 PRODUCTION,5.8301e-05,0.30565,0.2589,1,1
2,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.30557,0.27088,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.014138,0.305,0.3023,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.019283,0.30472,0.30503,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0010528,0.30438,0.22548,1,1
2,GO CHONDROCYTE PROLIFERATION,0.0016129,0.30433,0.37661,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0087944,0.30363,0.18653,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0090226,0.30346,0.27204,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0010859,0.30308,0.29313,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0010528,0.30198,0.25207,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00016595,0.29938,0.32981,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00072223,0.29931,0.23673,1,1
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.0020453,0.2993,0.2478,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.0020453,0.2992,0.25235,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.3418e-05,0.29884,0.2868,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00010092,0.29871,0.25627,1,1
2,GO RESPONSE TO GONADOTROPIN,0.0030654,0.29827,0.2272,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.0064317,0.29801,0.21124,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00040247,0.29755,0.24907,1,1
2,GO RESPONSE TO TUMOR CELL,0.001228,0.29688,0.2561,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00012512,0.29589,0.29569,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0001165,0.29584,0.32224,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0028141,0.29582,0.18248,1,1
2,GO NUCLEAR PORE ORGANIZATION,5.9841e-06,0.29577,0.36087,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0010859,0.29556,0.20829,1,1
2,GO ENTRY INTO HOST,0.0021689,0.29495,0.21752,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00010092,0.29466,0.24138,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.0012662,0.29446,0.24354,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,7.2111e-07,0.29425,0.2659,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0046564,0.2937,0.26234,1,1
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00022676,0.29315,0.29834,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.0010206,0.29304,0.23921,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0038387,0.29291,0.19189,1,1
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0097392,0.29273,0.26839,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00032948,0.29162,0.30054,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,7.013e-05,0.29107,0.24873,1,1
2,GO HISTONE H4 DEACETYLATION,4.4878e-05,0.29103,0.3279,1,1
2,GO ZYMOGEN INHIBITION,0.010245,0.29042,0.24546,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0032441,0.29041,0.22435,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001547,0.29001,0.29361,1,1
2,GO PODOSOME ASSEMBLY,0.0022332,0.28995,0.25805,1,1
2,GO REGULATION OF GTP BINDING,0.050569,0.28956,0.18015,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0034322,0.28871,0.23378,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.0038387,0.28853,0.27612,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,0.0010859,0.28853,0.22523,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.00022676,0.28845,0.29004,1,1
2,GO MRNA MODIFICATION,0.001191,0.28832,0.21786,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.00017796,0.28826,0.26875,1,1
2,GO GASTRIC ACID SECRETION,0.0024367,0.28823,0.22976,1,1
2,GO RIG I SIGNALING PATHWAY,9.389e-05,0.2881,0.25117,1,1
2,GO VIRAL TRANSLATION,0.00029782,0.2879,0.3207,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00027832,0.28729,0.27398,1,1
2,GO PEPTIDE CROSS LINKING,0.0021689,0.28685,0.26412,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.020205,0.28525,0.3749,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.0060989,0.28503,0.23448,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00018427,0.28472,0.21719,1,1
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.00032948,0.28463,0.2552,1,1
2,GO TELOMERASE RNA LOCALIZATION,0.001872,0.28431,0.27043,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,3.1888e-05,0.28428,0.28014,1,1
2,GO RESPONSE TO INTERLEUKIN 12,0.00012074,0.28381,0.26318,1,1
2,GO BLASTODERM SEGMENTATION,0.027803,0.28377,0.28331,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0054795,0.28375,0.24407,1,1
2,GO DETOXIFICATION,0.00023468,0.28367,0.25648,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.037747,0.28284,0.2367,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0001547,0.28128,0.25224,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00065623,0.28103,0.19887,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0037331,0.28095,0.2198,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00016023,0.28011,0.24105,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.00050664,0.27965,0.2655,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00023468,0.27964,0.36523,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.001228,0.27896,0.4369,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00031859,0.27855,0.2719,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0037331,0.2768,0.36624,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00054072,0.27659,0.25955,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0017641,0.27646,0.20075,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,2.0033e-05,0.27471,0.25233,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,4.3218e-05,0.27462,0.37623,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.0013457,0.27447,0.17784,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0059384,0.27414,0.33267,1,1
2,GO REGULATION OF CELL KILLING,0.0036303,0.27402,0.19491,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.001872,0.27392,0.26244,1,1
2,GO ARACHIDONIC ACID SECRETION,0.00029782,0.27323,0.27101,1,1
2,GO HIPPO SIGNALING,0.0017123,0.27315,0.33362,1,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.029719,0.27292,0.33387,1,1
2,GO CHROMATIN DISASSEMBLY,0.0033369,0.27261,0.19177,1,1
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.0038387,0.27242,0.24319,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015189,0.27208,0.20134,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00072223,0.27153,0.26824,1,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0036303,0.27045,0.252,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0013457,0.26947,0.21333,1,1
2,GO ANGIOTENSIN ACTIVATED SIGNALING PATHWAY,0.0032441,0.26892,0.23371,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0081404,0.26871,0.20036,1,1
2,GO MIRNA METABOLIC PROCESS,2.7343e-05,0.26846,0.21557,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,7.013e-05,0.2683,0.23074,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,8.1192e-05,0.26805,0.24199,1,1
2,GO L PHENYLALANINE METABOLIC PROCESS,0.0017641,0.26734,0.28463,1,1
2,GO GTP METABOLIC PROCESS,0.0021689,0.26711,0.27004,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.00047456,0.26689,0.19917,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031859,0.26667,0.23997,1,1
2,GO VIRAL GENE EXPRESSION,0.0013872,0.26609,0.24196,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00049035,0.2655,0.24123,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.009256,0.26545,0.19744,1,1
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0087944,0.2652,0.21549,1,1
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.046579,0.26516,0.14257,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0017123,0.26478,0.19242,1,1
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0064317,0.26433,0.24907,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.0019282,0.26309,0.20352,1,1
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.026586,0.263,0.21919,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.0020453,0.26282,0.18821,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0057817,0.26253,0.26756,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017549,0.26251,0.14963,1,1
2,GO RESPONSE TO CADMIUM ION,0.04854,0.26217,0.18851,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.004408,0.26155,0.19522,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.001986,0.26104,0.19359,1,1
2,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.0040578,0.26074,0.30895,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.00092958,0.26067,0.25007,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00041602,0.26031,0.22615,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0013054,0.26006,0.18805,1,1
2,GO EXTRACELLULAR MATRIX CONSTITUENT SECRETION,0.019739,0.26004,0.24362,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.017969,0.25969,0.15241,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00017186,0.25959,0.22385,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00035231,0.25894,0.24524,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0067808,0.25804,0.21197,1,1
2,GO T CELL CHEMOTAXIS,0.00018427,0.25766,0.2468,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0024367,0.25744,0.20189,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.029719,0.25735,0.17793,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.007729,0.2573,0.15246,1,1
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.04854,0.25722,0.18507,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0011549,0.25712,0.20929,1,1
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.00069957,0.2569,0.2449,1,1
2,GO MATURATION OF SSU RRNA,0.00084609,0.25673,0.29059,1,1
2,GO AMINE CATABOLIC PROCESS,0.0036303,0.25667,0.29734,1,1
2,GO CELL REDOX HOMEOSTASIS,0.00019079,0.25586,0.23492,1,1
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.0047853,0.25545,0.30462,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0014738,0.25496,0.20245,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0046564,0.25488,0.20254,1,1
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.010773,0.25458,0.16782,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.7118e-05,0.2542,0.27672,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0021689,0.2539,0.28436,1,1
2,GO HYPEROSMOTIC RESPONSE,0.0015653,0.25339,0.25632,1,1
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0040578,0.25298,0.25278,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.0013457,0.25295,0.22878,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,4.8379e-05,0.25284,0.22507,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0013054,0.25253,0.19678,1,1
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.0062634,0.25197,0.248,1,1
2,GO HISTONE H3 K9 ACETYLATION,7.2754e-05,0.25194,0.23856,1,1
2,GO NUCLEAR MIGRATION,0.015203,0.25191,0.17003,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0047853,0.25176,0.16018,1,1
2,GO LAMELLIPODIUM ORGANIZATION,0.00014418,0.25118,0.24104,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0024367,0.25058,0.24338,1,1
2,GO TRNA METHYLATION,0.00032948,0.25004,0.22206,1,1
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0010206,0.24986,0.17177,1,1
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.044685,0.24969,0.14031,1,1
2,GO TONIC SMOOTH MUSCLE CONTRACTION,0.017549,0.24908,0.15923,1,1
2,GO MITOCHONDRIAL TRANSLATION,0.00063551,0.24882,0.23474,1,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0049174,0.2486,0.2264,1,1
2,GO L SERINE METABOLIC PROCESS,0.010245,0.24727,0.27613,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00065623,0.24712,0.21993,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.050569,0.247,0.2102,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00038934,0.24674,0.24009,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00029782,0.24587,0.23021,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0034322,0.2458,0.24629,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0027346,0.24537,0.16134,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0006154,0.24507,0.18006,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.038561,0.24479,0.19904,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.001191,0.2446,0.23915,1,1
2,GO POSITIVE REGULATION OF TRANSLATION,4.1617e-05,0.24431,0.21518,1,1
2,GO PIGMENT ACCUMULATION,0.0018173,0.24311,0.23967,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.014138,0.24257,0.14992,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.0020453,0.2422,0.17979,1,1
2,GO ALDITOL METABOLIC PROCESS,0.00042998,0.24196,0.29156,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0033369,0.24189,0.25778,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.001986,0.24169,0.24642,1,1
2,GO SECRETION BY TISSUE,0.00084609,0.24153,0.26552,1,1
2,GO RESPONSE TO X RAY,0.00021167,0.24149,0.32623,1,1
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.02166,0.24111,0.23275,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.0010859,0.24071,0.20213,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00079435,0.24069,0.18663,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.0013054,0.24067,0.22835,1,1
2,GO RESPONSE TO PROTOZOAN,0.029719,0.24025,0.1423,1,1
2,GO RESPIRATORY BURST,0.0071468,0.24015,0.208,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00030804,0.2401,0.23034,1,1
2,GO RESPONSE TO SALT STRESS,0.015203,0.23956,0.21946,1,1
2,GO LIPID OXIDATION,0.0021062,0.23939,0.17205,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.00041602,0.23939,0.21465,1,1
2,GO BONE GROWTH,0.029068,0.23881,0.1969,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.0037331,0.23853,0.16552,1,1
2,GO RNA DESTABILIZATION,0.0024367,0.2384,0.17203,1,1
2,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.024846,0.2383,0.23175,1,1
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.025994,0.23823,0.18665,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00065623,0.23789,0.20556,1,1
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0025817,0.23788,0.2218,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.4205e-05,0.2378,0.21736,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0031536,0.23774,0.16335,1,1
2,GO PROTEASOME ASSEMBLY,0.0045306,0.23755,0.17653,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00092958,0.23742,0.22919,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00072223,0.23741,0.19308,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0033369,0.23721,0.1863,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,7.547e-05,0.23686,0.22712,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.0037331,0.23681,0.25739,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0013457,0.23666,0.23242,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00031859,0.23639,0.23097,1,1
2,GO MITOCHONDRIAL GENE EXPRESSION,0.00069957,0.23604,0.23027,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.010245,0.23464,0.22901,1,1
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.0069616,0.23437,0.19769,1,1
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.0042883,0.23412,0.21176,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0069616,0.23371,0.21872,1,1
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.014841,0.23354,0.15149,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0057817,0.23337,0.23912,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0033369,0.23332,0.25122,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.010773,0.23317,0.23857,1,1
2,GO PLATELET MORPHOGENESIS,0.00035231,0.23317,0.22927,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0045306,0.23289,0.16763,1,1
2,GO APOPTOTIC CELL CLEARANCE,0.0016129,0.23281,0.16276,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0014738,0.23278,0.1853,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.017969,0.232,0.23813,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.00087311,0.23158,0.14143,1,1
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.023205,0.23139,0.1733,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00069957,0.23138,0.18493,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.0021062,0.23137,0.2324,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001986,0.23108,0.20533,1,1
2,GO BLASTOCYST FORMATION,0.00018427,0.23087,0.21374,1,1
2,GO RESPONSE TO MANGANESE ION,0.0032441,0.23076,0.21233,1,1
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.0027346,0.23076,0.21381,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0006154,0.23059,0.22253,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.23008,0.16171,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,4.4878e-05,0.22963,0.18907,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0022332,0.22962,0.29499,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.0021062,0.22959,0.2365,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00012074,0.22931,0.24113,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0073363,0.22907,0.20161,1,1
2,GO GOLGI LOCALIZATION,0.013798,0.22894,0.17862,1,1
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0030654,0.22886,0.28273,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0029794,0.22867,0.16082,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00014418,0.22856,0.19017,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.0010528,0.22811,0.15312,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.029068,0.22789,0.2342,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,6.7728e-06,0.2271,0.20914,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.00028792,0.22699,0.22064,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00047456,0.22602,0.17607,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0051916,0.22589,0.25335,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0028957,0.22506,0.15516,1,1
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.0051916,0.22504,0.19169,1,1
2,GO LIVER REGENERATION,0.009256,0.22487,0.17921,1,1
2,GO MATURATION OF 5 8S RRNA,0.0013872,0.22463,0.26926,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0028141,0.22434,0.18227,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0059384,0.22408,0.14845,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.0025817,0.22397,0.23425,1,1
2,GO FATTY ACID BETA OXIDATION,0.0097392,0.22386,0.13625,1,1
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0022992,0.22377,0.25427,1,1
2,GO ARGININE METABOLIC PROCESS,0.042857,0.22346,0.19524,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.001191,0.22342,0.23147,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0024367,0.22328,0.16015,1,1
2,GO TRANSLATIONAL TERMINATION,0.001662,0.22313,0.21854,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00353,0.22311,0.19444,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.047551,0.22297,0.12548,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.001986,0.22295,0.22217,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001228,0.22269,0.1664,1,1
2,GO NUCLEUS LOCALIZATION,0.0022992,0.22255,0.17072,1,1
2,GO INTESTINAL ABSORPTION,0.0087944,0.22167,0.19457,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.1888e-05,0.22099,0.21191,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0021062,0.22023,0.22781,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,6.7596e-05,0.22022,0.21071,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.026586,0.21991,0.22807,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0073363,0.21941,0.17182,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0014299,0.21924,0.20608,1,1
2,GO RIBOSOME BIOGENESIS,0.00027832,0.21919,0.25342,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0013872,0.21916,0.1558,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00034072,0.21914,0.23942,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0001165,0.21882,0.18182,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.001986,0.21868,0.18629,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,6.2786e-05,0.21847,0.19701,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,7.547e-05,0.21796,0.18325,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.010245,0.21766,0.12813,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.017137,0.21665,0.1399,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00054072,0.21655,0.15534,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0013457,0.21629,0.18669,1,1
2,GO AMINO SUGAR CATABOLIC PROCESS,0.02843,0.21616,0.17568,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00042998,0.21578,0.23293,1,1
2,GO IRON ION HOMEOSTASIS,0.00353,0.21575,0.16266,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.00047456,0.21534,0.22068,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0054795,0.21529,0.23026,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.00028792,0.21523,0.20008,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.016339,0.21488,0.18081,1,1
2,GO REGULATION OF GENE SILENCING,5.0683e-06,0.21484,0.20369,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0045306,0.21476,0.17825,1,1
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0020453,0.2146,0.23118,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0024367,0.21452,0.16188,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.017969,0.21442,0.17791,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.0013457,0.21402,0.19559,1,1
2,GO AMYLOID BETA CLEARANCE,0.0053338,0.21354,0.19606,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0013054,0.21353,0.17504,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00035231,0.2133,0.22123,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.015953,0.21288,0.16625,1,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0087944,0.2128,0.19349,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0017641,0.21185,0.19463,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00038934,0.21182,0.21758,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0062634,0.21164,0.15797,1,1
2,GO B CELL APOPTOTIC PROCESS,0.012203,0.21164,0.14712,1,1
2,GO INTERACTION WITH HOST,0.0015653,0.21138,0.17433,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00059588,0.21126,0.22841,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00011241,0.21104,0.18282,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.0028957,0.21095,0.16386,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.00017186,0.21095,0.22245,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0031536,0.21046,0.1433,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00035231,0.21028,0.20847,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0025817,0.2102,0.1538,1,1
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.035393,0.21012,0.17625,1,1
2,GO LEUKOCYTE PROLIFERATION,0.00081984,0.20964,0.16127,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,5.0226e-05,0.2095,0.19498,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00024286,0.20924,0.16592,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.00012074,0.20924,0.19773,1,1
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.00353,0.20899,0.1704,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.010506,0.20862,0.17098,1,1
2,GO REGULATION OF NECROTIC CELL DEATH,0.010773,0.20837,0.21633,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0059384,0.20828,0.15751,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031059,0.20813,0.13046,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0064317,0.20764,0.17278,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0075304,0.20759,0.20384,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025817,0.20756,0.17138,1,1
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0079323,0.20737,0.13116,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00013433,0.20735,0.26378,1,1
2,GO RNA POLYADENYLATION,0.00090094,0.20729,0.15255,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0017123,0.20708,0.19953,1,1
2,GO CYTOPLASM ORGANIZATION,0.014138,0.20701,0.22853,1,1
2,GO RNA STABILIZATION,0.0010859,0.20696,0.15655,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.017549,0.20675,0.17263,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0040578,0.20642,0.15938,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00041602,0.20632,0.23578,1,1
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.043763,0.20628,0.15932,1,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0050528,0.20625,0.15868,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0010206,0.20549,0.16386,1,1
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.025994,0.20513,0.18979,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00011241,0.20513,0.18637,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00098941,0.20481,0.21861,1,1
2,GO NCRNA PROCESSING,0.00041602,0.20423,0.2166,1,1
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.0013872,0.20411,0.18274,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,9.7801e-06,0.20398,0.25326,1,1
2,GO CORNIFICATION,0.0054795,0.20373,0.26068,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.00063551,0.20371,0.1765,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.00079435,0.2034,0.26889,1,1
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0030654,0.20338,0.21657,1,1
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0099891,0.20327,0.15712,1,1
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.050569,0.2029,0.10848,1,1
2,GO HISTONE DEUBIQUITINATION,7.547e-05,0.2029,0.18267,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.00353,0.20256,0.21796,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0021062,0.20239,0.17034,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00021167,0.20213,0.2128,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0010859,0.20199,0.18167,1,1
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0006154,0.2018,0.18869,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0099891,0.20159,0.14887,1,1
2,GO CELL CELL JUNCTION MAINTENANCE,0.0075304,0.20095,0.25875,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.031748,0.20084,0.13299,1,1
2,GO COPII COATED VESICLE CARGO LOADING,0.0038387,0.20083,0.15725,1,1
2,GO RESPONSE TO ESTROGEN,0.0087944,0.20081,0.17641,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.031748,0.20068,0.16199,1,1
2,GO CELLULAR IRON ION HOMEOSTASIS,0.0028957,0.20054,0.14857,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0023671,0.20051,0.12722,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.02166,0.20016,0.1438,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.0038387,0.2001,0.20733,1,1
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.025994,0.20005,0.18769,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,9.0551e-05,0.20004,0.17681,1,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.025414,0.19993,0.16782,1,1
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029782,0.19988,0.18905,1,1
2,GO INTERACTION WITH SYMBIONT,0.00013917,0.19985,0.21832,1,1
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.03939,0.19964,0.14,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0039469,0.19936,0.23072,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.010506,0.19913,0.15499,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,9.0551e-05,0.19886,0.19566,1,1
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.030383,0.19871,0.14288,1,1
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.02268,0.19854,0.17481,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00013917,0.19847,0.1919,1,1
2,GO PROTEIN LOCALIZATION TO CELL CORTEX,0.0085714,0.19833,0.20911,1,1
2,GO MICROVILLUS ORGANIZATION,0.018398,0.19815,0.28573,1,1
2,GO RNA METHYLATION,0.00092958,0.19798,0.16294,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0030654,0.1979,0.13998,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.0094949,0.19781,0.19501,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.00017186,0.1976,0.2146,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0028957,0.19753,0.16624,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0014299,0.19602,0.1642,1,1
2,GO POLYOL BIOSYNTHETIC PROCESS,0.0075304,0.19591,0.12552,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0047853,0.1957,0.14912,1,1
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.049546,0.19565,0.13607,1,1
2,GO LEFT RIGHT PATTERN FORMATION,0.0085714,0.19557,0.23464,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0031536,0.19524,0.19626,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.016339,0.19508,0.18222,1,1
2,GO RRNA METABOLIC PROCESS,0.00055855,0.1949,0.22801,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,5.2139e-05,0.19463,0.21572,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.041967,0.19459,0.11585,1,1
2,GO PRIMARY MIRNA PROCESSING,0.0011549,0.19456,0.20914,1,1
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.011047,0.19441,0.16738,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.019283,0.19425,0.13959,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0013054,0.19389,0.16848,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.016734,0.19333,0.15527,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.00081984,0.19263,0.15868,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0053338,0.1925,0.15136,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.0054795,0.19231,0.21851,1,1
2,GO AXIS ELONGATION,0.0057817,0.19211,0.29493,1,1
2,GO DIGESTIVE SYSTEM PROCESS,0.0019282,0.19199,0.16639,1,1
2,GO DETERMINATION OF DORSAL VENTRAL ASYMMETRY,0.030383,0.19172,0.21302,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00021909,0.19153,0.23874,1,1
2,GO NEGATIVE T CELL SELECTION,0.0097392,0.19146,0.10581,1,1
2,GO TRNA TRANSPORT,1.2962e-05,0.19136,0.24443,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0022992,0.19126,0.18958,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00017186,0.19105,0.1935,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0013872,0.19076,0.15061,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.02166,0.19062,0.1709,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.1964e-05,0.19023,0.1697,1,1
2,GO TRNA METABOLIC PROCESS,0.00024286,0.19017,0.18626,1,1
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0064317,0.19007,0.16536,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.004408,0.18971,0.13579,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0071468,0.18946,0.13467,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.0087944,0.1893,0.17194,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.013798,0.18928,0.1723,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.0046564,0.18915,0.16219,1,1
2,GO T CELL PROLIFERATION,0.0013054,0.1891,0.16658,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00026903,0.18909,0.24946,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,1.8251e-06,0.18902,0.20438,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.00057693,0.18899,0.15748,1,1
2,GO THYMUS DEVELOPMENT,0.0037331,0.18875,0.16836,1,1
2,GO TOXIN TRANSPORT,0.0057817,0.1885,0.1456,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0051916,0.18804,0.21643,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0022332,0.18785,0.18755,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.041093,0.18769,0.11979,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.001662,0.18718,0.18496,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.104e-05,0.18701,0.20664,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0025817,0.18598,0.19064,1,1
2,GO FATTY ACID CATABOLIC PROCESS,0.016734,0.18597,0.12578,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0012662,0.18571,0.18463,1,1
2,GO PIGMENT GRANULE ORGANIZATION,8.7323e-05,0.18527,0.22708,1,1
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0069616,0.18433,0.11737,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0006154,0.18295,0.19425,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.0022332,0.18237,0.14422,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00012964,0.18213,0.16658,1,1
2,GO TERPENOID METABOLIC PROCESS,0.014138,0.18173,0.16093,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.035393,0.18155,0.17467,1,1
2,GO NECROTIC CELL DEATH,0.020205,0.18127,0.16414,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0045306,0.18087,0.15133,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.0069616,0.18054,0.22126,1,1
2,GO RESPONSE TO OSMOTIC STRESS,0.0015653,0.18012,0.16492,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.03245,0.18005,0.25633,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,7.547e-05,0.17989,0.2359,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.011047,0.17951,0.15129,1,1
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.023741,0.17946,0.15152,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001228,0.17842,0.16056,1,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.030383,0.17838,0.13751,1,1
2,GO FATTY ACID TRANSPORT,0.00047456,0.17825,0.15179,1,1
2,GO RNA MODIFICATION,0.00044439,0.17762,0.15747,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0024367,0.17744,0.16598,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.023205,0.17733,0.16175,1,1
2,GO SYMBIOTIC PROCESS,0.00024286,0.17731,0.1543,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.041093,0.17726,0.15127,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00095906,0.17713,0.16939,1,1
2,GO LIPID MODIFICATION,0.0021689,0.17696,0.12455,1,1
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034322,0.17693,0.1522,1,1
2,GO NATURAL KILLER CELL PROLIFERATION,0.024288,0.17676,0.2034,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00017796,0.17655,0.1617,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.0604e-05,0.17621,0.15951,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00044439,0.17616,0.15531,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00081984,0.17614,0.17901,1,1
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0039469,0.17582,0.12905,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.00026003,0.17577,0.17065,1,1
2,GO TRANSLATIONAL ELONGATION,0.0083534,0.17542,0.1696,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00023468,0.17535,0.20304,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.0028957,0.17527,0.15919,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0057817,0.17464,0.21213,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0090226,0.17438,0.13526,1,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0094949,0.17437,0.15959,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.047551,0.1743,0.13988,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0011549,0.17327,0.20141,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0042883,0.17306,0.17563,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0021689,0.17303,0.13629,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.014486,0.17283,0.1539,1,1
2,GO ANIMAL ORGAN REGENERATION,0.027188,0.17246,0.12398,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0059384,0.17209,0.13113,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.00050664,0.17196,0.17433,1,1
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.025414,0.17191,0.10941,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0015653,0.1718,0.17091,1,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.049546,0.17176,0.11927,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.001662,0.17143,0.14687,1,1
2,GO MYOBLAST DIFFERENTIATION,0.009256,0.17078,0.18835,1,1
2,GO HISTONE H2B UBIQUITINATION,0.007729,0.17077,0.14854,1,1
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.015574,0.17074,0.15454,1,1
2,GO TRNA PROCESSING,0.00049035,0.17067,0.17675,1,1
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.046579,0.17014,0.12077,1,1
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00054072,0.17004,0.17289,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0006154,0.16995,0.19681,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.00042998,0.1698,0.17626,1,1
2,GO APICAL JUNCTION ASSEMBLY,0.023205,0.16919,0.17737,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.01282,0.16889,0.11203,1,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.0046564,0.16874,0.16218,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.00038934,0.1686,0.16018,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.0027346,0.16813,0.18006,1,1
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.025414,0.16808,0.2129,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.00074557,0.16787,0.13555,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.03939,0.16748,0.16595,1,1
2,GO B CELL PROLIFERATION,0.0047853,0.16701,0.14361,1,1
2,GO MRNA METHYLATION,0.043763,0.16696,0.13958,1,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.025414,0.16674,0.14619,1,1
2,GO VIRAL LIFE CYCLE,0.0036303,0.16567,0.15337,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.0053338,0.16558,0.16805,1,1
2,GO KERATINOCYTE PROLIFERATION,0.049546,0.16557,0.26095,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0001165,0.16544,0.16381,1,1
2,GO SCHWANN CELL DIFFERENTIATION,0.018836,0.16524,0.13202,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0085714,0.16502,0.17276,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0057817,0.16474,0.13628,1,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.014486,0.16376,0.14946,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0024367,0.1636,0.14178,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.0042883,0.16351,0.16534,1,1
2,GO PHOTOPERIODISM,0.037747,0.163,0.10871,1,1
2,GO CYTOKINE PRODUCTION,0.0064317,0.16274,0.1265,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.044685,0.16235,0.15542,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0036303,0.16221,0.11467,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.00092958,0.16212,0.13204,1,1
2,GO MRNA TRANSCRIPTION,0.0054795,0.1621,0.15992,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0011199,0.16207,0.18441,1,1
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.023205,0.16192,0.14178,1,1
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.035393,0.16185,0.15526,1,1
2,GO INTERLEUKIN 17 PRODUCTION,0.0083534,0.16154,0.13889,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.00045924,0.16152,0.1328,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.017969,0.1614,0.10898,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.010506,0.16111,0.10097,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.0051916,0.16065,0.11368,1,1
2,GO RESPONSE TO BACTERIUM,0.013798,0.16045,0.1005,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.013139,0.16041,0.17544,1,1
2,GO INNATE IMMUNE RESPONSE,0.0066042,0.16021,0.13071,1,1
2,GO ERBB SIGNALING PATHWAY,0.0025083,0.16019,0.13469,1,1
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.023205,0.16015,0.15877,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0028141,0.15981,0.12407,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.0039469,0.15965,0.13605,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.001662,0.15962,0.17465,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.014841,0.1596,0.14453,1,1
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.035393,0.15896,0.12123,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.010773,0.1578,0.10157,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0099891,0.15693,0.16133,1,1
2,GO POLYAMINE METABOLIC PROCESS,0.018836,0.15685,0.13907,1,1
2,GO TRANSITION METAL ION HOMEOSTASIS,0.0032441,0.15641,0.15467,1,1
2,GO VIRAL RNA GENOME REPLICATION,0.037747,0.15628,0.13703,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.0071468,0.15591,0.12945,1,1
2,GO P BODY ASSEMBLY,0.0021062,0.15574,0.13824,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.00092958,0.15548,0.15424,1,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.0099891,0.15546,0.11883,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.00016023,0.15532,0.16415,1,1
2,GO NUCLEOBASE METABOLIC PROCESS,0.0010206,0.15521,0.19759,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0037331,0.1552,0.11424,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.0020453,0.1547,0.12485,1,1
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0038387,0.15392,0.11986,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.018836,0.15387,0.12064,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0007696,0.15353,0.18701,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00016023,0.15322,0.17951,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0012662,0.15321,0.26055,1,1
2,GO VESICLE TARGETING,0.0027346,0.15303,0.13314,1,1
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.0064317,0.15296,0.14558,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00055855,0.15295,0.14861,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00019753,0.15285,0.13176,1,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.038561,0.15271,0.13388,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.014138,0.1527,0.15803,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00054072,0.15264,0.1465,1,1
2,GO PHAGOCYTOSIS,0.0053338,0.15245,0.14532,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0023671,0.15244,0.16936,1,1
2,GO DIGESTION,0.010245,0.15226,0.12736,1,1
2,GO CELLULAR RESPONSE TO VIRUS,0.01282,0.15211,0.13598,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.013139,0.15199,0.095955,1,1
2,GO RESPONSE TO CYTOKINE,0.010245,0.15167,0.11094,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,8.1192e-05,0.15147,0.14497,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.2454e-05,0.15134,0.17892,1,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.0099891,0.15133,0.228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00025131,0.15068,0.1261,1,1
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0019282,0.15066,0.16843,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00026903,0.15027,0.16241,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029782,0.15017,0.14509,1,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.023741,0.14998,0.10987,1,1
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.0011549,0.14967,0.1426,1,1
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.0028957,0.14932,0.15495,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.029719,0.14929,0.20822,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0094949,0.14907,0.11794,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.0025083,0.1487,0.13906,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0069616,0.14791,0.18175,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.00055855,0.14791,0.14492,1,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.015203,0.14779,0.12728,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00065623,0.14779,0.13653,1,1
2,GO GOLGI VESICLE BUDDING,0.001191,0.1476,0.12614,1,1
2,GO PROTEIN IMPORT,0.0019282,0.14747,0.13069,1,1
2,GO TRANSEPITHELIAL TRANSPORT,0.0099891,0.14711,0.16459,1,1
2,GO REGULATION OF ACTION POTENTIAL,0.035393,0.14703,0.12533,1,1
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.009256,0.14702,0.13791,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0064317,0.14602,0.12032,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014299,0.14556,0.13322,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0013872,0.14542,0.16642,1,1
2,GO LIPOPROTEIN LOCALIZATION,0.041967,0.14542,0.10338,1,1
2,GO IMPORT INTO NUCLEUS,0.02166,0.14532,0.11211,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.013465,0.1451,0.10265,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0039469,0.1451,0.16692,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.029068,0.14507,0.1199,1,1
2,GO GMP METABOLIC PROCESS,0.029068,0.14505,0.14564,1,1
2,GO CELL KILLING,0.010245,0.14501,0.12763,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.011904,0.14415,0.10279,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.0097392,0.14404,0.10802,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0027346,0.14395,0.22552,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.010506,0.14334,0.10937,1,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.013139,0.14308,0.11518,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004408,0.1428,0.16105,1,1
2,GO GOLGI RIBBON FORMATION,0.018398,0.14271,0.13842,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.050569,0.14237,0.11908,1,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.01282,0.14237,0.09459,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.00065623,0.14228,0.12581,1,1
2,GO SIGNAL PEPTIDE PROCESSING,0.024846,0.14192,0.18904,1,1
2,GO OXIDATION REDUCTION PROCESS,0.0017641,0.14183,0.12411,1,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.016339,0.14159,0.09467,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0079323,0.1415,0.17319,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.0066042,0.14144,0.12496,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00045924,0.14128,0.12944,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.012508,0.14123,0.11833,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.001228,0.14088,0.18212,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.021165,0.14081,0.13514,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.00034072,0.14024,0.1391,1,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.010245,0.14011,0.14857,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0021062,0.14006,0.1955,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.0017641,0.13993,0.1523,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.015574,0.13976,0.11239,1,1
2,GO POLYOL METABOLIC PROCESS,0.00022676,0.13931,0.16091,1,1
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.014138,0.13922,0.1544,1,1
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.0060989,0.13914,0.11523,1,1
2,GO TISSUE HOMEOSTASIS,0.010506,0.13892,0.095562,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,7.8282e-05,0.13869,0.13004,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,5.8301e-05,0.13846,0.13368,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0090226,0.13832,0.11569,1,1
2,GO MALE SEX DIFFERENTIATION,0.050569,0.13817,0.12307,1,1
2,GO RESPONSE TO IRON ION,0.050569,0.13805,0.14981,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,3.1888e-05,0.13781,0.14227,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,7.8282e-05,0.1376,0.15382,1,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.0034322,0.13759,0.1665,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.00028792,0.13758,0.17884,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.018398,0.13753,0.087825,1,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.013465,0.13733,0.1162,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0027346,0.13732,0.13605,1,1
2,GO COPII COATED VESICLE BUDDING,0.0010859,0.13715,0.12497,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.014486,0.13686,0.14357,1,1
2,GO RESPONSE TO ACTIVITY,0.02843,0.13685,0.096477,1,1
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0059384,0.13645,0.15131,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.00025131,0.13617,0.13029,1,1
2,GO BASE EXCISION REPAIR,0.0038387,0.13528,0.12574,1,1
2,GO NUCLEAR EXPORT,9.7346e-05,0.13523,0.16091,1,1
2,GO FEVER GENERATION,0.050569,0.13509,0.1561,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.01282,0.13487,0.12132,1,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.027188,0.13476,0.15834,1,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.019283,0.13353,0.10579,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00029782,0.13335,0.15018,1,1
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.013798,0.13291,0.12961,1,1
2,GO TELOMERE ORGANIZATION,0.00038934,0.13287,0.13776,1,1
2,GO LIPID METABOLIC PROCESS,0.0011199,0.13283,0.11064,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.0025817,0.13282,0.11717,1,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.050569,0.13238,0.13667,1,1
2,GO DNA GEOMETRIC CHANGE,0.00014418,0.13213,0.15335,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.00049035,0.13205,0.12337,1,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.034637,0.13135,0.13753,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,7.2754e-05,0.13118,0.13638,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.0010859,0.13044,0.11862,1,1
2,GO CELL CELL RECOGNITION,0.016734,0.13043,0.10222,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00052342,0.13042,0.15987,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0054795,0.12974,0.12503,1,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.0036303,0.12951,0.12591,1,1
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0090226,0.12856,0.12848,1,1
2,GO MRNA CLEAVAGE,2.2524e-05,0.12849,0.1658,1,1
2,GO BODY FLUID SECRETION,0.00090094,0.12831,0.15203,1,1
2,GO MRNA 3 END PROCESSING,0.00045924,0.12808,0.14323,1,1
2,GO HISTONE PHOSPHORYLATION,0.0090226,0.12784,0.10778,1,1
2,GO OXIDATIVE DEMETHYLATION,0.020205,0.12765,0.092979,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.0090226,0.12752,0.13045,1,1
2,GO GOLGI VESICLE TRANSPORT,0.0015189,0.12696,0.098636,1,1
2,GO RESPONSE TO KETONE,0.050569,0.12686,0.092858,1,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.042857,0.1268,0.083463,1,1
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.046579,0.12674,0.081802,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.001872,0.12617,0.12099,1,1
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.019283,0.12555,0.088981,1,1
2,GO LIPID CATABOLIC PROCESS,0.011904,0.1254,0.099419,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,9.7346e-05,0.12488,0.11788,1,1
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.019739,0.12444,0.084239,1,1
2,GO HISTONE H3 DEACETYLATION,0.019283,0.12442,0.11692,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0015189,0.12418,0.16255,1,1
2,GO RNA PROCESSING,0.00016595,0.12406,0.15172,1,1
2,GO GENE SILENCING,1.4609e-05,0.12385,0.13436,1,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.041967,0.12359,0.091026,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.015574,0.1223,0.1206,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0026572,0.12217,0.14542,1,1
2,GO MRNA METABOLIC PROCESS,0.00017796,0.12179,0.13519,1,1
2,GO PROTEIN SUMOYLATION,0.00012074,0.12162,0.12794,1,1
2,GO STRESS GRANULE ASSEMBLY,0.012203,0.12125,0.11656,1,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.038561,0.1209,0.10299,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.016339,0.1207,0.11852,1,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.044685,0.12059,0.087742,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.0069616,0.1204,0.10391,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.00021909,0.12029,0.1183,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0053338,0.12013,0.14305,1,1
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0099891,0.11889,0.15156,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.027803,0.11866,0.083935,1,1
2,GO REGULATION OF MYELINATION,0.038561,0.11862,0.10344,1,1
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.033166,0.11851,0.10815,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0028957,0.11847,0.10615,1,1
2,GO RESPONSE TO STEROID HORMONE,0.047551,0.11788,0.095905,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00022676,0.11771,0.13518,1,1
2,GO ACTIN NUCLEATION,0.018836,0.11733,0.11748,1,1
2,GO REGULATION OF ORGAN GROWTH,0.044685,0.11715,0.1211,1,1
2,GO NON RECOMBINATIONAL REPAIR,0.0094949,0.11703,0.1006,1,1
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0037331,0.11662,0.091428,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00084609,0.11653,0.15272,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.0033369,0.11639,0.10396,1,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.0032441,0.11633,0.097154,1,1
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0033369,0.1161,0.10579,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.00035231,0.11606,0.10502,1,1
2,GO RESPONSE TO ALCOHOL,0.030383,0.11596,0.089355,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00042998,0.11559,0.13664,1,1
2,GO PEROXISOMAL TRANSPORT,0.0062634,0.11531,0.13382,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.0022992,0.11526,0.12147,1,1
2,GO PYRUVATE METABOLIC PROCESS,0.047551,0.11417,0.086022,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0083534,0.11383,0.10364,1,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.033166,0.11368,0.091151,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0046564,0.11353,0.16041,1,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.02268,0.11326,0.098049,1,1
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.017969,0.11311,0.078825,1,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.015203,0.11295,0.095117,1,1
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.046579,0.11292,0.15119,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00047456,0.11254,0.13846,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.033166,0.11249,0.11698,1,1
2,GO REGULATION OF MRNA 3 END PROCESSING,0.015203,0.11232,0.11,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.0053338,0.11221,0.11821,1,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.027803,0.11186,0.085733,1,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.033894,0.11167,0.081114,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0018173,0.11141,0.12801,1,1
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.02843,0.11116,0.10349,1,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.011047,0.11097,0.083466,1,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.031748,0.11092,0.13206,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0026572,0.11053,0.13885,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.010506,0.11016,0.10935,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0067808,0.11001,0.12022,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.035393,0.10958,0.078272,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.00020448,0.10956,0.14177,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0024367,0.1094,0.11329,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.00084609,0.10883,0.11147,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.0087944,0.10781,0.10084,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.0029794,0.10774,0.082699,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.013139,0.1067,0.087767,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.031748,0.10467,0.10111,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.036164,0.10462,0.10478,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.012203,0.10453,0.11572,1,1
2,GO MRNA TRANSPORT,0.00098941,0.10385,0.13743,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.004408,0.10246,0.096349,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,6.2786e-05,0.10215,0.13018,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0014738,0.10198,0.11941,1,1
2,GO MRNA PROCESSING,0.00098941,0.10175,0.10927,1,1
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.0022332,0.10162,0.13468,1,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.02068,0.1014,0.0759,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.00057693,0.099124,0.098164,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.036164,0.098715,0.07261,1,1
2,GO RNA LOCALIZATION,0.00018427,0.098195,0.15138,1,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.0025817,0.097503,0.12772,1,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.018398,0.096798,0.066552,1,1
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.017969,0.096777,0.11998,1,1
2,GO REGULATION OF CATABOLIC PROCESS,0.0045306,0.096121,0.075563,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.019283,0.094969,0.095211,1,1
2,GO DNA METHYLATION,0.009256,0.09471,0.090647,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.007729,0.094352,0.098635,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.03245,0.094176,0.085156,1,1
2,GO STEM CELL DIFFERENTIATION,0.010506,0.094058,0.12132,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.03939,0.093606,0.13947,1,1
2,GO DNA CONFORMATION CHANGE,0.0094949,0.090581,0.083715,1,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.033166,0.09009,0.05905,1,1
2,GO RESPONSE TO UV,0.0054795,0.089115,0.12713,1,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.029068,0.088773,0.086824,1,1
2,GO RNA SPLICING,0.0020453,0.088566,0.107,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0001165,0.088133,0.11976,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.00074557,0.0881,0.11853,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.021165,0.087472,0.072275,1,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.0064317,0.08741,0.077006,1,1
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.001986,0.087387,0.081898,1,1
2,GO CHROMATIN REMODELING,0.0028141,0.08717,0.097614,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.024288,0.086722,0.099406,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.023741,0.086541,0.12529,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.013465,0.084988,0.07816,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.043763,0.083876,0.064938,1,1
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.011904,0.083078,0.08958,1,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.001872,0.082814,0.090291,1,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.031059,0.080511,0.077587,1,1
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.014841,0.080462,0.056878,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.00092958,0.080457,0.097065,1,1
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040234,0.080415,0.094849,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015203,0.080293,0.083498,1,1
2,GO HISTONE H3 ACETYLATION,0.0027346,0.079136,0.091673,1,1
2,GO CELLULAR RESPONSE TO UV,0.0069616,0.078364,0.11375,1,1
2,GO PROTEIN CATABOLIC PROCESS,0.036948,0.077488,0.050192,1,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.024288,0.077301,0.066165,1,1
2,GO DOUBLE STRAND BREAK REPAIR,0.0094949,0.077022,0.090903,1,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.024288,0.07674,0.09339,1,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.02166,0.073512,0.070546,1,1
2,GO ALCOHOL CATABOLIC PROCESS,0.026586,0.073346,0.13253,1,1
2,GO MACROAUTOPHAGY,0.017137,0.0718,0.058488,1,1
2,GO RESPONSE TO RADIATION,0.026586,0.070833,0.063464,1,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.0051916,0.068134,0.076837,1,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.025994,0.067604,0.060824,1,1
2,GO REGULATION OF GTPASE ACTIVITY,0.046579,0.066185,0.065842,1,1
2,GO DNA INTEGRITY CHECKPOINT,0.023741,0.065549,0.083447,1,1
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.02268,0.063877,0.05164,1,1
2,GO DNA METABOLIC PROCESS,0.004408,0.0637,0.06765,1,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.017137,0.062306,0.080172,1,1
2,GO CHROMOSOME CONDENSATION,0.047551,0.061065,0.077465,1,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.011326,0.06093,0.084026,1,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.042857,0.060125,0.1171,1,1
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.044685,0.059932,0.075487,1,1
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.025414,0.059455,0.10878,1,1
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.044685,0.059404,0.068066,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0056288,0.058792,0.05732,1,1
2,GO DNA REPAIR,0.010506,0.056856,0.066843,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.025414,0.054148,0.046814,1,1
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.017137,0.053453,0.051302,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.04854,0.051571,0.065494,1,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.014486,0.048574,0.065694,1,1
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.6228e-06,0.94756,0.94014,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.9301e-06,0.91031,0.81499,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.071e-07,0.80365,0.80566,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.0311e-06,0.79422,0.73973,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.8936e-07,0.7916,0.92578,1,1
3,GO RESPONSE TO HISTAMINE,2.2658e-06,0.74477,0.72042,1,1
3,GO RESPONSE TO L GLUTAMATE,4.2876e-06,0.69465,0.60666,1,1
3,GO SYNAPSE MATURATION,1.4674e-06,0.68545,0.7436,1,1
3,GO SECRETORY GRANULE LOCALIZATION,2.0033e-05,0.65007,0.54422,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,2.8418e-05,0.62605,0.56859,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,1.2454e-05,0.61639,0.52145,1,1
3,GO PYRAMIDAL NEURON DIFFERENTIATION,3.3132e-05,0.60719,0.59391,1,1
3,GO TYPE B PANCREATIC CELL APOPTOTIC PROCESS,4.0073e-05,0.59411,0.55227,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.2754e-05,0.57877,0.59374,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.1112e-06,0.57691,0.53241,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,4.6623e-06,0.5716,0.67473,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,8.6584e-06,0.5636,0.52821,1,1
3,GO SYNAPTIC VESICLE MATURATION,1.5816e-05,0.56314,0.55209,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.2524e-05,0.55993,0.47787,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.906e-06,0.54883,0.56841,1,1
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.013465,0.5278,0.27946,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,3.1888e-05,0.52089,0.44522,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00026003,0.51822,0.43648,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,3.8583e-05,0.51426,0.60361,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.00029782,0.51233,0.39413,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,3.1904e-06,0.50604,0.55189,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.2366e-07,0.50581,0.55815,1,1
3,GO POSTSYNAPSE ASSEMBLY,2.2524e-05,0.50478,0.5522,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.001662,0.49835,0.41138,1,1
3,GO SUCKLING BEHAVIOR,2.6902e-06,0.49306,0.46816,1,1
3,GO PLASMA MEMBRANE REPAIR,6.0198e-07,0.49163,0.5509,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.00019753,0.4888,0.39291,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,5.2837e-06,0.48509,0.42077,1,1
3,GO UV PROTECTION,3.0576e-06,0.48315,0.47018,1,1
3,GO REGULATION OF GUANYLATE CYCLASE ACTIVITY,0.0026572,0.48243,0.39301,1,1
3,GO OXYGEN TRANSPORT,0.007729,0.48098,0.47859,1,1
3,GO ADULT HEART DEVELOPMENT,2.9532e-05,0.46765,0.43997,1,1
3,GO GLYCINE TRANSPORT,0.010245,0.46638,0.32803,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.1964e-05,0.46059,0.47156,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.547e-05,0.45958,0.48595,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.0037331,0.45649,0.45228,1,1
3,GO TELENCEPHALON REGIONALIZATION,0.0066042,0.45498,0.35935,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,3.3287e-06,0.45296,0.44,1,1
3,GO MATURATION OF LSU RRNA,0.00014935,0.4519,0.37323,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.00072223,0.45108,0.37243,1,1
3,GO RIBOSOME ASSEMBLY,0.00032948,0.44701,0.35206,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,3.3132e-05,0.44645,0.43335,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,2.3418e-05,0.44561,0.41876,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,1.5816e-05,0.44531,0.41464,1,1
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00026003,0.44497,0.40363,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.00013433,0.44103,0.35656,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,7.8282e-05,0.44058,0.41204,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0019282,0.43622,0.29455,1,1
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,3.7145e-05,0.43405,0.49431,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,5.2139e-05,0.43229,0.44291,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.02068,0.42852,0.26809,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.00090094,0.42822,0.27321,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,1.4039e-05,0.42626,0.40752,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.00036427,0.41768,0.35519,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00052342,0.41701,0.41583,1,1
3,GO IMP METABOLIC PROCESS,9.0551e-05,0.41481,0.41783,1,1
3,GO CGMP METABOLIC PROCESS,0.00045924,0.41082,0.36304,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.00040247,0.41063,0.57213,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00044439,0.40928,0.41246,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00034072,0.40609,0.35238,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,9.0551e-05,0.40382,0.32816,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.01282,0.40346,0.31243,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,8.3127e-06,0.4005,0.35991,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.0062634,0.3971,0.36548,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013139,0.39707,0.27753,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.3418e-05,0.39682,0.38372,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,6.5149e-05,0.39636,0.43113,1,1
3,GO ELASTIC FIBER ASSEMBLY,0.00045924,0.39581,0.47755,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.0059384,0.39443,0.26069,1,1
3,GO MYOBLAST PROLIFERATION,4.6623e-06,0.39425,0.4101,1,1
3,GO SIALYLATION,0.0013457,0.39342,0.40768,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,2.2524e-05,0.3916,0.34173,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00041602,0.39111,0.51814,1,1
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0057817,0.38824,0.30976,1,1
3,GO INNERVATION,0.00052342,0.38703,0.39486,1,1
3,GO FACIAL NERVE MORPHOGENESIS,0.0066042,0.38467,0.35033,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00031859,0.38363,0.34614,1,1
3,GO NEGATIVE CHEMOTAXIS,0.00012512,0.38309,0.34246,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.0057817,0.38233,0.2726,1,1
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.010773,0.38101,0.2694,1,1
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00019753,0.38097,0.35262,1,1
3,GO CYTOPLASMIC TRANSLATION,0.00049035,0.38017,0.35101,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,7.9801e-06,0.37741,0.47846,1,1
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.0069616,0.37522,0.29253,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.001228,0.37444,0.36944,1,1
3,GO HEART VALVE FORMATION,0.00037661,0.37386,0.39291,1,1
3,GO AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION,0.00045924,0.36967,0.38396,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00018427,0.36937,0.37404,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00012964,0.36873,0.41623,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.0020453,0.36777,0.26236,1,1
3,GO DENTATE GYRUS DEVELOPMENT,7.8282e-05,0.36694,0.51687,1,1
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.009256,0.36495,0.27525,1,1
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0036303,0.35922,0.25656,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.033166,0.35692,0.22823,1,1
3,GO L GLUTAMATE IMPORT,0.00045924,0.35529,0.29567,1,1
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00014418,0.3552,0.31646,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0014299,0.35044,0.24031,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0001547,0.34932,0.33442,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.00065623,0.34881,0.3587,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.00090094,0.34876,0.44965,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.5774e-06,0.34625,0.39766,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.00022676,0.34618,0.32216,1,1
3,GO ADULT FEEDING BEHAVIOR,0.00065623,0.34356,0.22249,1,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.021165,0.34351,0.2709,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0022992,0.34218,0.3393,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.00067758,0.34121,0.27606,1,1
3,GO TRANSLATIONAL INITIATION,0.0010528,0.3411,0.3039,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,1.7806e-05,0.34055,0.31045,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083534,0.33889,0.32249,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0010859,0.33694,0.25895,1,1
3,GO GAS TRANSPORT,0.0066042,0.33673,0.37192,1,1
3,GO LIMB BUD FORMATION,0.015203,0.33666,0.37697,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0017641,0.33651,0.28969,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0015189,0.33579,0.29889,1,1
3,GO TELOMERASE RNA LOCALIZATION,0.00013917,0.32701,0.32189,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.0604e-05,0.32643,0.36839,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,2.6307e-05,0.32293,0.28974,1,1
3,GO SYNAPTIC VESICLE PRIMING,3.0689e-05,0.32128,0.41314,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.027803,0.32032,0.19312,1,1
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.00090094,0.31727,0.30085,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.027803,0.317,0.2786,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.0023671,0.31699,0.27417,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1617e-05,0.31621,0.33865,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00016023,0.31598,0.29368,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00079435,0.31522,0.36813,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00087311,0.31486,0.26049,1,1
3,GO AORTA DEVELOPMENT,0.0016129,0.31397,0.20113,1,1
3,GO MATURATION OF SSU RRNA,0.00045924,0.31375,0.29689,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.4609e-05,0.3125,0.37367,1,1
3,GO NEURON PROJECTION ORGANIZATION,3.1904e-06,0.31218,0.30704,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00059588,0.31056,0.29615,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0047853,0.31015,0.32372,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00047456,0.3101,0.30501,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00081984,0.30788,0.31239,1,1
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.041967,0.30776,0.23304,1,1
3,GO RRNA PSEUDOURIDINE SYNTHESIS,0.011904,0.30728,0.28329,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00042998,0.30492,0.26796,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0021689,0.30332,0.24321,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0037331,0.30275,0.20971,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00069957,0.30273,0.3116,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.00019753,0.2983,0.34389,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0047853,0.29787,0.27686,1,1
3,GO DIVALENT METAL ION EXPORT,0.00059588,0.29766,0.39797,1,1
3,GO REGULATION OF LYASE ACTIVITY,3.0689e-05,0.29634,0.26996,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0021062,0.29468,0.22458,1,1
3,GO MATURATION OF 5 8S RRNA,0.0017641,0.29439,0.24399,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.041967,0.29417,0.18102,1,1
3,GO MATING BEHAVIOR,0.0025817,0.29386,0.21672,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0010206,0.29365,0.4059,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0037331,0.2933,0.23187,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0079323,0.29304,0.18715,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.00044439,0.29292,0.22038,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0038387,0.29273,0.25142,1,1
3,GO PEPTIDYL ARGININE N METHYLATION,0.00010462,0.29234,0.31636,1,1
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0075304,0.29187,0.24686,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.0026572,0.29084,0.22203,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,8.1192e-05,0.29082,0.31637,1,1
3,GO SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION,0.0036303,0.29063,0.33102,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.0010528,0.29002,0.23738,1,1
3,GO NAD METABOLIC PROCESS,0.0028957,0.28961,0.2362,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0025083,0.28931,0.23327,1,1
3,GO L SERINE METABOLIC PROCESS,0.011904,0.28863,0.29792,1,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0071468,0.28737,0.21499,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,9.7346e-05,0.28657,0.21378,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00072223,0.28487,0.2813,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0010206,0.28381,0.22364,1,1
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0057817,0.28372,0.27887,1,1
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.015203,0.2822,0.25272,1,1
3,GO RIBOSOME BIOGENESIS,0.00057693,0.27931,0.25228,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00025131,0.27665,0.31857,1,1
3,GO REGULATION OF MRNA BINDING,0.00026003,0.27398,0.297,1,1
3,GO PEPTIDYL HISTIDINE MODIFICATION,0.00063551,0.27295,0.21766,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.041093,0.27198,0.18829,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.004408,0.27146,0.1994,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.0015653,0.27089,0.28208,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.00054072,0.27016,0.23454,1,1
3,GO STRESS GRANULE ASSEMBLY,1.1493e-05,0.2701,0.24164,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,0.0021689,0.26871,0.22891,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00353,0.26731,0.20427,1,1
3,GO BONE GROWTH,0.009256,0.2629,0.2313,1,1
3,GO NEURON REMODELING,0.0010528,0.2624,0.29998,1,1
3,GO HYPOTONIC RESPONSE,0.025994,0.26188,0.17492,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.013139,0.26177,0.20083,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,4.0073e-05,0.26171,0.23927,1,1
3,GO LEARNING,3.5759e-05,0.26107,0.2771,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.016734,0.26084,0.2363,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0042883,0.26079,0.20316,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.00014935,0.26009,0.25265,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.00014935,0.25989,0.19652,1,1
3,GO TRANSLATIONAL ELONGATION,0.00038934,0.25826,0.22275,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0039469,0.25823,0.2013,1,1
3,GO RRNA MODIFICATION,0.007729,0.2571,0.21839,1,1
3,GO RRNA METABOLIC PROCESS,0.00084609,0.25574,0.22872,1,1
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.00087311,0.25477,0.26261,1,1
3,GO REPRODUCTIVE BEHAVIOR,0.0018173,0.25446,0.24261,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.0013054,0.25444,0.25289,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,9.0551e-05,0.25444,0.25267,1,1
3,GO VIRAL TRANSLATION,0.0013054,0.25369,0.28863,1,1
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0053338,0.25352,0.22196,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.013798,0.25024,0.23231,1,1
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.029068,0.24711,0.20917,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0051916,0.24683,0.26074,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.015574,0.2463,0.21943,1,1
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0022332,0.24555,0.21421,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.0066042,0.24493,0.19261,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0022332,0.24364,0.23682,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.0047853,0.24321,0.20474,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.0021689,0.24248,0.20411,1,1
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00079435,0.23776,0.19158,1,1
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.001228,0.23725,0.42057,1,1
3,GO ASSOCIATIVE LEARNING,5.2139e-05,0.23591,0.24356,1,1
3,GO ONE CARBON COMPOUND TRANSPORT,0.020205,0.23556,0.15196,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0060989,0.23513,0.18145,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00026903,0.23406,0.20807,1,1
3,GO FOREBRAIN REGIONALIZATION,0.016339,0.23337,0.24722,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.00026903,0.23286,0.2258,1,1
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.037747,0.23278,0.22524,1,1
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.0094949,0.23246,0.20721,1,1
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0039469,0.2296,0.2025,1,1
3,GO SNORNA 3 END PROCESSING,0.00098941,0.22817,0.34461,1,1
3,GO TRNA MODIFICATION,0.00019079,0.22811,0.22381,1,1
3,GO RRNA TRANSCRIPTION,0.00054072,0.22764,0.21113,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,6.2786e-05,0.22515,0.25885,1,1
3,GO VIRAL GENE EXPRESSION,0.011904,0.22434,0.20572,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.0028141,0.22387,0.20694,1,1
3,GO TRNA METHYLATION,0.0022992,0.22314,0.17565,1,1
3,GO SYNAPTIC VESICLE DOCKING,0.023741,0.22255,0.26474,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0057817,0.22244,0.24928,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00019753,0.22077,0.19118,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0031536,0.22073,0.17238,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0033369,0.22015,0.19904,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.0026572,0.21849,0.17044,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,8.7323e-05,0.21784,0.23145,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.004408,0.21751,0.34059,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.0028141,0.21551,0.28893,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.00087311,0.21531,0.21643,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0073363,0.21512,0.19907,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00024286,0.21398,0.23165,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0083534,0.21394,0.15885,1,1
3,GO REGULATION OF STORE OPERATED CALCIUM ENTRY,0.011612,0.21373,0.23113,1,1
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023205,0.21365,0.20936,1,1
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0097392,0.21356,0.18451,1,1
3,GO REGULATION OF RNA BINDING,0.00035231,0.21323,0.24793,1,1
3,GO TUBULIN DEACETYLATION,0.014841,0.2129,0.1902,1,1
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017969,0.21275,0.19516,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00045924,0.21256,0.19071,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.21208,0.1453,1,1
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.0045306,0.21,0.19261,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0015189,0.20967,0.16934,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0075304,0.20888,0.1496,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0024367,0.20799,0.17967,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.045624,0.20758,0.15517,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.0031536,0.20716,0.16271,1,1
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.010506,0.20713,0.17369,1,1
3,GO POSITIVE REGULATION OF HEART GROWTH,0.0071468,0.20653,0.178,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.00035231,0.20626,0.23644,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.00059588,0.20539,0.29311,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.00055855,0.20522,0.1716,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.016734,0.20408,0.20365,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0017641,0.20349,0.19653,1,1
3,GO TELOMERIC LOOP DISASSEMBLY,0.001191,0.20346,0.2066,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,6.0504e-05,0.2032,0.21928,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00012074,0.20188,0.20711,1,1
3,GO CRANIAL NERVE MORPHOGENESIS,0.033894,0.20162,0.20302,1,1
3,GO TRANSLATIONAL TERMINATION,0.0039469,0.20079,0.19092,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0034322,0.20069,0.15221,1,1
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.036948,0.19936,0.20169,1,1
3,GO FEAR RESPONSE,0.0097392,0.19857,0.16602,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00050664,0.19822,0.19569,1,1
3,GO NCRNA PROCESSING,0.0012662,0.19782,0.18397,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.011612,0.19776,0.2154,1,1
3,GO SNORNA METABOLIC PROCESS,0.0031536,0.1972,0.30796,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0049174,0.19691,0.19162,1,1
3,GO HISTONE ARGININE METHYLATION,0.00067758,0.1969,0.2115,1,1
3,GO AMINO ACID IMPORT,0.0041716,0.19661,0.18047,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,2.6902e-06,0.19536,0.20291,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00028792,0.19524,0.23795,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.014841,0.19511,0.13259,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0060989,0.19511,0.20831,1,1
3,GO AEROBIC RESPIRATION,0.0016129,0.1938,0.17211,1,1
3,GO RNA POLYADENYLATION,0.00042998,0.19367,0.14716,1,1
3,GO CELLULAR ANION HOMEOSTASIS,0.044685,0.19324,0.18555,1,1
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.017969,0.1928,0.15027,1,1
3,GO MRNA MODIFICATION,0.0007696,0.19273,0.23559,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0018173,0.19214,0.17905,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001191,0.19124,0.22808,1,1
3,GO PLASMA MEMBRANE TUBULATION,0.011326,0.19059,0.15792,1,1
3,GO PROTEIN NITROSYLATION,0.020205,0.18795,0.19961,1,1
3,GO MEMBRANE DISASSEMBLY,0.026586,0.1872,0.12351,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0028141,0.18641,0.16102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0039469,0.18635,0.20534,1,1
3,GO CRISTAE FORMATION,0.010773,0.18633,0.19498,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.001228,0.18625,0.18231,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0069616,0.18464,0.14181,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.0056288,0.18358,0.23025,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00032948,0.18283,0.21665,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.001191,0.18234,0.20343,1,1
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0049174,0.18212,0.1579,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.007729,0.18164,0.17887,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0007696,0.17987,0.13438,1,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.0022992,0.17916,0.17914,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.01282,0.17876,0.14442,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,7.547e-05,0.17796,0.2271,1,1
3,GO PYRUVATE METABOLIC PROCESS,0.0045306,0.17695,0.12067,1,1
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.0075304,0.17618,0.15109,1,1
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0034322,0.17482,0.21853,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.0023671,0.17411,0.13803,1,1
3,GO CELLULAR RESPIRATION,0.0041716,0.17387,0.14646,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0073363,0.17338,0.14406,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.010245,0.17319,0.13409,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00027832,0.17269,0.15609,1,1
3,GO EXCRETION,0.0056288,0.17257,0.13673,1,1
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0010859,0.17212,0.20056,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0013457,0.17064,0.12044,1,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.043763,0.17035,0.16556,1,1
3,GO L AMINO ACID TRANSPORT,0.00063551,0.17017,0.19111,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0067808,0.17,0.1241,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00023468,0.16976,0.15496,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0013457,0.16916,0.2218,1,1
3,GO TRNA PROCESSING,0.00090094,0.16875,0.17937,1,1
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.036948,0.16846,0.17184,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.010506,0.16785,0.18837,1,1
3,GO HIPPOCAMPUS DEVELOPMENT,0.0054795,0.16721,0.20077,1,1
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0064317,0.16709,0.21801,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00092958,0.1669,0.14928,1,1
3,GO RRNA METHYLATION,0.0081404,0.16645,0.18496,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.012203,0.16623,0.14042,1,1
3,GO STRIATUM DEVELOPMENT,0.016339,0.16617,0.18751,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0042883,0.16381,0.19525,1,1
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.01282,0.16366,0.17074,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.041093,0.16341,0.1333,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0046564,0.16254,0.19159,1,1
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.014486,0.16219,0.099699,1,1
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.010506,0.16121,0.17084,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.011047,0.1597,0.20058,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0029794,0.15835,0.14723,1,1
3,GO NUCLEAR PORE ORGANIZATION,0.041093,0.15717,0.11028,1,1
3,GO MITOTIC DNA REPLICATION CHECKPOINT,0.010506,0.15666,0.14296,1,1
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.029068,0.15409,0.1588,1,1
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.012203,0.15294,0.16955,1,1
3,GO MRNA METHYLATION,0.01282,0.15177,0.19339,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.011326,0.15121,0.21752,1,1
3,GO RNA SURVEILLANCE,0.033894,0.1503,0.12882,1,1
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.02268,0.14991,0.1987,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.014486,0.14824,0.12566,1,1
3,GO NCRNA METABOLIC PROCESS,0.0029794,0.14765,0.15371,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041093,0.1475,0.12282,1,1
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0046564,0.14683,0.19829,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.00069957,0.1464,0.12066,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015574,0.14537,0.10928,1,1
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.035393,0.14524,0.11023,1,1
3,GO PROTEIN TARGETING,0.007729,0.14409,0.10904,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.0064317,0.14323,0.14307,1,1
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00026003,0.14301,0.15939,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.013e-05,0.14268,0.18832,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.0054795,0.14261,0.13749,1,1
3,GO PROTEIN DENEDDYLATION,0.033166,0.14066,0.13452,1,1
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.031059,0.1397,0.13311,1,1
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0053338,0.13936,0.16664,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.0020453,0.13918,0.15842,1,1
3,GO RNA CATABOLIC PROCESS,0.012203,0.13892,0.11055,1,1
3,GO DNA REPLICATION INITIATION,0.0018173,0.13857,0.14311,1,1
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.036164,0.13815,0.12703,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00047456,0.13806,0.24592,1,1
3,GO REPLICATION FORK PROCESSING,0.0040578,0.13801,0.13472,1,1
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.03245,0.13664,0.1133,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0042883,0.13658,0.11355,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0011549,0.13652,0.13207,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0014738,0.13645,0.12815,1,1
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0026572,0.13383,0.1528,1,1
3,GO ARTERY DEVELOPMENT,0.049546,0.13343,0.062324,1,1
3,GO REGULATION OF CELL CYCLE ARREST,0.011047,0.13304,0.088991,1,1
3,GO RNA METHYLATION,0.0039469,0.1329,0.13947,1,1
3,GO DNA REPLICATION CHECKPOINT,0.0041716,0.13282,0.1289,1,1
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.01282,0.13277,0.23479,1,1
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.004408,0.13276,0.139,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.0016129,0.1315,0.11326,1,1
3,GO AMINO ACID TRANSPORT,0.00016595,0.13054,0.1682,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0090226,0.13023,0.11092,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0010206,0.12938,0.11393,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.019739,0.12764,0.15135,1,1
3,GO RESPONSE TO AMPHETAMINE,0.045624,0.1275,0.13089,1,1
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.01282,0.12653,0.14995,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.0056288,0.12485,0.12084,1,1
3,GO TRNA TRANSPORT,0.007729,0.12413,0.1308,1,1
3,GO NUCLEOTIDE PHOSPHORYLATION,0.0047853,0.12371,0.12014,1,1
3,GO ATP METABOLIC PROCESS,0.0024367,0.12365,0.10989,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.02268,0.12358,0.10602,1,1
3,GO REGULATION OF MRNA PROCESSING,0.001228,0.12321,0.10397,1,1
3,GO BASE EXCISION REPAIR,0.017549,0.12253,0.087776,1,1
3,GO MATING,0.033166,0.12237,0.091484,1,1
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.02843,0.12167,0.10248,1,1
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0039469,0.12166,0.10347,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.029719,0.12095,0.11361,1,1
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0075304,0.12071,0.11613,1,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042857,0.11906,0.073813,1,1
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.014138,0.11894,0.08456,1,1
3,GO REGULATION OF TELOMERE MAINTENANCE,0.0046564,0.1189,0.11692,1,1
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.03939,0.11847,0.11502,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.0087944,0.11847,0.11837,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0050528,0.11797,0.10938,1,1
3,GO NCRNA EXPORT FROM NUCLEUS,0.033166,0.11753,0.11239,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.024846,0.11601,0.12444,1,1
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.041967,0.11561,0.11825,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.007729,0.11555,0.076652,1,1
3,GO PROTEIN TETRAMERIZATION,0.00059588,0.11506,0.13276,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0099891,0.11483,0.10236,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0013054,0.1146,0.172,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.046579,0.1143,0.11196,1,1
3,GO NCRNA 3 END PROCESSING,0.01282,0.11383,0.095253,1,1
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.001986,0.11376,0.13349,1,1
3,GO MUSCLE ORGAN MORPHOGENESIS,0.031059,0.11238,0.095715,1,1
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.029068,0.11227,0.098242,1,1
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.022165,0.11169,0.12288,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0085714,0.11156,0.12578,1,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033166,0.1105,0.076747,1,1
3,GO TELENCEPHALON DEVELOPMENT,0.0028141,0.11012,0.13391,1,1
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.036948,0.10884,0.10272,1,1
3,GO RNA 3 END PROCESSING,0.0064317,0.10664,0.082163,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0050528,0.10659,0.091621,1,1
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.023741,0.10627,0.11456,1,1
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.031059,0.10453,0.11387,1,1
3,GO MRNA 3 END PROCESSING,0.0075304,0.10424,0.078822,1,1
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.018398,0.10337,0.13184,1,1
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.016734,0.1032,0.091181,1,1
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.034637,0.10317,0.086476,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.02843,0.10275,0.079815,1,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0037331,0.10232,0.09644,1,1
3,GO LEUKOCYTE TETHERING OR ROLLING,0.009256,0.1022,0.12556,1,1
3,GO TELOMERE ORGANIZATION,0.0059384,0.1018,0.092471,1,1
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.047551,0.10107,0.0937,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.024288,0.099497,0.10904,1,1
3,GO MRNA METABOLIC PROCESS,0.0014299,0.099475,0.10604,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.017969,0.098288,0.11512,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.024846,0.097809,0.086502,1,1
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.044685,0.097259,0.12093,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.004408,0.096457,0.12148,1,1
3,GO RNA PROCESSING,0.00044439,0.096204,0.11772,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.001986,0.096203,0.10604,1,1
3,GO INTERSTRAND CROSS LINK REPAIR,0.0028141,0.095757,0.09109,1,1
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.044685,0.095589,0.080866,1,1
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.02268,0.093868,0.12209,1,1
3,GO NCRNA TRANSCRIPTION,0.0025083,0.093842,0.09324,1,1
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.024846,0.091317,0.082704,1,1
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.0094949,0.090542,0.090551,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.017137,0.089889,0.14576,1,1
3,GO PHOSPHATE ION TRANSPORT,0.02166,0.089491,0.090965,1,1
3,GO PROTEIN HOMOOLIGOMERIZATION,0.0022992,0.089404,0.10202,1,1
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.045624,0.089295,0.096514,1,1
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.037747,0.087362,0.086978,1,1
3,GO RNA LOCALIZATION,0.0079323,0.084538,0.089299,1,1
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.025994,0.082868,0.082697,1,1
3,GO PROTEIN HETEROTETRAMERIZATION,0.0050528,0.082708,0.13026,1,1
3,GO NEGATIVE REGULATION OF DNA BINDING,0.044685,0.082305,0.1067,1,1
3,GO POSITIVE REGULATION OF RNA SPLICING,0.044685,0.081949,0.065575,1,1
3,GO MRNA PROCESSING,0.0010859,0.07968,0.091229,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.016339,0.07527,0.067584,1,1
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0056288,0.074586,0.08917,1,1
3,GO RNA SPLICING,0.0023671,0.072933,0.085108,1,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.037747,0.069404,0.071298,1,1
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.02068,0.061768,0.062723,1,1
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.037747,0.053063,0.05135,1,1
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.036164,0.048604,0.11244,1,1
3,GO METHYLATION,0.033166,0.032322,0.058393,1,1
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,1.4039e-05,1.2851,1.1061,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.00074557,1.0828,0.84134,1,1
4,GO CYTIDINE TO URIDINE EDITING,5.8301e-05,0.87532,0.72553,1,1
4,GO NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.4346e-05,0.8674,0.6819,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,5.0226e-05,0.78572,0.5775,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,1.349e-05,0.77816,0.74352,1,1
4,GO TOLERANCE INDUCTION,7.547e-05,0.7625,0.63625,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1493e-05,0.73848,0.5703,1,1
4,GO HISTAMINE SECRETION,2.3975e-07,0.72337,0.76773,1,1
4,GO LIPID DROPLET FORMATION,1.4044e-06,0.72109,0.6968,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.2524e-05,0.70915,0.61878,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.00014935,0.67288,0.48322,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.1788e-07,0.64091,0.62044,1,1
4,GO MUCUS SECRETION,0.00054072,0.64067,0.55538,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.004408,0.63112,0.50758,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,2.4346e-05,0.63067,0.46496,1,1
4,GO RESPONSE TO TYPE I INTERFERON,1.1964e-05,0.62682,0.60605,1,1
4,GO HISTAMINE TRANSPORT,3.9926e-07,0.62544,0.70658,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00019753,0.62185,0.62253,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,6.0504e-05,0.61796,0.50972,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.8418e-05,0.61712,0.59088,1,1
4,GO GERMINAL CENTER FORMATION,0.00023468,0.616,0.48235,1,1
4,GO EOSINOPHIL MIGRATION,0.00021167,0.6158,0.4541,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00092958,0.61318,0.44429,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.00026903,0.6098,0.73415,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.00036427,0.60914,0.50571,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0024367,0.60607,0.46306,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,2.1702e-06,0.5977,0.61669,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0011199,0.59561,0.39319,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,3.5759e-05,0.58169,0.49313,1,1
4,GO INTESTINAL LIPID ABSORPTION,9.3916e-06,0.58025,0.65762,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,6.5149e-05,0.57588,0.45608,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,4.3218e-05,0.57558,0.47672,1,1
4,GO RENAL ABSORPTION,6.0504e-05,0.56835,0.60871,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00029782,0.55479,0.52138,1,1
4,GO SEROTONIN METABOLIC PROCESS,6.5149e-05,0.55317,0.57168,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,7.013e-05,0.5529,0.47585,1,1
4,GO DETECTION OF OTHER ORGANISM,1.349e-05,0.54937,0.50663,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,1.2862e-06,0.54197,0.51576,1,1
4,GO ADHESION OF SYMBIONT TO HOST,0.00021909,0.54092,0.43016,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,8.1192e-05,0.53727,0.56994,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,1.7806e-05,0.53726,0.49417,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,7.0571e-06,0.53714,0.55529,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.6307e-05,0.53676,0.50943,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.2837e-06,0.53547,0.5362,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00069957,0.53497,0.42939,1,1
4,GO REGULATION OF PLASMINOGEN ACTIVATION,0.011904,0.53226,0.34796,1,1
4,GO KETONE CATABOLIC PROCESS,0.00019753,0.53151,0.47208,1,1
4,GO REGULATION OF PLATELET AGGREGATION,3.1888e-05,0.52876,0.48442,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.00057693,0.52216,0.42424,1,1
4,GO O GLYCAN PROCESSING,9.8628e-07,0.52045,0.49674,1,1
4,GO LONG CHAIN FATTY ACID CATABOLIC PROCESS,0.00067758,0.52039,0.50566,1,1
4,GO INTESTINAL ABSORPTION,2.1831e-07,0.51963,0.65049,1,1
4,GO LIPID DIGESTION,5.2139e-05,0.51795,0.57455,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,4.0073e-05,0.51559,0.6335,1,1
4,GO TOXIN METABOLIC PROCESS,5.2837e-06,0.51338,0.47554,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00040247,0.51313,0.40185,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0016129,0.50958,0.38101,1,1
4,GO NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY,8.4205e-05,0.50852,0.53856,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,4.6597e-05,0.50689,0.47509,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00017796,0.50596,0.50179,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.00029782,0.50517,0.50124,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00013917,0.50419,0.45545,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,3.5759e-05,0.49381,0.47236,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,9.7801e-06,0.49298,0.51606,1,1
4,GO ACTIN FILAMENT SEVERING,0.00038934,0.49226,0.41679,1,1
4,GO NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.00028792,0.49157,0.50448,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00019079,0.4888,0.38687,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.00030804,0.48639,0.45401,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0050528,0.48491,0.39223,1,1
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.019739,0.48452,0.46354,1,1
4,GO ACTIN FILAMENT NETWORK FORMATION,0.00095906,0.48286,0.43696,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,8.6584e-06,0.48278,0.44678,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00052342,0.48231,0.47265,1,1
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00036427,0.47847,0.45284,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.1964e-05,0.47533,0.5134,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.5331e-06,0.47377,0.41012,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.0689e-05,0.47305,0.45971,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00065623,0.47254,0.44027,1,1
4,GO REGULATION OF PLATELET ACTIVATION,3.9418e-06,0.47025,0.44158,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0007696,0.47018,0.46928,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00014935,0.46618,0.40309,1,1
4,GO RESPONSE TO COLD,9.8628e-07,0.46319,0.44455,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.8379e-05,0.46206,0.52728,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0001165,0.46163,0.43438,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,1.0604e-05,0.46117,0.42771,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.001191,0.45912,0.41852,1,1
4,GO REGULATION OF RESPIRATORY BURST,4.6623e-06,0.45823,0.42152,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,3.4772e-07,0.45693,0.4621,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.001986,0.4567,0.46187,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0023671,0.45608,0.30337,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,9.7346e-05,0.45242,0.36899,1,1
4,GO RESPONSE TO REDOX STATE,9.7346e-05,0.44772,0.36013,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0001547,0.44732,0.45666,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,2.6307e-05,0.44543,0.42512,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,4.2876e-06,0.44519,0.44822,1,1
4,GO RESPONSE TO DIETARY EXCESS,8.4205e-05,0.44188,0.42357,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0014299,0.44144,0.36882,1,1
4,GO REGULATION OF ANOIKIS,4.8379e-05,0.44121,0.49358,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,7.3528e-06,0.43985,0.41605,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.00016595,0.43969,0.34465,1,1
4,GO INSEMINATION,0.00034072,0.43903,0.39777,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00098941,0.43738,0.36084,1,1
4,GO MATURE B CELL DIFFERENTIATION,8.1192e-05,0.43734,0.4109,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00065623,0.43535,0.36449,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,9.7801e-06,0.43454,0.40278,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00027832,0.43283,0.34443,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00014418,0.43137,0.41996,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.6307e-05,0.43023,0.38942,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00032948,0.42975,0.38104,1,1
4,GO REGULATION OF NEURON MATURATION,0.00018427,0.4297,0.35842,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.7806e-05,0.42936,0.37586,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,0.0024367,0.42729,0.38325,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0011549,0.42506,0.38423,1,1
4,GO ZYMOGEN ACTIVATION,0.00057693,0.42489,0.32653,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0026572,0.42406,0.318,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00021167,0.42238,0.35654,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0013457,0.42138,0.396,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,2.9301e-06,0.42049,0.43696,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.027188,0.41858,0.29328,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.011047,0.41843,0.33332,1,1
4,GO REGULATION OF CHOLESTEROL ESTERIFICATION,0.0050528,0.41607,0.35898,1,1
4,GO CELLULAR DEFENSE RESPONSE,1.6455e-05,0.41362,0.36177,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,2.7343e-05,0.41109,0.36591,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0001165,0.41074,0.39131,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.3418e-05,0.4099,0.33407,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00044439,0.40981,0.38481,1,1
4,GO B CELL APOPTOTIC PROCESS,4.4712e-06,0.40965,0.43226,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.001662,0.40875,0.34848,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.00011241,0.40804,0.40592,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.001662,0.40734,0.36632,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,3.8583e-05,0.4052,0.46146,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.0026572,0.40298,0.32998,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.0051916,0.40279,0.36695,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,4.4878e-05,0.40268,0.30524,1,1
4,GO INOSITOL TRISPHOSPHATE METABOLIC PROCESS,0.0016129,0.40188,0.37618,1,1
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00038934,0.40185,0.46092,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.8612e-06,0.40095,0.43004,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,5.0226e-05,0.39885,0.38773,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0028141,0.39844,0.39951,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,3.5759e-05,0.39791,0.42275,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.00018427,0.39761,0.31353,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00092958,0.3976,0.33987,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00072223,0.39739,0.32786,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,0.00032948,0.39715,0.30283,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.0001165,0.39681,0.40762,1,1
4,GO LUNG CELL DIFFERENTIATION,0.00079435,0.39634,0.42871,1,1
4,GO STEROID ESTERIFICATION,0.0015189,0.39615,0.36368,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,9.0551e-05,0.39612,0.40199,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,6.5149e-05,0.39557,0.38448,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0001547,0.39346,0.31608,1,1
4,GO BONE RESORPTION,3.1904e-06,0.39309,0.39849,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0087944,0.3929,0.24507,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.4712e-06,0.39226,0.39717,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.2962e-05,0.39175,0.37161,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00084609,0.39005,0.36393,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,1.1493e-05,0.38897,0.33482,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.00032948,0.38794,0.42689,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,3.7145e-05,0.38613,0.35414,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00011241,0.38567,0.48063,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0018173,0.38387,0.25675,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.0779e-06,0.38176,0.3851,1,1
4,GO L PHENYLALANINE METABOLIC PROCESS,0.00072223,0.3815,0.50174,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.0689e-05,0.38112,0.43391,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.00035231,0.38092,0.31842,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,3.3132e-05,0.38019,0.33522,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,3.5759e-05,0.37964,0.41532,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.00010845,0.37746,0.27254,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.0081404,0.37731,0.47576,1,1
4,GO ANOIKIS,1.4039e-05,0.37697,0.39282,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.0022992,0.37665,0.35393,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00081984,0.37613,0.28759,1,1
4,GO REGULATION OF BONE REMODELING,5.9841e-06,0.37585,0.40492,1,1
4,GO PROTEIN DEMANNOSYLATION,4.3218e-05,0.37576,0.38348,1,1
4,GO VASODILATION,0.00038934,0.37534,0.33581,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.00052342,0.37511,0.38008,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00087311,0.37486,0.32347,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,1.0184e-05,0.37397,0.31716,1,1
4,GO REGULATION OF TISSUE REMODELING,9.3916e-06,0.37303,0.35403,1,1
4,GO LIVER MORPHOGENESIS,0.00063551,0.37302,0.33942,1,1
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0034322,0.37237,0.27428,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.0001547,0.37222,0.31182,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,1.9263e-05,0.37218,0.37006,1,1
4,GO SUPEROXIDE ANION GENERATION,0.00054072,0.3717,0.34192,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,2.8418e-05,0.37071,0.38633,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,0.0017123,0.36957,0.3025,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.8379e-05,0.36938,0.36508,1,1
4,GO REGULATION OF ACROSOME REACTION,0.0046564,0.36898,0.33025,1,1
4,GO RESPONSE TO LITHIUM ION,1.4039e-05,0.36896,0.44533,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.00037661,0.36739,0.4444,1,1
4,GO DIGESTIVE SYSTEM PROCESS,1.5201e-05,0.36568,0.30331,1,1
4,GO RESPONSE TO EPINEPHRINE,0.018398,0.36563,0.29136,1,1
4,GO NATURAL KILLER CELL PROLIFERATION,0.001986,0.36563,0.32721,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.9532e-05,0.36562,0.45829,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0025817,0.36515,0.37022,1,1
4,GO VITAMIN D METABOLIC PROCESS,0.00017796,0.36476,0.31876,1,1
4,GO RESPONSE TO STEROL DEPLETION,5.0226e-05,0.36464,0.41124,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER,0.00084609,0.36358,0.38967,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0011549,0.36329,0.40868,1,1
4,GO RESPONSE TO COPPER ION,0.00044439,0.36221,0.46114,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0012662,0.36177,0.30066,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,6.5149e-05,0.36146,0.32444,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00032948,0.36108,0.33375,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.4712e-06,0.36075,0.36427,1,1
4,GO RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION,0.00067758,0.3606,0.36396,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0006154,0.36002,0.33136,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,0.00025131,0.35985,0.3072,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,2.2524e-05,0.35866,0.37458,1,1
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00016595,0.35842,0.39596,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,0.00069957,0.35821,0.28768,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00052342,0.3577,0.29619,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0015653,0.35754,0.24991,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0042883,0.35686,0.44674,1,1
4,GO RESPONSE TO WATER,0.0049174,0.35662,0.2839,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.00016023,0.35587,0.25206,1,1
4,GO REGULATION OF ICOSANOID SECRETION,1.4044e-06,0.35577,0.40702,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.0046564,0.35548,0.23679,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,2.3654e-06,0.3552,0.34128,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,4.8379e-05,0.35508,0.29959,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.011904,0.35476,0.28081,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.0013457,0.35463,0.2993,1,1
4,GO PLASMINOGEN ACTIVATION,0.0075304,0.35421,0.29661,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0011199,0.35244,0.32921,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.7806e-05,0.35137,0.3927,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.0085714,0.35035,0.28286,1,1
4,GO N GLYCAN PROCESSING,0.0017123,0.34978,0.29163,1,1
4,GO DIGESTION,3.0689e-05,0.34933,0.31562,1,1
4,GO TISSUE REMODELING,4.6597e-05,0.34805,0.28432,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00020448,0.34732,0.30861,1,1
4,GO PHAGOSOME ACIDIFICATION,2.8077e-06,0.34703,0.32529,1,1
4,GO REGULATION OF BILE ACID METABOLIC PROCESS,0.0031536,0.34689,0.35691,1,1
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.00095906,0.34688,0.30705,1,1
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0081404,0.34685,0.28463,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00090094,0.34659,0.34646,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,2.1702e-06,0.34616,0.33676,1,1
4,GO MYOBLAST FUSION,0.00030804,0.34615,0.27361,1,1
4,GO QUINONE METABOLIC PROCESS,0.00028792,0.34609,0.55067,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00030804,0.34567,0.30616,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00023468,0.34549,0.41822,1,1
4,GO FOAM CELL DIFFERENTIATION,9.0551e-05,0.34545,0.28313,1,1
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00038934,0.34485,0.34926,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0022992,0.34478,0.30379,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,3.4728e-06,0.34366,0.32456,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00010092,0.34261,0.36928,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.00017186,0.34245,0.2867,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.0036303,0.34227,0.25245,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.014486,0.34143,0.23396,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001228,0.34123,0.2145,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00011241,0.34116,0.34575,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00014418,0.34116,0.32948,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.0090226,0.34095,0.26566,1,1
4,GO ETHER METABOLIC PROCESS,0.0011549,0.34078,0.22731,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,6.5149e-05,0.34048,0.23662,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,0.0039469,0.34047,0.40554,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0037331,0.34044,0.27763,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,5.8301e-05,0.33996,0.33768,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,5.8301e-05,0.33995,0.34626,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.009256,0.3396,0.26872,1,1
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00084609,0.33951,0.22539,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00052342,0.33936,0.29681,1,1
4,GO REGULATION OF B CELL PROLIFERATION,1.6729e-06,0.33919,0.35964,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.2962e-05,0.33902,0.32315,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0034322,0.33884,0.25059,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,1.9263e-05,0.33872,0.31754,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00037661,0.33829,0.30592,1,1
4,GO MAST CELL ACTIVATION,1.8521e-05,0.33823,0.29599,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.0010528,0.33808,0.336,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0032441,0.33761,0.33809,1,1
4,GO RESPONSE TO INTERLEUKIN 2,0.00010845,0.33761,0.28262,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00038934,0.33752,0.27148,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00059588,0.33732,0.35904,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.00013917,0.33635,0.27721,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.001662,0.33575,0.31021,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.4205e-05,0.33538,0.31738,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.0036303,0.33497,0.27468,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00027832,0.33451,0.26789,1,1
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0051916,0.33421,0.26199,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.6455e-05,0.33401,0.32413,1,1
4,GO SNARE COMPLEX ASSEMBLY,0.00030804,0.33363,0.26928,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,9.7346e-05,0.33347,0.30464,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.0073363,0.33333,0.21747,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.00052342,0.33312,0.25431,1,1
4,GO KERATINOCYTE DEVELOPMENT,0.011904,0.33305,0.28882,1,1
4,GO HORMONE CATABOLIC PROCESS,0.001872,0.3325,0.39364,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.00055855,0.3321,0.2775,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,9.389e-05,0.33186,0.2978,1,1
4,GO PHOSPHOLIPID EFFLUX,0.0013457,0.33175,0.34576,1,1
4,GO VIRAL GENOME REPLICATION,0.00016595,0.33156,0.2651,1,1
4,GO GLYCOSIDE METABOLIC PROCESS,0.013465,0.33085,0.61715,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0045306,0.32983,0.30368,1,1
4,GO ADRENAL GLAND DEVELOPMENT,4.4878e-05,0.32977,0.43598,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0033369,0.32937,0.32778,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0040578,0.32895,0.24665,1,1
4,GO CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.00022676,0.32836,0.33264,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,1.8251e-06,0.32716,0.3454,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0013054,0.32687,0.26571,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,1.906e-06,0.32685,0.33093,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.7728e-06,0.32646,0.36697,1,1
4,GO RETINAL METABOLIC PROCESS,0.010773,0.32625,0.43319,1,1
4,GO MICROVILLUS ORGANIZATION,0.001872,0.32598,0.31299,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.045624,0.32567,0.239,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.007729,0.32563,0.25576,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.00034072,0.32531,0.42674,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00095906,0.3253,0.3608,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,0.00011241,0.32526,0.30853,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0018173,0.32487,0.29768,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.0013872,0.32473,0.22617,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,8.1192e-05,0.32464,0.27954,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00026903,0.324,0.21922,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00055855,0.32348,0.29302,1,1
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00018427,0.32342,0.34714,1,1
4,GO RESPONSE TO THYROID HORMONE,0.0014738,0.32303,0.26202,1,1
4,GO OSTEOBLAST PROLIFERATION,0.0013872,0.323,0.27406,1,1
4,GO REGULATION OF COAGULATION,0.00095906,0.32207,0.26752,1,1
4,GO APICAL JUNCTION ASSEMBLY,1.8521e-05,0.32178,0.36277,1,1
4,GO TRANSPOSITION,0.0013457,0.32051,0.30473,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,9.7346e-05,0.32001,0.30282,1,1
4,GO BONE REMODELING,3.4421e-05,0.31964,0.31848,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00023468,0.31916,0.21707,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00012074,0.31914,0.36893,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00016023,0.31873,0.28613,1,1
4,GO MUSCLE ATROPHY,0.018398,0.31871,0.23496,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0045306,0.31868,0.2721,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.00034072,0.31834,0.32867,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.00092958,0.31817,0.35206,1,1
4,GO VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.00012074,0.31794,0.36839,1,1
4,GO PROTEIN DEGLYCOSYLATION,9.0551e-05,0.31783,0.3556,1,1
4,GO LIPID TRANSLOCATION,1.9263e-05,0.31766,0.29579,1,1
4,GO STEROL METABOLIC PROCESS,1.6455e-05,0.31724,0.26884,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.007729,0.31679,0.26789,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,8.6584e-06,0.3166,0.328,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,0.00032948,0.3159,0.27844,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00050664,0.31477,0.28443,1,1
4,GO UBIQUINONE METABOLIC PROCESS,5.6174e-05,0.31423,0.28073,1,1
4,GO EPOXYGENASE P450 PATHWAY,0.042857,0.31334,0.20949,1,1
4,GO INNATE IMMUNE RESPONSE,3.1888e-05,0.31281,0.23535,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00095906,0.31235,0.25018,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0028141,0.31221,0.31447,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00013433,0.31171,0.24013,1,1
4,GO LYTIC VACUOLE ORGANIZATION,4.7955e-07,0.31137,0.3249,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9263e-05,0.31107,0.26359,1,1
4,GO RESPONSE TO MAGNESIUM ION,0.001191,0.31049,0.34647,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,8.1192e-05,0.31024,0.27017,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00014418,0.30999,0.28301,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.00092958,0.30992,0.18916,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.02166,0.30962,0.26385,1,1
4,GO MEMBRANE FISSION,0.009256,0.30942,0.22375,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.00021167,0.30917,0.31265,1,1
4,GO METHIONINE METABOLIC PROCESS,4.1617e-05,0.30855,0.2972,1,1
4,GO CELL KILLING,1.1493e-05,0.3084,0.24842,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.0833e-05,0.30834,0.30066,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,4.1617e-05,0.30815,0.25808,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.0007696,0.30776,0.27265,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00028792,0.30684,0.33964,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,3.3132e-05,0.30665,0.2435,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0097392,0.30608,0.18146,1,1
4,GO IMMUNE EFFECTOR PROCESS,6.2786e-05,0.30591,0.22622,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00017186,0.3051,0.2708,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.0023671,0.30503,0.25268,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.7343e-05,0.30501,0.22887,1,1
4,GO MAGNESIUM ION TRANSPORT,5.8301e-05,0.30477,0.27804,1,1
4,GO CORNIFICATION,1.6455e-05,0.30467,0.32094,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.0030654,0.30459,0.2614,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,1.6455e-05,0.30444,0.2706,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,4.1617e-05,0.30443,0.25791,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.018836,0.30417,0.20804,1,1
4,GO MAST CELL MEDIATED IMMUNITY,4.8379e-05,0.30411,0.28553,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.1663e-05,0.30398,0.28631,1,1
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.012203,0.30389,0.33782,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00059588,0.30372,0.24256,1,1
4,GO VACUOLAR ACIDIFICATION,5.7413e-06,0.30365,0.31488,1,1
4,GO STEROID METABOLIC PROCESS,1.5816e-05,0.30325,0.28088,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,9.4334e-07,0.30322,0.30958,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.0039469,0.30299,0.20808,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,0.00027832,0.3027,0.26294,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00040247,0.30248,0.27842,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00010092,0.30207,0.29537,1,1
4,GO STEROID HORMONE SECRETION,0.0064317,0.30155,0.21006,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0011549,0.30108,0.36366,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.012203,0.30064,0.22016,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00050664,0.30001,0.26239,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00029782,0.29997,0.21754,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00049035,0.29966,0.30808,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.0184e-05,0.29933,0.28241,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00098941,0.29925,0.24637,1,1
4,GO DIET INDUCED THERMOGENESIS,0.00074557,0.29902,0.26423,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.00038934,0.29896,0.25423,1,1
4,GO KERATINIZATION,9.7801e-06,0.29894,0.28964,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.5201e-05,0.29888,0.32249,1,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.022165,0.29857,0.2538,1,1
4,GO NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.4121e-05,0.29856,0.25543,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.014841,0.29842,0.24656,1,1
4,GO RESPIRATORY BURST,0.00012074,0.29796,0.30068,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.009256,0.29778,0.19403,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0001165,0.29766,0.31354,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,3.3132e-05,0.29679,0.25682,1,1
4,GO RESPONSE TO VIRUS,0.0001165,0.29659,0.23003,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,5.0226e-05,0.29623,0.31622,1,1
4,GO TYPE I INTERFERON PRODUCTION,4.3218e-05,0.29556,0.26076,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,5.2139e-05,0.29522,0.31712,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00030804,0.29521,0.26835,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.5308e-05,0.29478,0.23635,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,2.4346e-05,0.29441,0.26249,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0019282,0.29414,0.28563,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00035231,0.29357,0.24279,1,1
4,GO PLATELET DEGRANULATION,0.00353,0.29318,0.19516,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.547e-05,0.29311,0.23103,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0099891,0.29307,0.29481,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0006154,0.29281,0.21294,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00079435,0.29251,0.26673,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0014738,0.29231,0.3133,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,2.5308e-05,0.2921,0.2983,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00012074,0.29157,0.32947,1,1
4,GO ICOSANOID METABOLIC PROCESS,7.547e-05,0.29148,0.31225,1,1
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.018398,0.29142,0.18535,1,1
4,GO REGULATION OF ACTIN NUCLEATION,6.0504e-05,0.29132,0.30377,1,1
4,GO REGULATION OF DENDRITE EXTENSION,0.00090094,0.29126,0.36172,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.00087311,0.2909,0.28183,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00054072,0.29045,0.24424,1,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0054795,0.29006,0.22616,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,2.0033e-05,0.28973,0.31796,1,1
4,GO NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00032948,0.28946,0.32917,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.00019079,0.28895,0.33139,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.001986,0.28852,0.2351,1,1
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0062634,0.28847,0.26286,1,1
4,GO POLYOL TRANSPORT,0.0015189,0.28821,0.27436,1,1
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0057817,0.28817,0.30831,1,1
4,GO INTEGRIN ACTIVATION,5.6174e-05,0.28796,0.27389,1,1
4,GO INTERLEUKIN 10 PRODUCTION,4.6597e-05,0.28714,0.26487,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.00041602,0.28707,0.32998,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0062634,0.28702,0.2048,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00026903,0.28652,0.22564,1,1
4,GO REGULATION OF FERTILIZATION,0.00044439,0.28643,0.27621,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,8.4205e-05,0.28632,0.28788,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.7118e-05,0.28616,0.30433,1,1
4,GO B CELL HOMEOSTASIS,0.00030804,0.28615,0.26024,1,1
4,GO FUCOSYLATION,0.0051916,0.28595,0.2277,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00042998,0.28574,0.32927,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,0.0019282,0.28572,0.22499,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00087311,0.28566,0.29555,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.001191,0.2854,0.22707,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0034322,0.28536,0.21132,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00049035,0.2852,0.20468,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00040247,0.28506,0.30224,1,1
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.012508,0.28461,0.38245,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0017123,0.2845,0.19665,1,1
4,GO RESPONSE TO FORSKOLIN,0.047551,0.28437,0.2219,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,7.2754e-05,0.28416,0.23104,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00010092,0.2836,0.28432,1,1
4,GO REGULATION OF CELL KILLING,0.00010462,0.28259,0.27553,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.01282,0.28252,0.24091,1,1
4,GO REGULATION OF WOUND HEALING,0.00034072,0.28199,0.25404,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,0.00041602,0.28154,0.25116,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0038387,0.28112,0.21151,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.00027832,0.28055,0.23556,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.8282e-05,0.27992,0.22709,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.001228,0.27971,0.31248,1,1
4,GO REGULATION OF VASCULOGENESIS,0.0033369,0.27946,0.32768,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00042998,0.27944,0.2113,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,2.0033e-05,0.27919,0.29116,1,1
4,GO HAIR CELL DIFFERENTIATION,0.00014418,0.27896,0.2526,1,1
4,GO STEROL HOMEOSTASIS,0.00029782,0.2788,0.3052,1,1
4,GO VITAMIN CATABOLIC PROCESS,0.019739,0.27866,0.27796,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0062634,0.27849,0.20306,1,1
4,GO B CELL PROLIFERATION,3.4728e-06,0.27833,0.28291,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,6.5149e-05,0.27781,0.25436,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00027832,0.2773,0.2623,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,1.7806e-05,0.27719,0.27773,1,1
4,GO LIPID DROPLET ORGANIZATION,5.2139e-05,0.27719,0.26783,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,6.2786e-05,0.27695,0.24513,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00012512,0.27651,0.24052,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0062634,0.2764,0.21661,1,1
4,GO PHOSPHOLIPID TRANSPORT,6.4994e-06,0.27628,0.23503,1,1
4,GO RESPONSE TO GROWTH HORMONE,6.2786e-05,0.2762,0.32047,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,4.1617e-05,0.27605,0.2572,1,1
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.025414,0.27541,0.23147,1,1
4,GO INTERLEUKIN 13 PRODUCTION,0.041967,0.27521,0.18475,1,1
4,GO AMINE METABOLIC PROCESS,1.5331e-06,0.27516,0.27967,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0024367,0.27509,0.27987,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,3.4421e-05,0.27503,0.26144,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00023468,0.27482,0.25734,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,0.00018427,0.2748,0.25408,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.011047,0.27439,0.16701,1,1
4,GO GLYCOSYLATION,5.508e-06,0.27424,0.26657,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.00036427,0.27402,0.23573,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0047853,0.27396,0.17488,1,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.027803,0.27379,0.29537,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00017796,0.2737,0.24077,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.01282,0.27311,0.18882,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00092958,0.27246,0.23921,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,0.00030804,0.27238,0.33342,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,0.00026003,0.27149,0.29227,1,1
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.00069957,0.27145,0.2507,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0010859,0.27086,0.19113,1,1
4,GO CHEMOKINE PRODUCTION,0.0014299,0.26967,0.19281,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0083534,0.2696,0.22144,1,1
4,GO BONE CELL DEVELOPMENT,0.0069616,0.26952,0.18889,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00084609,0.26945,0.24512,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,2.3654e-06,0.26941,0.30988,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.010773,0.26926,0.3511,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.00025131,0.26912,0.2953,1,1
4,GO ACUTE PHASE RESPONSE,0.00063551,0.26888,0.28397,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.02843,0.26878,0.20368,1,1
4,GO PARTURITION,0.026586,0.26859,0.24289,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,1.9263e-05,0.26853,0.24741,1,1
4,GO RESPONSE TO CAFFEINE,0.0029794,0.26844,0.23924,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00092958,0.268,0.21329,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00067758,0.2677,0.19414,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0018173,0.26766,0.22771,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0031536,0.26757,0.18996,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.00042998,0.26749,0.22622,1,1
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.011047,0.26727,0.26589,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,0.00030804,0.26702,0.21835,1,1
4,GO MALE MEIOSIS I,0.027803,0.26686,0.24826,1,1
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0085714,0.26675,0.16264,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,1.6455e-05,0.26674,0.34711,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,5.2139e-05,0.26634,0.24464,1,1
4,GO CYTOPLASM ORGANIZATION,0.00095906,0.26633,0.24489,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.9532e-05,0.26603,0.23449,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,6.0504e-05,0.26582,0.21684,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00029782,0.26517,0.25517,1,1
4,GO RETINOL METABOLIC PROCESS,0.0023671,0.26515,0.32504,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,0.00030804,0.26493,0.21811,1,1
4,GO DEFENSE RESPONSE,3.4421e-05,0.26488,0.21176,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.00069957,0.26431,0.23426,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,1.9904e-06,0.2641,0.26224,1,1
4,GO REGULATION OF B CELL ACTIVATION,1.0604e-05,0.26401,0.25645,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00072223,0.26376,0.20108,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,7.2754e-05,0.26376,0.2239,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.025414,0.26334,0.3121,1,1
4,GO INTERLEUKIN 12 PRODUCTION,2.8077e-06,0.26287,0.31718,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,4.4878e-05,0.26282,0.28205,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.00095906,0.26268,0.22958,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.001191,0.26229,0.19327,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,4.6597e-05,0.26211,0.29519,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.00037661,0.26205,0.19084,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.001662,0.26161,0.37087,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0017641,0.26159,0.17302,1,1
4,GO LIPID LOCALIZATION,5.508e-06,0.26155,0.24761,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.00045924,0.26141,0.28702,1,1
4,GO WATER HOMEOSTASIS,4.6597e-05,0.26129,0.27112,1,1
4,GO DENDRITIC CELL MIGRATION,0.0047853,0.26118,0.18711,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,0.001872,0.26101,0.22371,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00017796,0.26091,0.22482,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00029782,0.26088,0.22659,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,0.00010845,0.26086,0.28056,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.0020453,0.26051,0.20184,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.00037661,0.26028,0.21142,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.00041602,0.25979,0.22616,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.00035231,0.25968,0.21356,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.2524e-05,0.25938,0.27154,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,9.0551e-05,0.25917,0.30544,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,1.6455e-05,0.25911,0.22273,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.001986,0.25901,0.31059,1,1
4,GO RESPONSE TO PROTOZOAN,0.0022332,0.25893,0.17468,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00098941,0.25891,0.19611,1,1
4,GO LYMPHOCYTE MIGRATION,0.00032948,0.25889,0.19619,1,1
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.00081984,0.25881,0.19771,1,1
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.013798,0.25878,0.17939,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,0.00054072,0.25869,0.22268,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,7.2754e-05,0.25858,0.18954,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.5759e-05,0.25855,0.25463,1,1
4,GO ENDOCRINE PROCESS,0.0001547,0.25851,0.25112,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.01282,0.25849,0.28455,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,3.5759e-05,0.25847,0.26978,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00050664,0.25792,0.2625,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.547e-05,0.25786,0.22335,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.041093,0.25775,0.19139,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0006154,0.25765,0.20496,1,1
4,GO PANCREATIC JUICE SECRETION,0.022165,0.25759,0.17752,1,1
4,GO AMELOGENESIS,0.0066042,0.25754,0.2294,1,1
4,GO TRANSFERRIN TRANSPORT,7.9801e-06,0.25715,0.28025,1,1
4,GO LEUKOCYTE PROLIFERATION,0.00014418,0.25713,0.20108,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0020453,0.25711,0.215,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00038934,0.25693,0.25767,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,7.2111e-07,0.25673,0.25064,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,6.2786e-05,0.25662,0.21982,1,1
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.00072223,0.25617,0.25894,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.00063551,0.25594,0.29969,1,1
4,GO RESPONSE TO CADMIUM ION,0.0028141,0.25583,0.23585,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0026572,0.25578,0.26294,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.8521e-05,0.25483,0.25651,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,4.0073e-05,0.25481,0.22606,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.034637,0.25477,0.15356,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0059384,0.25456,0.17681,1,1
4,GO PIRNA METABOLIC PROCESS,0.0021689,0.25452,0.27366,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0010528,0.25354,0.26503,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,2.4346e-05,0.25342,0.33539,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,0.00012074,0.25341,0.34333,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.0006154,0.25287,0.33059,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0007696,0.25279,0.21591,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0045306,0.25258,0.23662,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,5.6174e-05,0.25212,0.26182,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.00031859,0.25172,0.20012,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,6.7596e-05,0.25134,0.24411,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.025414,0.25115,0.28088,1,1
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.037747,0.25085,0.25393,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0025083,0.25083,0.18577,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.013e-05,0.25061,0.21521,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,1.2962e-05,0.25045,0.23195,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,4.3218e-05,0.24914,0.24277,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00057693,0.24879,0.1736,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00036427,0.24866,0.15936,1,1
4,GO LEUKOCYTE MIGRATION,6.7596e-05,0.2485,0.21991,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0033369,0.24805,0.20081,1,1
4,GO MUSCLE HYPERTROPHY,0.00037661,0.24771,0.20155,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0050528,0.24734,0.16296,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,1.4039e-05,0.24691,0.23039,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,0.00017796,0.24684,0.24023,1,1
4,GO INTERFERON ALPHA PRODUCTION,9.0551e-05,0.24662,0.25607,1,1
4,GO KERATINOCYTE DIFFERENTIATION,7.2754e-05,0.24625,0.23972,1,1
4,GO SECRETION BY TISSUE,0.0013872,0.24604,0.21694,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.0017641,0.24602,0.20659,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.104e-05,0.24575,0.24087,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.349e-05,0.24575,0.22326,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0010528,0.24573,0.31787,1,1
4,GO T CELL MIGRATION,0.0057817,0.2457,0.18139,1,1
4,GO SYNCYTIUM FORMATION,0.0014299,0.2457,0.18522,1,1
4,GO HEART TRABECULA FORMATION,0.013139,0.24558,0.27025,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0015653,0.24553,0.19598,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00026003,0.24548,0.20642,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.021165,0.24535,0.16732,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,5.2139e-05,0.24514,0.25959,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,7.8282e-05,0.24428,0.29963,1,1
4,GO ER OVERLOAD RESPONSE,0.0047853,0.24407,0.21363,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0025817,0.244,0.34233,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0013457,0.24322,0.20704,1,1
4,GO PH REDUCTION,2.4346e-05,0.24288,0.22408,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,9.0551e-05,0.24186,0.22844,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00044439,0.24176,0.20844,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0090226,0.24157,0.16769,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,0.00027832,0.24157,0.23987,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.011612,0.24119,0.20553,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,2.6307e-05,0.24076,0.238,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.8521e-05,0.24066,0.24856,1,1
4,GO ORGANELLE MEMBRANE FUSION,0.00025131,0.24046,0.19125,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00084609,0.24046,0.23057,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.015203,0.24024,0.12345,1,1
4,GO ZINC ION HOMEOSTASIS,0.014138,0.2401,0.24548,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.015574,0.24001,0.2182,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0006154,0.23999,0.22393,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.029068,0.23961,0.16855,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.001872,0.23954,0.25765,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,1.4609e-05,0.23949,0.23782,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0042883,0.23935,0.1863,1,1
4,GO CELLULAR RESPONSE TO STARVATION,4.4712e-06,0.23913,0.24811,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,7.8282e-05,0.23895,0.24951,1,1
4,GO PROSTANOID METABOLIC PROCESS,0.0094949,0.23877,0.28919,1,1
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.02166,0.23863,0.17993,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00012512,0.23835,0.28147,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.0067808,0.2383,0.22554,1,1
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0094949,0.2383,0.17362,1,1
4,GO HORMONE METABOLIC PROCESS,0.00074557,0.23826,0.24217,1,1
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.0010859,0.23809,0.27179,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,4.8379e-05,0.23796,0.20373,1,1
4,GO STEROID CATABOLIC PROCESS,0.014486,0.23794,0.25666,1,1
4,GO RESPONSE TO CYTOKINE,0.00012964,0.23767,0.18713,1,1
4,GO PROTEIN KINASE C SIGNALING,0.0090226,0.23732,0.21443,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.0017123,0.23692,0.19484,1,1
4,GO FUCOSE METABOLIC PROCESS,0.041093,0.23656,0.20513,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,9.389e-05,0.23647,0.20568,1,1
4,GO POSITIVE CHEMOTAXIS,0.0017123,0.23628,0.17647,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.0039469,0.23626,0.26654,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.00024286,0.23541,0.25293,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00030804,0.23537,0.21996,1,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.011612,0.23529,0.22565,1,1
4,GO NADP METABOLIC PROCESS,0.0094949,0.23526,0.23089,1,1
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.0057817,0.23523,0.22115,1,1
4,GO CELL CHEMOTAXIS,5.4121e-05,0.23498,0.20491,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0037331,0.2348,0.16313,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,5.6174e-05,0.23474,0.2129,1,1
4,GO POSITIVE REGULATION OF HEART RATE,0.004408,0.2347,0.26235,1,1
4,GO PRODUCTION OF SIRNA INVOLVED IN RNA INTERFERENCE,0.017137,0.23466,0.17654,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.0026572,0.23425,0.19942,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.00032948,0.23412,0.22688,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.014841,0.23388,0.17521,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.001986,0.23372,0.19004,1,1
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0049174,0.23362,0.23052,1,1
4,GO INTERLEUKIN 6 PRODUCTION,5.2139e-05,0.23322,0.21621,1,1
4,GO RESPONSE TO PROGESTERONE,0.011326,0.2329,0.16672,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,2.2524e-05,0.23285,0.21883,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.4609e-05,0.23268,0.2357,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.00041602,0.23263,0.19226,1,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.031059,0.23261,0.1903,1,1
4,GO GRANULOCYTE MIGRATION,0.00012074,0.23209,0.19282,1,1
4,GO EPIDERMIS DEVELOPMENT,0.00023468,0.23201,0.18835,1,1
4,GO LIPID STORAGE,0.00031859,0.23191,0.23664,1,1
4,GO FUSION OF SPERM TO EGG PLASMA MEMBRANE INVOLVED IN SINGLE FERTILIZATION,0.017969,0.2315,0.2202,1,1
4,GO DIOL METABOLIC PROCESS,0.00020448,0.23137,0.28402,1,1
4,GO CERAMIDE METABOLIC PROCESS,7.3528e-06,0.23135,0.23726,1,1
4,GO PURINE NUCLEOTIDE TRANSPORT,6.2786e-05,0.23133,0.23402,1,1
4,GO INFLAMMATORY RESPONSE,0.00010462,0.23132,0.19334,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,6.2786e-05,0.23115,0.23567,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00087311,0.23107,0.19822,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.5308e-05,0.2309,0.2463,1,1
4,GO PANCREAS DEVELOPMENT,0.0069616,0.2308,0.17536,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.00027832,0.23068,0.26256,1,1
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.027188,0.23045,0.15105,1,1
4,GO NEUTROPHIL MIGRATION,1.9263e-05,0.23035,0.19742,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.0032441,0.23034,0.22886,1,1
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.017549,0.23029,0.22808,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.007729,0.22981,0.16758,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0097392,0.22941,0.2013,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00063551,0.22939,0.31692,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.033166,0.2293,0.15848,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0012662,0.22928,0.2103,1,1
4,GO CYTOKINE PRODUCTION,0.00014935,0.22913,0.19459,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.013139,0.22913,0.17188,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.00045924,0.22905,0.25127,1,1
4,GO MEMBRANE FUSION,0.00019079,0.22901,0.18655,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.00021167,0.22884,0.23471,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00012964,0.22875,0.21291,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0013872,0.22858,0.26971,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.5759e-05,0.22834,0.28398,1,1
4,GO AMMONIUM TRANSPORT,0.020205,0.22832,0.14978,1,1
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.027803,0.22823,0.18332,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.00052342,0.22801,0.21579,1,1
4,GO TISSUE HOMEOSTASIS,6.0504e-05,0.22779,0.19461,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00079435,0.22757,0.19322,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,8.6584e-06,0.22757,0.19066,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.04854,0.22686,0.18807,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0028141,0.22668,0.2018,1,1
4,GO REGULATION OF BLOOD PRESSURE,3.4421e-05,0.22652,0.19681,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0067808,0.22641,0.17046,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.0090226,0.22609,0.30315,1,1
4,GO SKIN DEVELOPMENT,0.00034072,0.22608,0.1844,1,1
4,GO STEROL TRANSPORT,0.00036427,0.22606,0.23842,1,1
4,GO ARACHIDONIC ACID SECRETION,6.7596e-05,0.22593,0.24656,1,1
4,GO NOTCH SIGNALING PATHWAY,0.00022676,0.22557,0.19686,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00032948,0.22541,0.25473,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.00055855,0.22487,0.18447,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0032441,0.22461,0.1968,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.007729,0.22452,0.20289,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.0021689,0.22445,0.17255,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.0083534,0.22442,0.18571,1,1
4,GO INSULIN SECRETION,3.1888e-05,0.22428,0.20941,1,1
4,GO LYMPHOCYTE HOMEOSTASIS,0.00017796,0.22424,0.19882,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.00038934,0.2238,0.25548,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.03245,0.22362,0.10829,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0045306,0.22352,0.21825,1,1
4,GO ALANINE TRANSPORT,0.0085714,0.22333,0.22067,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.019283,0.22309,0.15321,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.001191,0.22307,0.20862,1,1
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00016023,0.22284,0.22225,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,7.2754e-05,0.22264,0.21171,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.1663e-05,0.22264,0.22849,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0034322,0.22244,0.15433,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00029782,0.22242,0.25947,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0025083,0.2224,0.15255,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.02068,0.22221,0.17126,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0030654,0.22209,0.19343,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,0.00019753,0.22206,0.31199,1,1
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.04854,0.22198,0.15921,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.00059588,0.22177,0.20568,1,1
4,GO REGULATION OF ACTION POTENTIAL,0.0049174,0.22166,0.19824,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0051916,0.22164,0.16287,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,3.8583e-05,0.22117,0.20692,1,1
4,GO PHAGOSOME MATURATION,0.00028792,0.22091,0.23174,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0015653,0.22082,0.18096,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00044439,0.22057,0.18158,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0017641,0.2203,0.21824,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0067808,0.22022,0.34486,1,1
4,GO RENAL SYSTEM PROCESS,0.0007696,0.21996,0.18612,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,5.508e-06,0.21996,0.24118,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,3.4421e-05,0.21988,0.2172,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,0.00049035,0.21951,0.28992,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0056288,0.21913,0.19218,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.0038387,0.21905,0.18936,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0037331,0.21878,0.15484,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00021167,0.2187,0.22266,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.00022676,0.21861,0.16557,1,1
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.030383,0.21847,0.23077,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.029719,0.2181,0.1702,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.0054795,0.21787,0.15114,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,0.00045924,0.21763,0.24669,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0014299,0.21753,0.21567,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00012964,0.21749,0.19411,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.00090094,0.2174,0.15973,1,1
4,GO COPULATION,0.014841,0.21722,0.1762,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,5.0683e-06,0.21719,0.22204,1,1
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0049174,0.21693,0.14887,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,7.3528e-06,0.21676,0.19424,1,1
4,GO DOPAMINE METABOLIC PROCESS,0.0023671,0.21649,0.26094,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0042883,0.21648,0.29442,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0040578,0.21637,0.14685,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0024367,0.21635,0.23505,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.4205e-05,0.21627,0.21883,1,1
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.026586,0.21626,0.33425,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,7.547e-05,0.21592,0.22038,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00010092,0.21588,0.22148,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,0.00092958,0.21569,0.17248,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0016129,0.21565,0.17798,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00081984,0.21486,0.2238,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00012512,0.21479,0.2114,1,1
4,GO RESPONSE TO DSRNA,0.00037661,0.21471,0.17683,1,1
4,GO NEGATIVE REGULATION OF GLUCOSE IMPORT,0.049546,0.2146,0.18082,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.0031536,0.21459,0.19712,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,5.8301e-05,0.21453,0.23144,1,1
4,GO LEUKOCYTE CHEMOTAXIS,5.0226e-05,0.21448,0.20392,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,3.8583e-05,0.21447,0.20597,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00040247,0.21419,0.18493,1,1
4,GO RESPONSE TO NUTRIENT,0.0097392,0.21411,0.13691,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.0016129,0.21398,0.20114,1,1
4,GO SODIUM ION HOMEOSTASIS,0.0027346,0.21374,0.16953,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00034072,0.21372,0.16609,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.00047456,0.21355,0.19258,1,1
4,GO ALCOHOL METABOLIC PROCESS,9.389e-05,0.21353,0.21034,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.00014935,0.2125,0.21092,1,1
4,GO RESPONSE TO BACTERIUM,0.00020448,0.21234,0.18185,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00069957,0.21209,0.17994,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,1.1964e-05,0.21204,0.25393,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.011047,0.21204,0.23446,1,1
4,GO WOUND HEALING,0.0069616,0.21192,0.13317,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.00029782,0.21132,0.2999,1,1
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0014299,0.21072,0.15011,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00095906,0.21064,0.17949,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,6.2786e-05,0.21057,0.20557,1,1
4,GO PROTEIN HYDROXYLATION,0.045624,0.2105,0.15729,1,1
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0014738,0.21049,0.17935,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.02068,0.21043,0.15291,1,1
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0060989,0.2102,0.20252,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,0.00072223,0.20998,0.25245,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.02166,0.2099,0.1402,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.0015653,0.20985,0.22239,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.044685,0.20943,0.10948,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.011904,0.20928,0.18134,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,3.8583e-05,0.20918,0.20617,1,1
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.013465,0.20903,0.13772,1,1
4,GO T CELL PROLIFERATION,0.00047456,0.20874,0.18913,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00065623,0.20836,0.21207,1,1
4,GO PROTEIN AUTOPROCESSING,0.0015653,0.20833,0.28688,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.0073363,0.20831,0.15368,1,1
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.011326,0.20829,0.20857,1,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.042857,0.20829,0.10356,1,1
4,GO PROTEIN ADP RIBOSYLATION,0.023205,0.20795,0.14414,1,1
4,GO EXOCYTOSIS,7.8282e-05,0.20795,0.18192,1,1
4,GO B CELL ACTIVATION,5.8301e-05,0.20778,0.19348,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00084609,0.20775,0.2463,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.00037661,0.20773,0.17883,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.0029794,0.20748,0.17843,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00031859,0.20739,0.19709,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.023205,0.20735,0.1706,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,6.4994e-06,0.20734,0.24236,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.013798,0.20722,0.13863,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,1.1964e-05,0.20719,0.21539,1,1
4,GO ACTIN NUCLEATION,7.013e-05,0.20704,0.19146,1,1
4,GO REGULATION OF HORMONE SECRETION,5.4121e-05,0.207,0.19387,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0049174,0.20687,0.20508,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,3.9418e-06,0.20683,0.24907,1,1
4,GO PIGMENTATION,0.0011549,0.20668,0.14029,1,1
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.02166,0.20651,0.11488,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0011199,0.2062,0.21954,1,1
4,GO CYTOKINE SECRETION,0.00016023,0.20609,0.18958,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0053338,0.20605,0.1753,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.030383,0.20602,0.15944,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,6.0504e-05,0.206,0.18938,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00041602,0.20591,0.34935,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.0071468,0.20579,0.17003,1,1
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00042998,0.20566,0.15829,1,1
4,GO MUSCLE ADAPTATION,0.0014738,0.20553,0.16703,1,1
4,GO HORMONE TRANSPORT,2.1663e-05,0.20545,0.21295,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.014138,0.2051,0.24089,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,0.00031859,0.20502,0.19545,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00049035,0.2044,0.17598,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0027346,0.20421,0.1795,1,1
4,GO WHITE FAT CELL DIFFERENTIATION,0.0071468,0.20407,0.18907,1,1
4,GO PLATELET ACTIVATION,0.00038934,0.20404,0.18701,1,1
4,GO PEPTIDE HORMONE SECRETION,2.6307e-05,0.20402,0.206,1,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0013457,0.20399,0.166,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00092958,0.20395,0.20984,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.0028957,0.20383,0.17497,1,1
4,GO RESPONSE TO METAL ION,6.7596e-05,0.20368,0.20048,1,1
4,GO REGULATION OF PEPTIDE SECRETION,5.2837e-06,0.2035,0.19439,1,1
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.038561,0.20346,0.12415,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.001872,0.20335,0.16028,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0021689,0.20328,0.17584,1,1
4,GO CELL CELL ADHESION,0.0034322,0.20323,0.1373,1,1
4,GO REGULATION OF INSULIN SECRETION,7.8282e-05,0.20308,0.19053,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0011549,0.20282,0.13334,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.0014299,0.20276,0.20718,1,1
4,GO MEMBRANE DEPOLARIZATION,0.0060989,0.20259,0.18619,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00067758,0.20245,0.16212,1,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.043763,0.2022,0.18735,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.0040578,0.20202,0.17487,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.012203,0.20188,0.16467,1,1
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.0038387,0.20175,0.2125,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.027803,0.20154,0.17487,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,5.8301e-05,0.20146,0.23191,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0018173,0.20135,0.18276,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0015653,0.20133,0.1541,1,1
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.024846,0.20132,0.17046,1,1
4,GO CELL ACTIVATION,0.00022676,0.20107,0.17065,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0073363,0.20098,0.15228,1,1
4,GO REGULATION OF PH,1.104e-05,0.20089,0.18937,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00055855,0.20087,0.22389,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0021689,0.20083,0.2189,1,1
4,GO NEUTRAL AMINO ACID TRANSPORT,0.0094949,0.2008,0.21395,1,1
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0021689,0.20075,0.15635,1,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0011549,0.20063,0.18122,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0049174,0.20059,0.14232,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,1.6455e-05,0.2001,0.24797,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.0032441,0.2,0.2231,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.03939,0.1997,0.17192,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,2.4346e-05,0.19959,0.21283,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0025083,0.19955,0.16592,1,1
4,GO DENDRITIC CELL CHEMOTAXIS,0.0060989,0.19953,0.1717,1,1
4,GO RESPONSE TO ALCOHOL,0.00063551,0.19944,0.1535,1,1
4,GO CHOLESTEROL STORAGE,0.0018173,0.19924,0.25205,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0006154,0.19917,0.2837,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00010462,0.19909,0.16978,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.0097392,0.19894,0.14249,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.023741,0.19848,0.20814,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0094949,0.19836,0.17732,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.041967,0.19816,0.12602,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0023671,0.19813,0.14799,1,1
4,GO REGULATION OF DEFENSE RESPONSE,6.2786e-05,0.19813,0.18925,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00022676,0.19806,0.19797,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.00037661,0.19761,0.16718,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0028141,0.19757,0.17226,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.025994,0.19751,0.14266,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00074557,0.19699,0.24281,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.0097392,0.19698,0.14304,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.001228,0.1968,0.14657,1,1
4,GO TRANSCYTOSIS,0.010773,0.19667,0.18863,1,1
4,GO T CELL ACTIVATION,0.00036427,0.19618,0.17033,1,1
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.0099891,0.196,0.15861,1,1
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.023741,0.196,0.16846,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00024286,0.19584,0.17703,1,1
4,GO PLASMA MEMBRANE FUSION,0.019739,0.19573,0.19402,1,1
4,GO T CELL DIFFERENTIATION,0.00019753,0.19552,0.16069,1,1
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.04854,0.19529,0.1548,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.00016595,0.1952,0.20755,1,1
4,GO REGULATION OF CELLULAR PH,1.104e-05,0.19512,0.19215,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0011549,0.1951,0.15536,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.0067808,0.19496,0.14896,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00065623,0.19479,0.1883,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.00095906,0.19458,0.15237,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0060989,0.1943,0.17141,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.7118e-05,0.19422,0.19641,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00027832,0.19414,0.17847,1,1
4,GO B CELL DIFFERENTIATION,5.4121e-05,0.19408,0.19447,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.013798,0.19404,0.19859,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0013054,0.19366,0.14737,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0041716,0.19347,0.20031,1,1
4,GO CARNITINE METABOLIC PROCESS,0.047551,0.19344,0.16941,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.00019753,0.19312,0.16064,1,1
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0056288,0.19294,0.14211,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,8.7323e-05,0.19283,0.18814,1,1
4,GO ADAPTIVE THERMOGENESIS,1.5201e-05,0.19274,0.19845,1,1
4,GO ORGANELLE FUSION,0.00026903,0.19273,0.15221,1,1
4,GO REGULATION OF APPETITE,0.0071468,0.19264,0.13044,1,1
4,GO INTERLEUKIN 4 PRODUCTION,0.03939,0.1926,0.16296,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.00013433,0.19253,0.22929,1,1
4,GO MANNOSYLATION,5.8301e-05,0.19248,0.2198,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.6455e-05,0.1923,0.22257,1,1
4,GO RENAL TUBULE DEVELOPMENT,0.012508,0.19198,0.12014,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.00020448,0.19186,0.16767,1,1
4,GO PEPTIDE SECRETION,1.349e-05,0.19183,0.19136,1,1
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.03939,0.19168,0.14159,1,1
4,GO TERPENOID METABOLIC PROCESS,0.0075304,0.19163,0.19066,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00017186,0.19155,0.17527,1,1
4,GO CARBOHYDRATE TRANSPORT,1.6455e-05,0.19146,0.22338,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.001191,0.19135,0.16018,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0006154,0.19131,0.14767,1,1
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.0022332,0.1912,0.26613,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.0016129,0.19115,0.15829,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.029068,0.19106,0.20026,1,1
4,GO RESPONSE TO CALCIUM ION,0.0011199,0.19104,0.1848,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.00036427,0.1907,0.16772,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.00036427,0.19055,0.17942,1,1
4,GO REGULATION OF HORMONE LEVELS,1.8521e-05,0.19042,0.2161,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0015653,0.1903,0.16328,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.00072223,0.19027,0.17431,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.5201e-05,0.19026,0.19674,1,1
4,GO RESPONSE TO FATTY ACID,0.0013872,0.19012,0.20075,1,1
4,GO RESPONSE TO STARVATION,1.9263e-05,0.18983,0.22746,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0075304,0.18945,0.18805,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.011047,0.18931,0.1535,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.041093,0.18926,0.15791,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.0062634,0.18895,0.20012,1,1
4,GO PROTEIN KINASE B SIGNALING,0.014138,0.18885,0.11397,1,1
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00054072,0.18858,0.29039,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.0006154,0.18855,0.14888,1,1
4,GO RESPONSE TO CHEMOKINE,0.00024286,0.18854,0.17497,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.02068,0.1885,0.169,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00020448,0.1883,0.19105,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.01282,0.18828,0.16556,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.00041602,0.18826,0.1578,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,4.8379e-05,0.18805,0.16448,1,1
4,GO RESPONSE TO STEROL,0.0083534,0.18795,0.17167,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0085714,0.18794,0.16249,1,1
4,GO HUMORAL IMMUNE RESPONSE,3.7145e-05,0.18786,0.19216,1,1
4,GO GOLGI VESICLE BUDDING,0.00032948,0.18785,0.18227,1,1
4,GO GLUTAMATE METABOLIC PROCESS,0.0028957,0.18779,0.17214,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0036303,0.18728,0.1649,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.0083534,0.18699,0.29676,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.7806e-05,0.18693,0.21475,1,1
4,GO NEUTROPHIL CHEMOTAXIS,4.8379e-05,0.18691,0.16202,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0013457,0.18686,0.14805,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.00084609,0.18679,0.14946,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,5.0226e-05,0.18661,0.17316,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,4.6597e-05,0.18656,0.17205,1,1
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.8583e-05,0.18602,0.2146,1,1
4,GO ENDOCYTIC RECYCLING,0.0050528,0.18601,0.12412,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.001228,0.186,0.2026,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,0.00023468,0.18596,0.17854,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00018427,0.18593,0.16232,1,1
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.00055855,0.18581,0.27989,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0016129,0.18551,0.16574,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.00079435,0.18551,0.19895,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.0013872,0.18541,0.16924,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0012662,0.18528,0.14451,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0013457,0.18503,0.27152,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.0014299,0.18499,0.15921,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0054795,0.18491,0.17809,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.018398,0.18478,0.14123,1,1
4,GO GOLGI RIBBON FORMATION,0.009256,0.18462,0.16491,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.029068,0.18452,0.19429,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.01282,0.1845,0.14115,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.0032441,0.18427,0.13441,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0023671,0.18413,0.1862,1,1
4,GO AUTOPHAGIC CELL DEATH,0.03245,0.18405,0.13897,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0015653,0.18392,0.15881,1,1
4,GO ACID SECRETION,0.0028141,0.18391,0.15897,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0022992,0.18382,0.15679,1,1
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.021165,0.1832,0.17797,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,0.00017796,0.18318,0.18533,1,1
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0027346,0.18297,0.14198,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.009256,0.18294,0.24837,1,1
4,GO RESPONSE TO WOUNDING,0.0099891,0.1826,0.11939,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0001547,0.18259,0.15975,1,1
4,GO VESICLE TARGETING,0.0039469,0.18238,0.17322,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.00084609,0.18226,0.18598,1,1
4,GO LYMPHOCYTE ACTIVATION,0.00065623,0.18217,0.14341,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0020453,0.18207,0.16088,1,1
4,GO XENOBIOTIC TRANSPORT,0.0087944,0.18204,0.21601,1,1
4,GO EPITHELIUM DEVELOPMENT,0.00087311,0.1815,0.13099,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0012662,0.18135,0.13915,1,1
4,GO REGULATION OF CELL ADHESION,0.0030654,0.18097,0.14474,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.01282,0.18071,0.11879,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.00019753,0.18069,0.16951,1,1
4,GO REGULATION OF GLUCONEOGENESIS,0.00016023,0.18017,0.23379,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.001228,0.17998,0.1552,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.01282,0.17996,0.18095,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0073363,0.17988,0.17434,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00030804,0.17986,0.20922,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.007729,0.17975,0.13064,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,8.4205e-05,0.17957,0.1699,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0012662,0.17942,0.15436,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.00040247,0.17936,0.13977,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.004408,0.17932,0.15885,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0021689,0.17898,0.1767,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,0.00095906,0.17881,0.16877,1,1
4,GO VACUOLE ORGANIZATION,1.6455e-05,0.17877,0.20288,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00044439,0.17874,0.15218,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0056288,0.17829,0.21699,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0050528,0.17819,0.19669,1,1
4,GO RESPONSE TO KETONE,0.0026572,0.17806,0.15387,1,1
4,GO ORGANELLE INHERITANCE,0.001662,0.17796,0.15382,1,1
4,GO OXALATE TRANSPORT,0.0099891,0.17778,0.15734,1,1
4,GO MANGANESE ION TRANSPORT,0.0038387,0.17775,0.18369,1,1
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.022165,0.17769,0.12716,1,1
4,GO DNA DEMETHYLATION,0.043763,0.17768,0.14128,1,1
4,GO RESPONSE TO GONADOTROPIN,0.0030654,0.17764,0.19624,1,1
4,GO LIPID METABOLIC PROCESS,0.00010092,0.17747,0.16875,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.015953,0.17736,0.152,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.001228,0.17726,0.17165,1,1
4,GO LIPID HOMEOSTASIS,0.0010528,0.17723,0.2047,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0047853,0.17713,0.18523,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0011199,0.17694,0.13767,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00040247,0.17685,0.18628,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0007696,0.17684,0.14757,1,1
4,GO FLUID TRANSPORT,0.0021689,0.17674,0.1531,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.00023468,0.17662,0.15197,1,1
4,GO ORGANIC ANION TRANSPORT,3.3132e-05,0.17644,0.17159,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.013139,0.17599,0.21056,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.0010859,0.1759,0.12325,1,1
4,GO SENSORY PERCEPTION OF TASTE,0.0028957,0.1757,0.14767,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,5.2837e-06,0.17553,0.19937,1,1
4,GO SPLEEN DEVELOPMENT,0.0041716,0.17525,0.18288,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.001986,0.17518,0.14344,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.0034322,0.17518,0.26321,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0014299,0.17517,0.21258,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.00050664,0.17515,0.1419,1,1
4,GO FATTY ACID TRANSPORT,0.00016023,0.17513,0.1883,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0011549,0.1745,0.15355,1,1
4,GO CHLORIDE TRANSPORT,0.00054072,0.17432,0.14709,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0026572,0.17431,0.21316,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.0006154,0.17424,0.16221,1,1
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.00081984,0.17421,0.16093,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,0.00042998,0.17402,0.18957,1,1
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.010773,0.17389,0.15927,1,1
4,GO TRANSITION METAL ION HOMEOSTASIS,0.014138,0.17374,0.12028,1,1
4,GO LIPID OXIDATION,0.0019282,0.17365,0.15698,1,1
4,GO AMYLOID BETA FORMATION,0.050569,0.17283,0.11975,1,1
4,GO PROTEIN PROCESSING,3.0689e-05,0.17264,0.22376,1,1
4,GO REGULATION OF HEMOPOIESIS,0.00042998,0.17241,0.14262,1,1
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.020205,0.17231,0.10975,1,1
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00028792,0.17203,0.16016,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.010773,0.17188,0.15235,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0059384,0.17184,0.15485,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.00038934,0.17178,0.17168,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.00090094,0.17169,0.13974,1,1
4,GO RESPONSE TO ETHER,0.0037331,0.17168,0.17425,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.04854,0.17159,0.1386,1,1
4,GO OOCYTE DIFFERENTIATION,0.00079435,0.1715,0.15171,1,1
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.011904,0.17147,0.16633,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.0046564,0.17137,0.20634,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00028792,0.17136,0.15466,1,1
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0032441,0.17106,0.16196,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00012512,0.17099,0.1769,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,3.1888e-05,0.17095,0.19048,1,1
4,GO T CELL HOMEOSTASIS,0.0039469,0.17089,0.13863,1,1
4,GO METAL ION HOMEOSTASIS,0.00055855,0.17073,0.1263,1,1
4,GO MUSCLE CELL MIGRATION,0.03939,0.17063,0.11452,1,1
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.0090226,0.17053,0.13949,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0018173,0.16968,0.15187,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.018398,0.1694,0.12638,1,1
4,GO CELLULAR PIGMENTATION,0.0026572,0.16927,0.13973,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.0001165,0.16914,0.19264,1,1
4,GO RESPONSE TO FUNGUS,0.00029782,0.16914,0.17135,1,1
4,GO PROTEIN MATURATION,7.8282e-05,0.16908,0.17632,1,1
4,GO REGULATION OF TUBE SIZE,0.0033369,0.16833,0.1439,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00019079,0.16827,0.15236,1,1
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.042857,0.16805,0.14392,1,1
4,GO REGULATION OF LIPID STORAGE,0.00098941,0.16778,0.19519,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00026903,0.16766,0.17829,1,1
4,GO METANEPHROS MORPHOGENESIS,0.043763,0.16654,0.14584,1,1
4,GO BIOLOGICAL ADHESION,0.015953,0.16627,0.10265,1,1
4,GO PLATELET MORPHOGENESIS,0.013798,0.16624,0.16275,1,1
4,GO HEPATOCYTE DIFFERENTIATION,0.026586,0.16589,0.19328,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,3.8583e-05,0.16586,0.19448,1,1
4,GO IRON ION TRANSPORT,0.00050664,0.16581,0.18456,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.041093,0.1658,0.13421,1,1
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.016339,0.16562,0.14078,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.02166,0.16558,0.17593,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.014138,0.16549,0.15014,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.00069957,0.16518,0.15543,1,1
4,GO POSITIVE REGULATION OF SECRETION,4.4878e-05,0.16504,0.1828,1,1
4,GO RESPONSE TO ALKALOID,0.0067808,0.16471,0.1377,1,1
4,GO OXIDATION REDUCTION PROCESS,0.00036427,0.16414,0.16467,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,0.00059588,0.16398,0.18907,1,1
4,GO LIPID CATABOLIC PROCESS,7.013e-05,0.16389,0.20246,1,1
4,GO COPII COATED VESICLE BUDDING,0.00065623,0.16384,0.16742,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.00020448,0.1628,0.15162,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0073363,0.16255,0.10994,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.001228,0.16231,0.13002,1,1
4,GO LIPID EXPORT FROM CELL,0.0081404,0.16154,0.21727,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,1.8521e-05,0.16108,0.19477,1,1
4,GO LEUKOCYTE HOMEOSTASIS,0.007729,0.16106,0.12406,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.00059588,0.16093,0.15359,1,1
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0087944,0.16089,0.15454,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,8.7323e-05,0.16086,0.14835,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0030654,0.16086,0.12729,1,1
4,GO GLUCOSE METABOLIC PROCESS,1.4039e-05,0.1608,0.20042,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0067808,0.16061,0.13862,1,1
4,GO ION HOMEOSTASIS,0.00047456,0.1603,0.12611,1,1
4,GO NEPHRON DEVELOPMENT,0.019739,0.16027,0.099648,1,1
4,GO TEMPERATURE HOMEOSTASIS,0.00016023,0.16014,0.16448,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,0.00074557,0.15972,0.19656,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00057693,0.15968,0.16802,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.009256,0.15935,0.22831,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0031536,0.15931,0.12393,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,2.6307e-05,0.15903,0.15445,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,8.4205e-05,0.1589,0.19989,1,1
4,GO VITAMIN METABOLIC PROCESS,0.0099891,0.15875,0.18514,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.014138,0.1584,0.1752,1,1
4,GO ENDOTHELIAL CELL MIGRATION,0.0083534,0.15829,0.14271,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00037661,0.15824,0.14357,1,1
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.035393,0.15789,0.21304,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0011549,0.15774,0.14126,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00052342,0.15734,0.21761,1,1
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.027803,0.15731,0.11324,1,1
4,GO DETECTION OF STIMULUS,0.00013433,0.15724,0.12575,1,1
4,GO SECRETION,7.8282e-05,0.1571,0.15959,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0012662,0.15669,0.15411,1,1
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.014841,0.15664,0.23646,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.00025131,0.15649,0.13162,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00034072,0.15638,0.17874,1,1
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0020453,0.15634,0.14926,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.024288,0.15589,0.13972,1,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.015203,0.15588,0.12992,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.00016023,0.15567,0.20275,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.0050528,0.15555,0.16013,1,1
4,GO LYSOSOME LOCALIZATION,0.00050664,0.1555,0.16659,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.011326,0.15522,0.1227,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.013465,0.15482,0.1699,1,1
4,GO PROSTAGLANDIN SECRETION,0.0064317,0.15479,0.21813,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.0016129,0.15478,0.13396,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0012662,0.15467,0.12954,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.014841,0.15457,0.10964,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0026572,0.15452,0.13839,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.011612,0.15431,0.1098,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0022992,0.15419,0.11227,1,1
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.0056288,0.1541,0.14161,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.00069957,0.15403,0.158,1,1
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.0064317,0.15396,0.14402,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.024846,0.15384,0.12213,1,1
4,GO RESPONSE TO LIPID,0.0042883,0.15363,0.11709,1,1
4,GO CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS,0.043763,0.15337,0.17543,1,1
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0033369,0.15329,0.14037,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.00038934,0.15324,0.15535,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00030804,0.15292,0.18209,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00069957,0.15273,0.18939,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.00013917,0.15252,0.1707,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0073363,0.15247,0.13685,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00029782,0.15233,0.15258,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.0047853,0.15193,0.16279,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,7.2754e-05,0.15192,0.16055,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00013917,0.15186,0.16045,1,1
4,GO ESTROGEN BIOSYNTHETIC PROCESS,0.040234,0.15155,0.2175,1,1
4,GO GLAND DEVELOPMENT,0.0018173,0.15138,0.12215,1,1
4,GO MYELOID CELL DEVELOPMENT,0.0062634,0.15135,0.12327,1,1
4,GO DRUG METABOLIC PROCESS,0.0022992,0.15134,0.26866,1,1
4,GO CALCIUM ION IMPORT,0.010773,0.15116,0.11767,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.011326,0.15079,0.11237,1,1
4,GO AGING,0.0021062,0.15045,0.10476,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.0066042,0.15042,0.1128,1,1
4,GO ANION TRANSPORT,5.2139e-05,0.1504,0.15662,1,1
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.010245,0.15022,0.14088,1,1
4,GO CHEMICAL HOMEOSTASIS,7.8282e-05,0.15018,0.15156,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.036164,0.15009,0.1667,1,1
4,GO KILLING OF CELLS OF OTHER ORGANISM,9.0551e-05,0.14959,0.19658,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.041093,0.14955,0.12191,1,1
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00025131,0.14919,0.13782,1,1
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.041967,0.14913,0.22608,1,1
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0054795,0.14908,0.19891,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0010528,0.14898,0.16896,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00034072,0.14891,0.14844,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.0057817,0.14877,0.10896,1,1
4,GO TRANSLESION SYNTHESIS,0.0090226,0.14872,0.11187,1,1
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.0090226,0.14839,0.15428,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00026903,0.1483,0.17141,1,1
4,GO RESPONSE TO ANTIBIOTIC,0.0067808,0.14808,0.1438,1,1
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0013872,0.148,0.14706,1,1
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0075304,0.14791,0.11455,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,0.00028792,0.14785,0.15747,1,1
4,GO RESPONSE TO DRUG,0.0053338,0.14765,0.11889,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0066042,0.14747,0.209,1,1
4,GO FATTY ACID BETA OXIDATION,0.010506,0.14678,0.14845,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00049035,0.14675,0.13285,1,1
4,GO REGULATION OF LIPID TRANSPORT,0.0011549,0.14636,0.19867,1,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.010773,0.14628,0.12077,1,1
4,GO RUFFLE ORGANIZATION,0.0094949,0.14625,0.14866,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.040234,0.14581,0.14646,1,1
4,GO DEFINITIVE HEMOPOIESIS,0.036164,0.14577,0.14006,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.0023671,0.14544,0.15721,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.00079435,0.14543,0.13495,1,1
4,GO GLUCOSE IMPORT,0.0066042,0.14521,0.14376,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0010206,0.145,0.18618,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.045624,0.14423,0.11302,1,1
4,GO NEGATIVE REGULATION OF STEROL TRANSPORT,0.021165,0.14413,0.30926,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0053338,0.1441,0.13166,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.0087944,0.14399,0.13839,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.024846,0.14366,0.12057,1,1
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0046564,0.14363,0.11648,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0079323,0.14343,0.19963,1,1
4,GO EPITHELIAL CELL PROLIFERATION,0.013465,0.14336,0.10493,1,1
4,GO CELL MATURATION,0.00092958,0.14327,0.13425,1,1
4,GO ORGANIC ACID TRANSPORT,0.00013433,0.14295,0.16245,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.023205,0.14236,0.10657,1,1
4,GO RESPONSE TO ISCHEMIA,0.004408,0.14219,0.17136,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.4121e-05,0.14201,0.14958,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.012508,0.14179,0.16513,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0038387,0.1417,0.14956,1,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0038387,0.14132,0.13922,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0015653,0.14075,0.11219,1,1
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0026572,0.14063,0.14389,1,1
4,GO PROTEIN DESTABILIZATION,0.00081984,0.14054,0.15665,1,1
4,GO BIOMINERALIZATION,0.0099891,0.14021,0.12566,1,1
4,GO RETINA HOMEOSTASIS,0.02068,0.14015,0.077789,1,1
4,GO RESPONSE TO HORMONE,0.0024367,0.13995,0.12025,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0067808,0.13984,0.15511,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0087944,0.13977,0.12329,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0059384,0.13952,0.10706,1,1
4,GO RESPONSE TO ETHANOL,0.020205,0.13943,0.099385,1,1
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.041967,0.13928,0.096282,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.0067808,0.13913,0.15554,1,1
4,GO REGULATION OF ANION TRANSPORT,0.0018173,0.13904,0.18437,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0041716,0.13884,0.13695,1,1
4,GO VESICLE ORGANIZATION,0.00090094,0.13864,0.14308,1,1
4,GO DEVELOPMENTAL INDUCTION,0.045624,0.13853,0.10448,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0090226,0.13785,0.1084,1,1
4,GO REGULATION OF CHEMOTAXIS,0.0081404,0.13767,0.10265,1,1
4,GO RESPONSE TO STEROID HORMONE,0.007729,0.13764,0.11625,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.015574,0.13763,0.10944,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00067758,0.1376,0.16068,1,1
4,GO MAMMARY GLAND DEVELOPMENT,0.017969,0.13759,0.10116,1,1
4,GO CELL MOTILITY,0.020205,0.13753,0.087434,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0007696,0.13752,0.1265,1,1
4,GO REGULATION OF CELL MATURATION,0.036164,0.13751,0.11355,1,1
4,GO REGULATION OF SECRETION,0.00019753,0.13735,0.14742,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0026572,0.13694,0.11902,1,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.049546,0.13688,0.097974,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00098941,0.13683,0.12747,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0032441,0.13669,0.13645,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.029068,0.13654,0.16179,1,1
4,GO PROTEIN MANNOSYLATION,0.023741,0.13642,0.1363,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.0036303,0.136,0.10588,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0001547,0.13595,0.15567,1,1
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.045624,0.13575,0.12141,1,1
4,GO TISSUE MIGRATION,0.0085714,0.13569,0.1304,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.0016129,0.13554,0.10943,1,1
4,GO ORGANIC ACID CATABOLIC PROCESS,0.0059384,0.13549,0.15249,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.019283,0.13528,0.12306,1,1
4,GO EXOCYTIC PROCESS,0.013465,0.13513,0.15748,1,1
4,GO RESPONSE TO INSULIN,0.00031859,0.13491,0.1595,1,1
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.014841,0.13474,0.14236,1,1
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.017969,0.13469,0.15001,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.00028792,0.13427,0.10945,1,1
4,GO ALCOHOL CATABOLIC PROCESS,0.013465,0.13404,0.1401,1,1
4,GO ORGANELLE DISASSEMBLY,0.0007696,0.13402,0.13071,1,1
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.026586,0.13399,0.087039,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.023205,0.13327,0.093682,1,1
4,GO NCRNA CATABOLIC PROCESS,0.029719,0.13308,0.11137,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.016734,0.13298,0.10694,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.010773,0.13292,0.12939,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.0079323,0.13278,0.13289,1,1
4,GO RESPONSE TO MONOSACCHARIDE,0.0020453,0.13261,0.13995,1,1
4,GO REGULATION OF ION TRANSPORT,0.015203,0.13231,0.097897,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.049546,0.1322,0.10215,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.035393,0.13191,0.12939,1,1
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0094949,0.13189,0.10568,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0025817,0.13176,0.11367,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0073363,0.13161,0.14436,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0026572,0.13153,0.11197,1,1
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.027803,0.13137,0.12985,1,1
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.023741,0.13127,0.095453,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.0019282,0.13087,0.11575,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00067758,0.13065,0.21538,1,1
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.010506,0.13064,0.14195,1,1
4,GO T CELL SELECTION,0.0027346,0.13011,0.12246,1,1
4,GO SODIUM ION TRANSPORT,0.010506,0.12984,0.11229,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.046579,0.1296,0.13044,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0087944,0.12957,0.11419,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00092958,0.12927,0.14396,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.030383,0.12917,0.082688,1,1
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.037747,0.12916,0.082482,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00063551,0.12912,0.12273,1,1
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.02843,0.12908,0.079651,1,1
4,GO SOMITOGENESIS,0.0032441,0.12902,0.11971,1,1
4,GO ORGANIC ACID METABOLIC PROCESS,0.0021689,0.12884,0.13878,1,1
4,GO CELLULAR RESPONSE TO LIPID,0.011612,0.1285,0.10192,1,1
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.03939,0.1283,0.16597,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.0097392,0.12816,0.13302,1,1
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0045306,0.1279,0.10217,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0060989,0.12762,0.10914,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.015953,0.12741,0.091466,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0036303,0.12725,0.13085,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.00059588,0.12719,0.10473,1,1
4,GO INORGANIC ANION TRANSPORT,0.00054072,0.12715,0.12587,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,2.7343e-05,0.1271,0.14044,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.018836,0.12678,0.16117,1,1
4,GO PEROXISOME ORGANIZATION,0.0054795,0.12669,0.15692,1,1
4,GO RESPONSE TO IRON ION,0.046579,0.1265,0.11985,1,1
4,GO GOLGI ORGANIZATION,0.00032948,0.12648,0.13429,1,1
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0041716,0.12609,0.12418,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,6.5149e-05,0.12542,0.14417,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0067808,0.12494,0.12605,1,1
4,GO MACROPHAGE ACTIVATION,0.0039469,0.12492,0.12025,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0042883,0.12491,0.093536,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00045924,0.12473,0.13082,1,1
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0067808,0.12464,0.10194,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.010245,0.1241,0.096647,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0025083,0.12409,0.12127,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.031748,0.12369,0.10241,1,1
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0042883,0.12349,0.10476,1,1
4,GO PROTEOLYSIS,0.00032948,0.1234,0.12133,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,9.7346e-05,0.12337,0.14883,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00095906,0.12317,0.1173,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.049546,0.12311,0.090766,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.00026903,0.12308,0.15113,1,1
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00030804,0.12298,0.1327,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0050528,0.12265,0.095145,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0007696,0.1223,0.10939,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.041967,0.12226,0.081057,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0038387,0.12221,0.12646,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0025817,0.12205,0.12245,1,1
4,GO REGULATION OF CELL DEATH,0.0034322,0.12113,0.094614,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.011047,0.1211,0.18363,1,1
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.0017641,0.12096,0.15369,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0020453,0.12078,0.11719,1,1
4,GO TRANSITION METAL ION TRANSPORT,0.00047456,0.12063,0.1679,1,1
4,GO EXCRETION,0.018836,0.12047,0.10822,1,1
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.045624,0.12006,0.1317,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.0033369,0.11977,0.10836,1,1
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.00353,0.11971,0.10522,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.036948,0.1194,0.080528,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.0032441,0.11933,0.13212,1,1
4,GO INTERFERON GAMMA PRODUCTION,0.016734,0.11926,0.11483,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.007729,0.11912,0.13768,1,1
4,GO HOMEOSTATIC PROCESS,0.00010092,0.11897,0.12296,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0097392,0.11863,0.1225,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.010773,0.11847,0.12511,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0050528,0.11837,0.12113,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0017641,0.11831,0.16849,1,1
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.001872,0.1183,0.12232,1,1
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.0013054,0.11824,0.1317,1,1
4,GO SIGNAL RELEASE,0.0012662,0.11786,0.13863,1,1
4,GO SINGLE FERTILIZATION,0.027188,0.11785,0.079469,1,1
4,GO REGULATION OF TOR SIGNALING,0.00038934,0.1169,0.12544,1,1
4,GO FAT CELL DIFFERENTIATION,0.0064317,0.11682,0.13137,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0073363,0.11669,0.10422,1,1
4,GO TOR SIGNALING,8.1192e-05,0.11657,0.11356,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0032441,0.11617,0.1538,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0014738,0.11608,0.10907,1,1
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0034322,0.11591,0.11432,1,1
4,GO RESPONSE TO PEPTIDE,0.001986,0.11585,0.10932,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.04854,0.11538,0.072649,1,1
4,GO PEROXISOMAL TRANSPORT,0.0042883,0.11536,0.16911,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.049546,0.11515,0.073615,1,1
4,GO LIPID MODIFICATION,0.0021689,0.11492,0.11888,1,1
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.011612,0.11474,0.12942,1,1
4,GO POLYOL METABOLIC PROCESS,0.0083534,0.11467,0.10806,1,1
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.0015189,0.11369,0.11417,1,1
4,GO MESONEPHROS DEVELOPMENT,0.029068,0.11352,0.10347,1,1
4,GO APOPTOTIC PROCESS,0.0025817,0.11327,0.096113,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0038387,0.11315,0.098446,1,1
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.02068,0.11274,0.098954,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.042857,0.11268,0.1222,1,1
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00034072,0.1124,0.15713,1,1
4,GO DNA CATABOLIC PROCESS,0.001228,0.11206,0.12079,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.025414,0.11186,0.085991,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.009256,0.11184,0.11613,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.001228,0.1114,0.12133,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0011549,0.11135,0.099732,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.0047853,0.11083,0.13433,1,1
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.011047,0.11075,0.095757,1,1
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0073363,0.11049,0.10685,1,1
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.013465,0.10959,0.085323,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.015574,0.10952,0.12599,1,1
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0019282,0.10928,0.14722,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.0010528,0.1089,0.10618,1,1
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.025994,0.10885,0.063079,1,1
4,GO MELANOCYTE DIFFERENTIATION,0.02268,0.10875,0.13186,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.0022992,0.1086,0.10593,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0046564,0.1081,0.092075,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.0049174,0.1081,0.10948,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0087944,0.10803,0.13349,1,1
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.02268,0.10796,0.1113,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.045624,0.1077,0.15189,1,1
4,GO T CELL LINEAGE COMMITMENT,0.0062634,0.10749,0.13696,1,1
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.036164,0.10739,0.10896,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.046579,0.1073,0.10784,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0013457,0.10717,0.14001,1,1
4,GO TRANSMEMBRANE TRANSPORT,0.00040247,0.10589,0.12032,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00032948,0.10567,0.12002,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.033166,0.10543,0.14164,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00038934,0.10537,0.12055,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.034637,0.10537,0.11121,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.007729,0.10522,0.076944,1,1
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.045624,0.10511,0.10084,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00042998,0.10491,0.13383,1,1
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.036948,0.10401,0.087787,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.011326,0.10338,0.096446,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0022992,0.10324,0.10656,1,1
4,GO BICARBONATE TRANSPORT,0.050569,0.10256,0.10752,1,1
4,GO MEMBRANE ORGANIZATION,0.009256,0.10241,0.083839,1,1
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0067808,0.10236,0.1119,1,1
4,GO CELLULAR HOMEOSTASIS,0.0025083,0.10195,0.10002,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.019739,0.10168,0.089871,1,1
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.029719,0.10167,0.1007,1,1
4,GO REGULATION OF MAPK CASCADE,0.013798,0.1014,0.094124,1,1
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.0054795,0.10138,0.10915,1,1
4,GO ION TRANSPORT,0.00047456,0.10064,0.12649,1,1
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.038561,0.10019,0.094296,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0025083,0.099903,0.10129,1,1
4,GO CIRCADIAN RHYTHM,0.0054795,0.099818,0.098372,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.014138,0.099547,0.12048,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.018398,0.099182,0.082753,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.0030654,0.09904,0.1035,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0033369,0.097975,0.11991,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.020205,0.096847,0.15046,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0038387,0.096835,0.099624,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.0075304,0.096699,0.091186,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.02268,0.096581,0.080264,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.0073363,0.096524,0.09629,1,1
4,GO METAL ION TRANSPORT,0.007729,0.096367,0.0929,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0099891,0.096187,0.081362,1,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.038561,0.095438,0.074877,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00353,0.095366,0.091816,1,1
4,GO ANATOMICAL STRUCTURE MATURATION,0.010506,0.095022,0.092088,1,1
4,GO DNA MODIFICATION,0.0069616,0.094687,0.074566,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0041716,0.092739,0.095785,1,1
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0021062,0.092432,0.10266,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.027803,0.091679,0.078144,1,1
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.041093,0.091455,0.069461,1,1
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.0097392,0.089909,0.081321,1,1
4,GO JNK CASCADE,0.017549,0.089573,0.090823,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.009256,0.089201,0.10085,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.013465,0.089066,0.085966,1,1
4,GO MALE SEX DIFFERENTIATION,0.02268,0.088778,0.097393,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.03939,0.08751,0.074076,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.041093,0.087265,0.07838,1,1
4,GO REPRODUCTION,0.018398,0.086817,0.071802,1,1
4,GO BLASTOCYST DEVELOPMENT,0.004408,0.085403,0.10064,1,1
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.049546,0.085321,0.082213,1,1
4,GO REGULATION OF EXOCYTOSIS,0.024846,0.085234,0.11072,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.018398,0.08523,0.068437,1,1
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0094949,0.084985,0.084216,1,1
4,GO BODY FLUID SECRETION,0.045624,0.084793,0.062805,1,1
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.016339,0.084518,0.074193,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.023741,0.084164,0.074253,1,1
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.017549,0.083862,0.13992,1,1
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.050569,0.083825,0.061175,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0028957,0.083385,0.10251,1,1
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.03245,0.083285,0.07088,1,1
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.025994,0.082209,0.071748,1,1
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.010506,0.081893,0.076432,1,1
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0036303,0.081426,0.12236,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.0079323,0.081327,0.084358,1,1
4,GO MULTI ORGANISM PROCESS,0.041967,0.080565,0.060429,1,1
4,GO REGULATION OF TRANSPORT,0.0034322,0.079877,0.087344,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0079323,0.079849,0.095202,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.009256,0.079799,0.080505,1,1
4,GO POLYOL CATABOLIC PROCESS,0.038561,0.078533,0.11094,1,1
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.031748,0.078139,0.087839,1,1
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.029068,0.077553,0.084918,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.013139,0.077203,0.0743,1,1
4,GO FERTILIZATION,0.024846,0.077036,0.072147,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.036948,0.076406,0.082766,1,1
4,GO POSITIVE REGULATION OF NEURON DEATH,0.041093,0.076092,0.10441,1,1
4,GO CYTOSOLIC TRANSPORT,0.023205,0.075814,0.066296,1,1
4,GO SOMITE DEVELOPMENT,0.043763,0.075568,0.079013,1,1
4,GO MITOCHONDRIAL TRANSPORT,0.0085714,0.075283,0.070835,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.0040578,0.074362,0.09345,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.018398,0.074131,0.068922,1,1
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.0054795,0.074061,0.080255,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.02166,0.073864,0.083864,1,1
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.0066042,0.072518,0.087836,1,1
4,GO VESICLE LOCALIZATION,0.038561,0.071559,0.071776,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.02843,0.071015,0.064473,1,1
4,GO DNA METHYLATION OR DEMETHYLATION,0.024288,0.070618,0.079779,1,1
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.035393,0.069874,0.064537,1,1
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.007729,0.067621,0.080019,1,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.036948,0.066874,0.064042,1,1
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.040234,0.066057,0.061776,1,1
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.017549,0.06582,0.10968,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.031059,0.063888,0.094619,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.04854,0.057917,0.070558,1,1
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.022165,0.056875,0.072276,1,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.043763,0.055215,0.05323,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.030383,0.054742,0.10365,1,1
4,GO INTRACELLULAR TRANSPORT,0.010245,0.054562,0.051944,1,1
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.012508,0.051948,0.069955,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.034637,0.05034,0.050375,1,1
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.04854,0.046188,0.044175,1,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,3.8583e-05,0.71711,0.828,1,1
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00026903,0.59301,0.47626,1,1
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00081984,0.5738,0.4844,1,1
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,7.3528e-06,0.55173,0.50397,1,1
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00055855,0.43354,0.46665,1,1
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,9.0179e-06,0.42961,0.42742,1,1
5,GO RESPONSE TO FORSKOLIN,0.014486,0.35977,0.25759,1,1
5,GO COMMISSURAL NEURON AXON GUIDANCE,0.0094949,0.3463,0.27041,1,1
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0049174,0.34268,0.397,1,1
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.001986,0.32964,0.3051,1,1
5,GO ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT,4.1617e-05,0.30278,0.46926,1,1
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.0053338,0.29799,0.38862,1,1
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.00037661,0.26723,0.24408,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.0018173,0.25473,0.3535,1,1
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.027188,0.24932,0.23695,1,1
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.0022332,0.247,0.21158,1,1
5,GO DENDRITE SELF AVOIDANCE,0.023741,0.24466,0.17606,1,1
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00052342,0.24398,0.2661,1,1
5,GO ESTROUS CYCLE,0.018836,0.24131,0.20464,1,1
5,GO MRNA SPLICE SITE SELECTION,0.0001165,0.23498,0.25552,1,1
5,GO GAMMA DELTA T CELL DIFFERENTIATION,0.010773,0.23068,0.3588,1,1
5,GO GDP METABOLIC PROCESS,0.011326,0.22497,0.22945,1,1
5,GO MEGAKARYOCYTE DEVELOPMENT,0.012508,0.22226,0.22609,1,1
5,GO V D J RECOMBINATION,0.0046564,0.21886,0.2243,1,1
5,GO NEURON PROJECTION ARBORIZATION,0.021165,0.21442,0.17263,1,1
5,GO HISTONE H4 K16 ACETYLATION,7.8282e-05,0.20893,0.21089,1,1
5,GO SYNAPTIC VESICLE CLUSTERING,0.042857,0.20768,0.33913,1,1
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0046564,0.20246,0.17198,1,1
5,GO DENDRITIC TRANSPORT,0.007729,0.20026,0.20904,1,1
5,GO VIRAL LATENCY,0.0081404,0.19322,0.17617,1,1
5,GO HISTONE H2A MONOUBIQUITINATION,0.00016595,0.19233,0.21534,1,1
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.017549,0.18901,0.21401,1,1
5,GO GENETIC IMPRINTING,0.0012662,0.18716,0.20529,1,1
5,GO CELL JUNCTION MAINTENANCE,0.037747,0.18624,0.161,1,1
5,GO KINETOCHORE ORGANIZATION,0.016339,0.18291,0.15913,1,1
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.02268,0.17925,0.17599,1,1
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.0062634,0.17748,0.14946,1,1
5,GO KINETOCHORE ASSEMBLY,0.041093,0.1759,0.12592,1,1
5,GO HISTONE H4 K5 ACETYLATION,0.00010462,0.17219,0.22548,1,1
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.031059,0.16964,0.13941,1,1
5,GO MITOTIC DNA REPLICATION CHECKPOINT,0.04854,0.1694,0.10903,1,1
5,GO CHROMATIN REMODELING AT CENTROMERE,0.0097392,0.16714,0.15189,1,1
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.0015653,0.1671,0.16335,1,1
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.044685,0.16553,0.15291,1,1
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.025994,0.16508,0.25425,1,1
5,GO NEURAL NUCLEUS DEVELOPMENT,0.041967,0.1635,0.16092,1,1
5,GO ACROSOME ASSEMBLY,0.017137,0.16188,0.13813,1,1
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.00055855,0.15959,0.1543,1,1
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.012203,0.15797,0.14695,1,1
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.0053338,0.15466,0.13497,1,1
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.001662,0.15423,0.15463,1,1
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0059384,0.15217,0.1905,1,1
5,GO MAINTENANCE OF ORGANELLE LOCATION,0.0079323,0.14562,0.10486,1,1
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.0047853,0.1445,0.18168,1,1
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0019282,0.1411,0.1773,1,1
5,GO MITOTIC SISTER CHROMATID COHESION,0.0057817,0.14086,0.1684,1,1
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.020205,0.13962,0.1506,1,1
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.031748,0.13771,0.11518,1,1
5,GO HISTONE H2A UBIQUITINATION,0.0040578,0.13737,0.13416,1,1
5,GO DOSAGE COMPENSATION,0.0042883,0.13736,0.11924,1,1
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.016734,0.13727,0.10569,1,1
5,GO HISTONE H2A ACETYLATION,0.0036303,0.13688,0.15157,1,1
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.020205,0.13621,0.16052,1,1
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.0011199,0.13517,0.13284,1,1
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.014841,0.13186,0.11375,1,1
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.011904,0.13153,0.11306,1,1
5,GO CENTROMERE COMPLEX ASSEMBLY,0.01282,0.13144,0.13913,1,1
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.007729,0.13119,0.17365,1,1
5,GO RESPONSE TO HYDROXYUREA,0.021165,0.13004,0.1752,1,1
5,GO DNA DEMETHYLATION,0.045624,0.12979,0.097415,1,1
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0071468,0.12909,0.15138,1,1
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0029794,0.12899,0.11187,1,1
5,GO REGULATION OF CILIUM ASSEMBLY,0.021165,0.12858,0.10028,1,1
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.0022332,0.1282,0.25741,1,1
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.025414,0.12794,0.081035,1,1
5,GO HISTONE H3 K9 ACETYLATION,0.046579,0.12603,0.081236,1,1
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0062634,0.12444,0.12691,1,1
5,GO CENTRIOLE ASSEMBLY,0.017549,0.12441,0.095982,1,1
5,GO CENTROSOME DUPLICATION,0.0057817,0.12346,0.12014,1,1
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0011549,0.11827,0.11967,1,1
5,GO HISTONE H4 ACETYLATION,0.00030804,0.11655,0.12401,1,1
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.015203,0.11285,0.11776,1,1
5,GO HISTONE MONOUBIQUITINATION,0.001191,0.11174,0.12161,1,1
5,GO PEPTIDYL LYSINE ACETYLATION,0.00042998,0.10762,0.091799,1,1
5,GO G0 TO G1 TRANSITION,0.0071468,0.10607,0.12393,1,1
5,GO RETROGRADE AXONAL TRANSPORT,0.027803,0.10533,0.15888,1,1
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.013798,0.10315,0.077813,1,1
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.020205,0.10143,0.098535,1,1
5,GO PROTEIN ACETYLATION,0.0020453,0.091896,0.069289,1,1
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.0097392,0.085892,0.10077,1,1
5,GO MICROTUBULE ANCHORING AT CENTROSOME,0.027803,0.085188,0.12583,1,1
5,GO POSITIVE REGULATION OF DNA REPAIR,0.0060989,0.084598,0.09676,1,1
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.013139,0.084265,0.070203,1,1
5,GO HISTONE UBIQUITINATION,0.021165,0.083672,0.072801,1,1
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.023205,0.082585,0.10439,1,1
5,GO REGULATION OF PROTEIN ACETYLATION,0.03245,0.080598,0.071103,1,1
5,GO RECOMBINATIONAL REPAIR,0.025994,0.079086,0.060864,1,1
5,GO INTERSTRAND CROSS LINK REPAIR,0.010506,0.077163,0.084542,1,1
5,GO CHROMOSOME SEGREGATION,0.047551,0.066098,0.049536,1,1
5,GO PEPTIDYL LYSINE MODIFICATION,0.044685,0.066025,0.041951,1,1
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.013139,0.064359,0.088364,1,1
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.050569,0.058823,0.064583,1,1
5,GO SISTER CHROMATID SEGREGATION,0.03245,0.055683,0.064028,1,1
5,GO PROTEIN MONOUBIQUITINATION,0.044685,0.055354,0.055601,1,1
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.02068,0.052939,0.065073,1,1
5,GO CELL CYCLE CHECKPOINT,0.03245,0.044776,0.050233,1,1
